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ABSTRACT 
Plants employ a complex network of signaling pathways to regulate 
developmental processes and to mediate the responses to both environmental and 
biological stress factors. Ethylene is one of the key plant hormones involved in 
controlling this network, which has made it and its signaling pathway a target of intense 
research for several decades. In the model plant Arabidopsis thaliana, the plant hormone 
is detected by a group of five receptors (ETR1, ERS1, ETR2, ERS2 and EIN4) that 
resemble the sensor histidine kinases of bacterial two-component system. The main aim 
in this thesis study was the expression and purification of the full-length ETR1 for 
structural studies to gain insights into the initial steps in ethylene signaling. The FL ETR1 
was successfully expressed in baculovirus expression vector system but the isolation of 
the receptor from the membrane was hampered. In addition to the FL ETR1, the cytosolic 
portion of the receptor was studied using Small Angle X-ray Scattering. The resulting 
SAXS model had the expected dimeric arrangement.  
EDR1 from A. thaliana is a CTR1-like MAPKKK that is involved in regulating 
disease resistance responses, cell death and also ethylene-induced senescence. It 
possesses an N-terminal regulatory domain and C-terminal catalytic domain wit Ser/Thr 
kinase activity. As EDR1 has been shown to autophosphorylate in trans, the mechanism 
of this was studied using X-ray crystallography. A crystal structure for the catalytically 
inactive kinase domain of EDR1 (EDR1-D792N) was obtained in the presence of the 
ATP substrate analog AMP-PNP. The asymmetric unit contained two molecules, one of 
which surprisingly was in an active-like conformation. Furthermore, the active-like 
EDR1-D792N molecule was found to form an authentic trans-autophosphorylation 
complex with the inactive monomer from the adjacent asymmetric unit. 
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In addition to the plant defense signaling proteins, an adenylation (A) domain 
from cyanobacterial non-ribosomal peptide synthetase (NRPS) was studied. NRPSs are 
large multidomain enzymes that are found from a number of fungal and bacterial species 
and catalyze the ribosome-independent assembly of biologically active peptides with 
diverse composition and function. The A domain plays a central role in the NRPS system 
as it recognizes and activates the amino acid, which is incorporated into the growing 
peptide. The A domain ApnA A1 from the Anabaenopeptin synthetase of Planktothrix 
agardhii is an interesting member of its class as it has an unusual ability to activate two 
very distinct amino acids (arginine and tyrosine). Structural studies on this enzyme were 
performed to elucidate its bi-specificity. Based on the solved ApnA A1 structures, two 
active site residues with a crucial role in the substrate binding were identified. The 
mutation of these residues led to enzyme variants, which were mono-specific for either 
tyrosine or arginine, or in some instances were able to activate L-tryptophan. Additionally 
a number of ApnA A1 mutants were shown to activate unnatural amino acids (4-
fluorophenylalanine and 4-azidophenylalanine). A final peptide product with an unnatural 
amino acid incorporated, could possibly have useful industrial or pharmaceutical 
applications. 
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ZUSAMMENFASSUNG 
Pflanzen nutzen ein komplexes Signalweiterleitungsnetzwerk zur Regulierung von 
Entwicklungsprozessen und zur Reaktion auf umweltbedingte und biologische 
Belastungen. Ethylen ist ein Schlüsselhormon in der Kontrolle dieses Netzwerks, weshalb 
es zusammen mit seinem Signalweg Objekt jahrzehntelanger intensiver Untersuchungen 
wurde. Im Modellsystem Arabidopsis thaliana wird das Hormon von einer Gruppe aus 
fünf Rezeptoren (ETR1, ERS1, ETR2, ERS2 und EIN4) erkannt, die den 
Sensorhistidinkinasen bakterieller zwei-komponenten Systeme ähneln. Hauptziel dieser 
Arbeit war die Expression und Reinigung des gesamten ETR1 zur strukturellen 
Untersuchung, um einen Einblick in die ersten Schritte der Ethylensignalisierung zu 
erhalten. Der vollständige ETR1 wurde erfolgreich im Baculovirussystem exprimiert, die 
Isolation des Rezeptors aus der Membran gelang allerdings nicht. Zuätzlich zum 
vollständigen ETR1 wurde die zytosolische Domäne des Rezeptors mit Hilfe der 
Kleinwinkelstreuung untersucht. Das entsprechende SAXS Modell war wie erwartet ein 
Dimer. 
EDR1 aus A. thaliana ist eine CTR1- ähnliche MAPKKK, die Resistenzen, 
Zelltod und ethyleninduzierte Seneszenz reguliert. Es besteht aus einer N-terminalen 
Regulationsdomäne und einer katalytischen C-terminalen Domäne mit Ser/Thr 
Kinaseaktivität. Da gezeigt wurde, dass EDR1 trans autophosphoryliert, sollte dieser 
Mechanismus röntgenkristallographisch untersucht werden. Die Kristallstruktur der 
katalytischen Domäne von EDR1 (EDR1-D792N) zusammen mit dem ATP-Analogon 
AMPPNP wurde gelöst. Die asymmetrische Einheit enthält 2 Moleküle, wovon eines 
überraschenderweise  in der aktiven Konformation vorlag. Außerdem formt das aktive 
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EDR1-D792N einen trans-autophosphorylierenden Komplex mit dem inaktiven Monomer 
einer benachbarten asymmetrischen Einheit.  
Zusätzlich zum pflanzlichen Abwehrmechanismus wurde die 
Adenylierungsdomäne der cyanobakteriellen nicht-ribosomalen Peptidsynthetase (non-
ribosomal peptide synthetase, NRPS) untersucht. NRPS sind große 
Multidomänenenzyme, die in einer Reihe von Pilzen und bakterieller Spezies vorkommen 
und den ribosomenunabhängigen Aufbau biologisch aktiver Peptide unterschiedlicher 
Zusammensetzung und Funktion katalysieren. Die A-Domäne spielt eine zentrale Rolle in 
den NRPS, da sie die Aminosäure erkennt und aktiviert, die in das wachsende Peptid 
eingebaut wird. Die A-Domäne ApnA A1 aus Planktothrix agardhii der 
Anabaenopeptinsynthetase is ein aufschlussreicher Vertreter seiner Klasse, da es die 
außergewöhnliche Fähigkeit besitzt zwei sehr unterschiedliche Aminosäuren (Arginin 
und Tyrosin) zu aktivieren. Strukturelle Untersuchungen zur Klärung der doppelten 
Spezifität wurden durchgeführt. Basierend auf Strukturen der ApnA A1 wurden 2 Reste 
des aktiven Zentrums identifiziert, die eine zentrale Rolle bei der Substratbindung 
spielen. Mutation dieser Reste resultierte in Enzymvarianten, die entweder für Tyrosin 
oder Arginin mono-spezifisch waren, oder in einigen Fällen in der Lage waren L-
Tryptophan zu aktivieren. Außerdem konnten einige ApnA A1 Mutanten unnatürliche 
Aminosäuren (4-Fluorophenylalanin und 4-Azidophenylalanin) aktivieren. Ein 
Peptidprodukt mit einer eingebauten unnatürliche Aminosäuren könnte für industrielle 
oder pharmazeutische Anwendungen nützlich sein. 
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1. INTRODUCTION 
1.1 Production of antimicrobial compounds in plants 
and bacteria 
All organisms are in constant competition for living space and more importantly 
nutrients. Plants are one of the central and crucial sources of energy for many 
heterotrophic organisms. As sessile entities they cannot resort to changing their location 
when acquiring nutrients or confronted with an attacker. Instead, they have developed 
other mechanisms to protect their integrity. One of the key defence mechanisms in plants 
is the production of chemical compounds that in the case of pathogen attack halt its 
progression in the plant cell or in case of natural enemies like herbivores, make the plant 
undesirable for consumption. These antimicrobial compounds have a variety of shapes 
and forms, ranging from small toxic organic or inorganic molecules to larger protein 
molecules that interfere with the invader’s biological systems and have ultimately lethal 
consequences for the attacker. Some of these compounds are produced as a part of the 
plant innate immune system and are stored in specialized organs and tissues whereas 
others are synthesized or expressed only in response to pathogen attack (Bednarek & 
Osbourn, 2009). The first group includes essential oils (e.g. spearmint oil), alkaloids (e.g. 
nicotine and atropine) and phenolics (e.g. terpenoids, lignin precursors, catechols, 
coumarins and tannins) (Bennett & Wallsgrove, 1994). The production of defence 
molecules of the latter kind requires detection of the pathogen, which provides a signal 
for the plant to activate their synthesis. These include proteins such as glucanases, 
chitinases and defensins, which target specific structural features of the pathogen by 
degrading them but also enzymes that needed for the biosythesis of phytoalexins (Ahuja 
 14 
et al., 2012) and other often phenylpropanoid- or fatty acid-derived secondary metabolites 
(Scheel, 1998). Expression of these proteins is under tight control and regulated by 
several plant hormones such as ethylene, salicylic acid and jasmonic acid.  
Despite the abundancy of pathogenic species in the bacterial phyla, the bacteria 
themselves are also faced with situations where elaborate defence mechanims are needed. 
Main reasons for bacterial defence responses arise from the environmental stress factors, 
such as the presence of harmful chemicals, UV radiation or the lack of nutrients but also 
from the presence of other microorganisms. These factors form a range of cues that drive 
the bacterial movement. Bacteria, like plants have a number of signaling systems that are 
employed to detect changes in its enviroment and accordingly trigger a suitable response.  
As microorganisms, bacteria are one of the most abundant species in the planet and very 
often are forced to compete for the available nutrients with other bacterial species. 
Possibly due to this, some bacteria are capable of producing chemicals with antimicrobial 
properties that function against another microorganism. A selection of bacterial species 
possesses a special enzymatic system that produces complex amino acid derivatives as 
secondary metabolites in a ribosome-independent manner. These non-ribosomal peptides, 
produced by the multienzyme Non-Ribosomal peptide synthetase, form an important 
group of antimicrobial compounds that not only are useful for the organism itself but 
have also valuable applications in pharmaceutical industry. The details of the non-
ribosomal peptide synthesis and the concominant applications are discussed further in 
dedicated chapter of this thesis. 
1.2. Plant immunity 
Plants are exposed on a daily basis to various different stress factors that include 
both biotic ones, i.e. pathogens and abiotic ones such as drought, radical changes in 
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temperature, ultraviolet radiation, lack of nutrients and pollution. To overcome these 
external threats they have developed elaborate defense mechanisms. Unlike vertebrates, 
plants lack mobile cells that are an essential part of the adaptive immune system and 
therefore rely on their innate immune system and activation of resistance (R) genes 
leading eventually to systemic resistance that confers a whole-plant wide protection 
against the attacker (Jones & Dangl, 2006).  
As a part of their first line of defense plants use constitutive defenses, which 
includes an array of structural barriers, such as cell walls, waxy epidermal cuticles and 
bark but also preformed antimicrobial metabolites (Nürnberger et al., 2004; Pieterse et 
al., 2009). The latter ones are usually formed as secondary metabolites and belong to one 
of three large chemical classes: terpenoids, phenolics or alkaloids. Plants also employ 
inducible defenses as basal level protection against the invading pathogen. The activation 
of these defenses is based on the recognition of specific molecular determinants that 
originate either from the pathogenic organism itself or from its activity. The former ones 
are commonly referred as pathogen- or microbe-associated molecular patterns (PAMPs or 
MAMPs) and include compounds abundant in certain type of pathogens such as flagellin, 
chitin, glycoproteins and lipopolysaccharides (Nürnberger et al., 2004; Pieterse et al., 
2009). In addition to PAMPs and MAMPs, the plant immune response can be triggered 
by damage-associated molecules, also referred as damage-associated molecular patterns 
(DAMPs), which are generated from the degradation of the plant cell wall by the lytic 
enzymes of the pathogen (Nürnberger et al., 2004; Muthamilarasan & Prasad, 2013). For 
simplicity the triggering of plant immune responses by these microbial elicitors is further 
described using only the term PAMPs. It should be noted that the basic mechanisms also 
apply for MAMPs and DAMPs. 
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PAMPs are perceived by specific receptors called pattern recognition receptors 
(PRR), which localize at the plant cell surface (Jones & Dangl, 2006; de Wit, 2007; 
Boller & He, 2009; Muthamilarasan & Prasad, 2013). Upon the detection of PAMPs, an 
immune response known as PAMP-triggered immunity (PTI) is activated. The PTI 
associated initial responses include changes in ion fluxes across the plasma membrane, 
activation of MAPK cascades, production of reactive oxygen species (ROS) and 
production of reactive nitrogen intermediates (RNI) (Jabs et al., 1997; Muthamilarasan & 
Prasad, 2013). These responses can lead into or occur in parallel with transcriptional 
activation of pathogenesis-related genes, which include production of lytic enzymes 
(chitinases, glucanases and proteases) aimed to degrade pathogen-specific structural 
materials, or synthesis of antimicrobial proteins or antimicrobial secondary metabolites 
(Nürnberger et al., 2004).  
A well-known example of PAMP-PRR interaction is the recognition of the 22 
amino acid epitope in the N terminus of flagellin (flg22) by the FLS2 (flagellin sensitive 
2) (Gomez-Gomez & Boller, 2000). Flagellin is the basic building block of the flagellum, 
which is needed for bacterial motility and consequently is also important for the 
pathogenicity of the bacteria (Zipfel & Felix, 2005; Ramos et al., 2004; Tans-Kersten et 
al., 2001). In addition to the importance of flagellin to bacteria, the fact that its N- and C-
terminus are conserved among several bacterial species makes it a prime candidate as an 
immune response elicitor not only in plants but also in other eukaryotic organisms.  
Pathogens have also developed means to overcome the defence mechanisms of 
PTI by producing specific effector molecules (Jones & Dangl, 2006). These effectors act 
against the PTI-related defence molecules either through direct interaction or indirect 
interference with the signaling pathway that is required for their production. The 
pathogen effectors derive their origin from the so-called avirulence (avr) genes, the 
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products of which can be recognized by the plant. In the course of evolution, plants have 
developed a set of pathogen resistance (R) genes, which recognize the avr genes or their 
corresponding gene products. This recognition is based on either gene-to-gene interaction 
or expression of proteins that bind and thus inactivate the pathogenic elicitors. Currently 
it is known that most of the R genes encode for membrane-bound receptor proteins with a 
nucleotide binding (NB) domain and a leucine-rich repeat (LRR) domain and are 
therefore referred as NB-LRR proteins. The recognition of the pathogenic effector 
molecule leads into the effector-triggered immunity (ETI), which sets out a complex set 
of signaling events that culminate in the hypersensitive response (HR) in the form of 
programmed cell death. The distruction of the infected tissue aims to prevent the spread 
of the pathogen to other tissues and functions as a signal to activate the global defence, 
known as systemic acquired resistance (SAR). 
The detection of a pathogen does not only trigger responses at the infection site 
but also in distal tissues that have not yet been affected by the pathogen attack. This is 
achieved by the expression of specific signaling molecules, such as salicylic acid (SA), 
that activate the systemic expression of antimicrobial pathogenesis-related (PR) genes in 
the distal tissues in order to avoid secondary infection (Fu & Dong, 2013). This 
phenomenon is also known as SAR and provides the plant protection against the 
reoccurent attack of a pathogen. Besides SAR, plants also employ another similar form of 
systemic resistance called induced systemic resistance (ISR) to achieve long-term 
protection against attacking microorganisms. Unlike SAR, ISR is independent of SA-
signaling but relies on the jasmonic acid and ethylene signaling pathways instead. The 
key to the effectiveness and fine-tuning of the both local and global defense mechanisms 
lies in the crosstalk between the different phytohormone signaling pathways.  
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1. 3 Ethylene signaling 
1.3.1 Phytohormone ethylene 
Ethylene (C2H4) is a simple unsaturated hydrocarbon molecule that belongs to the 
diverse group of plant hormones (i.e. phytohormones). The history of ethylene research 
dates back to the 19
th
 century when it was observed that leaks of illuminating gas induced 
premature senescence and defoliation in plants (Lin et al., 2009). In 1901 the biologically 
active compound in the illuminating gas was identified as ethylene. This discovery was 
made by the Russian plant physiologist Neljubov and was based on his experiments on 
etiolated pea seedlings (Bleecker & Kende, 2000). A few decades later it was shown that 
plants are also capable of producing ethylene themselves (Gane, 1934). Since its 
discovery, ethylene and the molecules involved in its signaling pathway have been a great 
interest to many researchers, not only due to its importance in planta but also in 
agriculture. Currently, ethylene is known to regulate various important developmental 
aspects and the responses to many environmental factors, making it a prime target for 
biotechnological applications that aim to produce more long-lasting and pathogen-
resistant plants. 
As phytohormone ethylene regulates various processes in the plant life cycle from 
plant growth and senescence of plant organs to response to biological and environmental 
stress factors as a part of plant immune system (Bleecker & Kende, 2000; Chang & 
Stadler, 2001; Johnson & Ecker, 1998; Guo & Ecker, 2004; Lin et al., 2009). Ethylene is 
recognized as a one of the classical phytohormones, which additionally include auxins, 
abscisic acid, cytokinins and gibberellins (Gaspar et al., 1996). Due to its versitile 
function, ethylene is produced in virtually all plant tissues, and like other plant hormones, 
exists by default in low levels in these tissues (Santner et al., 2009). Plants are highly 
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sensitive in ethylene perception and changes in nanomolar range in the ethylene 
concentration are sufficient to induce a response. 
One of the most studied and best-known effects of ethylene is the inducement of 
fruit ripening. Fruits can be divided into two categories, climateric and non-climateric 
fruits, based on their mechanism of ripening (Alexander & Grierson, 2002). In non-
climateric fruits, such as grape, orange and pineapple, there is very little change in 
respiration and the levels of ethylene remain low. The opposite is observed for the 
climacteric fruits, where the onset of ripening is accompanied with sharp increase in 
ethylene production and a concominant rise in respiration (Bleecker & Kende, 2000). 
Application of exogenous ethylene in the young fruits in the preclimacteric state has been 
shown to accelarate the ripening process. Examples of climacteric fruits include several 
common fruits, like apples, bananas and tomatoes. Due to the key role of ethylene in the 
ripening of the climacteric fruits, it is of high value and interest also in agricultural 
applications. The control of ethylene production and the onset of the ripening enable the 
preservation of fruits in the pre-ripening (preclimacteric) state and prevent them from 
spoilage during long transportations from the harvesting location to the customer. 
Besides fruit ripening, there is a great number of other senescence and growth 
related processes that are regulated by ethylene in plants. In flowering plants, ethylene-
induced responses include flower senescence together with abscission of the leaves and 
pedals. In some instances, the effect of ethylene in aging of flowering plants is highly 
similar to the fruit ripening as a significant increase in ethylene production and a 
concominant rise in respiration is also observed at the onset of flower senescence (Yang 
& Hoffman, 1984).  Ethylene also plays an important role in regulating morphological 
changes related to growth and in sex determination (Lin et al., 2009). Ethylene-induced 
growth responses include root nodulation, seed germination, the asymmetric growth of 
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stem and petiole, and the apical hook formation. Ethylene is also important part of plant 
immunity and regulates responses to pathogen attack in concert with other plant 
hormones. 
In the model plant Arabidopsis thaliana, one of the most profound effects of 
ethylene is observed when dark-grown germinating seeds are exposed to this plant 
hormone. These seedlings exhibit a phenotype that is characterized by the exaggerated 
curvature of the apical hook, radial swelling of the hypocotyl and shortening of the 
hypocotyl and root (Bleecker & Kende, 2000; Chang & Stadler, 2001; Wang et al., 2002). 
This triple response phenotype has provided the means to screen and subsequently 
identify A. thaliana mutants that have altered synthesis of ethylene or sensitivity to it 
(Wang et al., 2002). This genomic tool has been particularly useful in discovering 
components in ethylene signaling pathway.  Based on the response that A. thaliana 
seedlings exhibit upon exposure to ethylene, the identified mutants from the triple 
response assay can be categorized into three separate groups: ethylene-insensitive 
mutants, constitutive triple response mutants and tissue-specific ethylene-insensitive 
mutants (Guo & Ecker, 2004). The mutants of the first group show little or no response 
when high levels of the plant hormone or its precursor 1-aminocyclopropane-1-carboxylic 
acid (ACC) are present, and are called ethylene-resistant (etr), ethylene-insensitive (ein) 
or ACC-insensitive (ain) (Chang & Stadler, 2001; Wang et al., 2002). The second group 
consists of the ethylene-response mutants that show a constitutive triple response even in 
the absence of the hormone or its precursor. These mutants can be further divided into 
subgroups depending on whether the phenotype they exhibit can be suppressed by 
inhibitors of ethylene biosynthesis and perception or not. Mutants of A. thaliana that are 
insensitive to these inhibitors and retain their altered phenotype are referred to as the 
constitutive triple response (ctr) mutants (Wang et al., 2002). These differ from the plants 
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with ethylene-overproducer (eto) phenotype, which revert back to wild type phenotype 
after application of the inhibitor. A. thaliana plants with eto morphology have a defect in 
the regulation of ethylene production (Wang et al., 2002). The last group of ethylene-
response mutants is the tissue-specific ones, which have more localized effect on ethylene 
sensing or production. These include examples like hookless1 (hls1) and ethylene 
insensitive root1 (eir1) (Guzman & Ecker, 1990; Roman et al., 1995; Guo & Ecker, 
2004) 
1.3.2 Ethylene synthesis in plants 
The pathway that describes the steps in the synthesis of ethylene in plants is called 
the methionine or Yang cycle (Yang & Hoffman, 1984) (Figure 1). Ethylene synthesis 
proceeds through three main reactions (numbered from 1-3 in the Figure 1), in which S-
Adenosyl-L-methionine (S-AdoMet) and a cyclic, non-proteinogenic amino acid 1-
aminocyclopropane-1-carboxylic acid (ACC) are the key intermediates in turning L-
methionine into ethylene (Adams & Yang, 1979). The conversion of methionine to 
ethylene requires oxygen and ATP, and in addition to ethylene, carbon dioxide (CO2), 
hydrogencyanide (HCN), water and 5'-methylthioadenosine (MTA) are formed as 
byproducts. Due to its toxicity, the gaseous hydrogen cyanide is further metabolized into 
β- yanoalanine  y β-cyanoalanine synthase. The MTA molecule on the other hand is 
used to preserve the methylthiogroup and to enable the regeneration of methionine in the 
methionine cycle.  
The first step in ethylene biosynthesis is the conversion of L-methionine to S-
AdoMet (reaction 1 in Figure 1). Besides its involvement in ethylene synthesis, S-
AdoMet is also needed in several other metabolic reactions important to plant growth and 
development, such as a methyl donor in a number of transmethylation reactions and in the 
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biosynthesis of spermidine, spermine and biotin (Ravanel et al., 1998). The production of 
S-AdoMet from L-methionine is an ATP-dependent reaction and catalyzed by the enzyme 
S-AdoMet synthase (Wang et al., 2002).  
The formation of S-AdoMet is followed by the rate-limiting step in ethylene 
biosynthesis that is the conversion of S-AdoMet to ACC (reaction 2 in Figure 1) (Adams 
& Yang, 1979; Yang and Hoffman, 1984). ACC synthase (ACS) is the enzyme 
responsible for the synthesis of ACC and requires pyridoxal 5’-phosphate as a cofactor. 
ACC synthesis proceeds through a γ-elimination reaction, where the MTA-byproduct is 
further utilized to regenerate methionine (Yang & Hoffman, 1984; Kende, 1993; Bleecker 
& Kende, 2000). The regeneration of methionine enables the maintenance of ethylene 
biosynthesis at high rates even when the levels of methionine are low (Yang & Hoffman, 
1984; Kende, 1993). ACC is the immediate precursor of ethylene, which arises from the 
enzymatic activity of ACC oxidase (ACO). The formation of ethylene from ACC is 
oxygen-dependent and lack of oxygen results in accumulation of ACC and halted 
synthesis of ethylene. This phenomenon was observed when plants were kept in nitrogen 
atmosphere and was followed by rapid synthesis of ethylene after exposure of the plant to 
air. 
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Figure 1. The biosynthesis of ethylene via Yang cycle (Yang & Hoffmann, 1984). The first step in ethylene 
synthesis is the formation of S-Adenosylmethionine (S-AdoMet) from L-methionine (1). The S-AdoMet is 
further processed in the rate-limiting step of ethylene synthesis that produ es 5’-methylthioadenosine 
(MTA) and 1-aminocyclopropanecarboxylic acid (ACC) (2). The latter one is the direct precursor of 
ethylene, which results from the catalytic activity of ACC oxidase in the third and final step of this plant 
hormone (3). The abbreviations MTR and KMTB stand for 5’-Methylthiori ose and α-Keto-γ-methylthio-
butyric acid, respectively. Both are intermediate products in the regeneration cycle of L-methionine. 
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1.3.3 Regulation of ethylene synthesis 
All plant tissues are capable of producing ethylene and already nanomolar 
quantities of ethylene are sufficient to induce a response. Therefore the synthesis of 
ethylene needs to be tightly regulated. One of the main targets of regulation is the enzyme 
ACS, which catalyzes the important conversion of S-AdoMet into ACC in the rate-
limiting step of ethylene synthesis. The important role of ACS as a regulator of ethylene 
synthesis is emphasized by the existence of multiple ACS isoforms in a single plant 
species (Johnson & Ecker, 1998). The variety of ACS isoforms provides the means to 
control the ethylene synthesis both in protein and gene level. On the protein level this can 
be observed in the altered rate in ACC production by the different ACS isoforms. This 
allows the plant to differentiate between steady state and induced synthesis of ethylene. 
The availability of multiple ACS genes on the other hand enables the differential 
expression of the encoded protein in response to environmental and developmental 
signals as well as hormones (Tsuchisaka & Theologis, 2004). It has been shown that in 
preclimacteric fruits the compound ACC is only present in small amounts and that this is 
accompanied with low levels of the ACC synthase. Furthermore a significant increase in 
the amount of both ACC and ACC synthase is detected upon the inducement of ripening 
process (Adams & Yang, 1977; Adams & Yang, 1979; Kende & Boller, 1981). The 
phytohormones that have been shown to be involved in the regulation of ACS production 
include auxin and cytokinin (Johnson & Ecker, 1998). In Arabidopsis these two 
hormones are involved in promoting the transcription of specific ACS genes that 
subsequently also enhances ethylene synthesis (Abel et al., 1995; Johnson & Ecker, 1998; 
Vogel et al., 1998). Auxin acts by rapidly inducing the expression of ACS4, a member of 
ACS family in Arabidopsis, whereas cytokinin influences expression of another ACS 
isoform, ACS5. However, the effect of cytokinin is concentration dependent and only 
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when the cytokinin levels are low, the ethylene-induced phenotype can be observed 
(Vogel et al., 1998). The ACS levels in the plant tissues are also regulated by a group of 
BTB (broad-complex, Tramtrack and bric-a-brac) ubiquitin ligases, called Ethylene 
overproducer 1 (ETO1), ETO1-like1 (EOL1) and EOL2, all of which promote the 
degradation of ACS proteins (Santner et al. 2009). Additional diversity to the ACS-
mediated regulation of ethylene synthesis arises from the ability of these enzymes to form 
dimers (Lin et al., 2009). Through both homo- and heterodimerization, the different ACS 
isoforms are capable of fine-tuning their responses. 
There are also a number of chemicals, which inhibit ethylene synthesis when 
applied exogenously. These include compounds that effect on the membrane structures, 
such as phosphaditylcholine, Tween 20 and Triton X-100 but also ones that suppress the 
auxin-induced increase in ethylene synthesis, i.e.  y loheximide, a tinomy in D and α-
amanitin. Also ethylene itself can function as an inhibitor of its own synthesis. It has been 
shown that in flavedo tissues of citrus fruit the wounding-induced ethylene production 
was decreased in the presence of exogenous ethylene (Riov & Yang, 1982). Since the 
application of ACC was able to recover the loss in the synthesis rate of ethylene, it was 
suggested that inhibitory effect would be mainly targeted on the activity of ACC synthase 
(Riov & Yang, 1982). 
1.3.4 Arabidopsis thaliana ethylene signaling pathway  
The ethylene signaling is initiated by a family of membrane-bound receptors that 
in A. thaliana consists of five members: Ethylene Receptor 1 and 2 (ETR1 and 2), 
Ethylene Response Sensor 1 and 2 (ERS1 and 2) and Ethylene Insensitive 4 (EIN4). 
These are further classified into two subfamilies, one consisting of ETR1 and ERS1 
(subfamily I), and the other including the remaining three receptors (ETR2, ERS2 and 
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EIN4; subfamily II) (Hua et al., 1998; Chang et al., 2004). All five Arabidopsis ethylene 
receptors have a similar overall architecture, which includes an N-terminal trans-
membrane domain and a cytosolic part with a GAF (cGMP-specific phosphodiesterase, 
adenylyl cyclases and FhlA) domain, a histidine kinase and in some case a receiver 
domain (Moussatche & Klee, 2004). Furthermore, they are known to share sequence 
similarity with the prokaryotic two-component systems, which regulate the adaptive 
responses to environmental stimuli in their host organism and typically consist of a 
membrane-associated sensor with cytosolic histidine kinase domain and a separate 
response regulator (Chang et al., 1993; Lin et al., 2009). Due to the similarity with these 
bacterial two-component signaling molecules, ethylene signaling has also been postulated 
to involve similar His-Asp phosphorelay in the signal transfer from cytosol to nucleus as 
observed in the bacterial system. However, its role as the main signaling mechanism 
remains speculative since only the receptors in the subfamily I contain all the conserved 
histidine kinase motifs found in the prokaryotic two-component sensor kinases (Hua et 
al., 1998; Mason & Schaller, 2005). The subfamily II receptors are more diverged in their 
kinase region and have been shown to possess Ser/Thr kinase activity instead (Hua et al., 
1998; Chang et al., 2004, Moussatche & Klee, 2004).  
The amphiphilic nature of ethylene enables the unusual location of ethylene 
receptors at the endoplasmic reticulum (ER) (Chen et al., 2002). The functional form of 
ETR1 is disulfide-linked dimer that requires a copper co-factor for ethylene binding 
(Schaller et al., 1995; Hirayama & Alonso, 2000). This co-factor is provided by a P-type 
ATPase copper transporter Responsive-to-Antagonist 1 (RAN1), which despite its 
location at the Golgi apparatus has been shown to directly interact with ETR1 (Hirayama 
et al., 1999). The binding site for both the copper and for the ethylene is embedded in the 
ER-membrane and locates between the N-terminal transmembrane domains of the 
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receptor dimer. The ethylene binding presumably causes a conformational change that 
allows the signal to be transmitted to the cytosolic part of the receptor and further on to 
the downstream targets. 
The cytosolic portion of the ethylene receptors has been shown to directly interact 
with a putative Mitogen-activated protein kinase kinase kinase (MAPKKK). This 
downstream component of ethylene-signaling pathway was identified from an A. thaliana 
mutant carrying a recessive mutation that caused constitutive ethylene responses even in 
the absence of the hormone (Kieber et al., 1993). The responsive gene, constitutive triple 
response 1 (ctr1) encodes a member of a Raf-1 like mitogen-activated protein kinase 
kinase kinase (MAPKKK) family. CTR1 comprises an N-terminal regulatory domain that 
interacts with the ethylene receptor and a C-terminal catalytic domain with 
serine/threonine kinase activity. As a MAPKKK, CTR1 is assumed to take part in a 
canonical MAPK cascade, which in eukaryotic cells mediates the perception of external 
stimuli to cellular responses. Therefore the discovery of CTR1 revealed an intruiging 
feature in ethylene signaling since it would represent an unusual combination of 
prokaryotic and eukaryotic signaling components.  
In the absence of ethylene, both the ethylene receptors and CTR1 are active and 
repress the downstream signaling in a phosphorylation dependent manner (Figure 2, left 
panel). In its active state, CTR1 phosphorylates another ER-bound member of ethylene 
signaling protein family, Ethylene Insensitive 2 (EIN2). EIN2 is a membrane protein with 
an N-terminal domain that resembles NRAMP (natural resistance-associated macrophage 
protein) metal ion transporters and a cleavable, cytosolic C-terminal domain (Alonso et 
al. 1999; Bisson et al. 2010; Wang et al. 2009). EIN2 has shown to be critical in ethylene 
signaling and to act as a positive regulator of ethylene response. In its phosphorylated 
form, EIN2 is subjected to ubiquitin-dependent degradation by the 26S proteosome. Upon 
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binding of ethylene to the receptor, both the receptor and CTR1 become inactive thus 
preventing the phosphorylation of EIN2 (Figure 2, right panel). This results in targeted 
proteolytic clevage of the EIN2 C-terminal domain and its re-location to the nucleus 
where it activates a transcription factor cascade with yet unknown mechanism. An 
important group of transcription factors that function downstream of EIN2 includes 
Ethylene Insensitive 3 (EIN3) and EIN3-like (EIL) proteins (Chao et al., 1997). These 
transcription factors have been shown to bind to a specific region in the promoter of 
ethylene response factor 1 (erf1) and promote the expression of the encoded transcrition 
factor. ERF1 is a GCC box-binding transcription factor that belongs to the Ethylene-
Response-Element-Binding-Protein (EREBP) protein family. The binding of ERF1 to the 
promoters of the secondary target genes eventually leads to activation and transcription of 
the ethylene response genes (Zhao & Guo, 2011).  
Other proteins involved in ethylene signaling include EIN3-targeting F-box 
proteins 1 and 2 (EBF1 and EBF2), both of which target EIN3 to degradation in absence 
of ethylene (Wang et al. 2009). It is proposed that a protein called Ethylene Insensitive 5 
(EIN5) facilitates the turnover of these two F-box proteins (Olmedo et al. 2006). 
However, the mechanism behind this is currently not known. Also the amount of EIN2 at 
protein level is controlled by two F-box proteins, EIN2 targeting protein 1 and 2 (ETP1 
and 2). In absence of ethylene they target EIN2 to degradation through ubiquitination and 
interaction with Skp-1/Cullin-1 proteasome complex.  
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Figure 2. Schematic and simplified representation of the ethylene-signaling pathway in absence and 
presence of the plant hormone. In the absence of the plant hormone, both the ethylene receptor (represented 
by ETR1) and its cytosolic interaction partner CTR1 are active, and together suppress the downstream 
signaling components in a phosphorylation-dependent manner (left panel). Ethylene binding inactivates 
both the receptor and CTR1, which allows the C-terminal domain of EIN2 to be proteolytically cleaved and 
relocated to the nucleus. This results in the activation of transcription factors, such as EIN3 and ERF1 and 
finally to the triggering of ethylene responses. 
 
1.3.5 Enhanced Disease Resistance 1 
The gene for enhanced disease resistance 1 (edr1) was first discovered from A. 
thaliana mutant plant that showed resistance to the fungus Erysiphe cichoracearum, the 
causative agent for powdery mildew (Frye & Innes, 1998). EDR1 is a serine/threonine-
protein kinase that belongs to the superfamily of Raf-like MAPKKKs (Frye et al., 2001). 
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Its closest homolog is the well-known A. thaliana ethylene-signaling molecule CTR1. 
Like CTR1, EDR1 consists of an N-terminal domain with a putative regulatory function 
and C-terminal catalytic domain with the kinase activity. EDR1 acts as a negative 
regulator of disease resistance and programmed cell death in a salisylic acid dependent 
manner (Frye et al., 2001; Tang et al., 2005). The edr1 mutant plant also shows enhanced 
drought-induced growth inhibition, enhanced ethylene-induced senescence and enhanced 
sensitivity to the plant hormone abscisic acid (ABA) therefore linking EDR1 to at least 
two other plant hormone signaling pathway (Frye et al., 2001; Tang et al., 2005).  
Ubiquitin-mediated protein degradation has been suggested as a control 
mechanism in the EDR1 mediated signaling pathway based on the involvement of F-box 
protein ORE9 in the drought-induced growth inhibition and ethylene-induced senescence 
phenotypes (Tang et al., 2005). EDR1 is also known to interact with KEG (Keep On 
Going), a RING finger E3-ubiquitin ligase that negatively regulates the protein levels of 
the transcription factor ABI5 (Abcisic acid Insensitive 5) (Wawrzynska et al., 2008; Gu 
& Innes 2011). The interaction of EDR1 with KEG was shown to be important for EDR1 
function since a missense mutation in keg suppresses all EDR1-mediated phenotypes 
(Wawrzynska et al., 2008). It has been proposed that KEG could serve as a substrate for 
EDR1 and EDR1 might therefore regulate its downstream components by KEG-mediated 
ubiquitination (Gu & Innes 2011). 
Recently, EDR1 was found to negatively regulate the MKK4/MKK5-
MPK3/MPK6 kinase cascade, which is required for the basal defense responses in plants 
(Zhao et al., 2014). It was shown that EDR1 directly interacts with MKK4 and MKK5 via 
its N-terminal domain and additionally suppresses the protein levels of MKK4, MKK5, 
MPK3 and MPK6.  
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1.4 Non-Ribosomal peptide synthetase 
1.4.1 Non-Ribosomal peptides  
A peptide is defined as a compound that consists of two or more amino acids 
joined covalently together by an amide bond, also known as peptide bond. The main 
system for the synthesis of naturally occurring peptides or small proteins relies on the 
translation of the nucleotide sequence in mRNA by the complex assembly of 
macromolecules, called the ribosome. Prior to reaching the final and functional form, the 
peptides of ribosomal origin usually go through a proteolytic processing from their gene-
encoded precursors. In addition to proteolysis, the produced peptides can be subjected to 
post-translational modifications, such as glycosylation, dehydration and addition of 
neighboring sulfhydryl groups to form thioesters. The peptides formed this way have a 
wide range of important biological functions, both in the source organism and in 
industrial applications. Examples of important ribosomal peptides include the vertebrate 
hormones oxytocin, bradykinin and thyrotropin. Also the group of lanthionine-containing 
peptide antibiotics, also referred as lantibiotics, that are produced mainly by Gram-
positive bacteria belong to the category of ribosomal peptides (Sahl et al., 1995). Known 
lantibiotics include nisin, subtilin and epidermin, which have industrial use as food 
preservatives (Marahiel et al., 1997). However, there are several 
antimicrobial/biologically active peptides of microbial origin that are produced in a 
ribosome-independent manner.  
Non-ribosomal peptide synthesis is a unique feature of mainly fungal and bacterial 
organisms that include members of the Gram-positive Actinomycetes and Bacilli, 
cyanobacteria and species of eukaryotic filamentous fungi, such as Aspergillus (Mootz et 
al., 2002). These microorganisms use an alternative system to produce these peptides, a 
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large multimodular enzyme known as the non-ribosomal peptide synthetase (NRPS). The 
NRPS enzymes consist of several modules that contain the necessary enzymatic units to 
recognize, activate and add the residue into the growing peptide chain (Marahiel et al., 
1997). The order and number of these modules define the sequence and the length of the 
end product, respectively. The length of the final non-ribosomal peptide can vary between 
2 and 48 residues, but on average their size is limited to 4 – 10 residues (Konz & 
Marahiel, 1999; Gewolb, 2002).  
The nonribosomal peptides form a group of molecules with remarkable structural 
diversity. In addition to the system responsible for their synthesis, the feature that 
differentiates these peptides from their ribosomal counterparts is the significantly greater 
selection of starting materials. The synthesis of ribosomal peptides is limited mainly to 
the classical proteinogenic amino acids and the existance of non-proteinogenic/unnatural 
amino acids usually arises from post-translational modifications. The non-ribosomal 
peptides are known also to incorporate many unusual, non-proteinogenic residues, which 
increase the number of available monomers to over 300 (Konz & Marahiel, 1999). These 
include D-enantiomers of the common amino acids, N-methylated amino acids, hydroxy 
acids and fatty acids, among others (Konz & Marahiel, 1999; Kleinkauf, 1979; Walsh, 
2008). The structural variety of nonribosomal peptides is further increased by 
modification of the peptide product through acylation, glycosylation or heterocyclic ring 
formation (Marahiel et al., 1997; Konz & Marahiel, 1999; Walsh, 2004). The end product 
of nonribosomal peptide synthesis can be linear, cyclic or branched but as a common 
factor they exhibit a constrained structure. The rigidity of these compounds is most often 
derived from cyclization of the peptide product through formation of macrocyclic lactams 
or lactones (Sieber & Marahiel, 2003; Mootz et al., 2002). Other ways include oxidative 
cross-linking and heterocyclization (Sieber & Marahiel, 2003). The restricted 
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conformation of the peptide product enables the selective recognition by biological 
targets and also protects the peptide from degradation by proteases (Gewalb, 2002; Sieber 
& Marahiel, 2003; Walsh, 2004). 
The non-ribosomal peptides are usually produced as secondary metabolites in 
their source organism and are proposed to be involved in coordination of growth and 
differentiation as signaling molecules, in the breakdown of cellular metabolites, in iron 
uptake as chelating siderophores, in resistance to oxidative stress, in virulence as effector 
molecules and in defence as antimicrobial compounds (Lee et al., 2005; Williams et al., 
1989; Gewalb, 2002). Many non-ribosomal peptides also possess biological properties 
that make them highly useful in medicinal, agricultural and biological research (Finking 
& Marahiel, 2004; Marahiel et al., 1997). For the pharmaceutical industry non-
ribosomally produced peptides have important applications as antibiotics, 
immunosuppressants, antitumor or antifungal drugs (Marahiel, 1997). Examples of 
nonribosomal peptides with antimicrobial properties include bacitracin from Bacillus 
licheniformis, daptomycin from Streptomyces roseosporus, vancomycin from 
Amycolatopsis orientalis and tyrocidine A from Bacillus subtilis (Konz et al., 1997; 
Nagarajan, 1991; Wittmann et al., 2008; Hu et al., 2009). Also the tripeptide δ-(L-α-
aminoadipyl)-L-cysteinyl-D-valine (ACV), the precursor molecule of the antiobiotics in 
the penicillin and cephalosporine families, is synthesized by NRPS machinery (Finking & 
Marahiel, 2004). Cyclosporin A is a powerful immunosuppressant that enabled organ 
transplantation whereas bleomycin is a potential cancer drug (Kunz & Hall, 1993; Bierer 
et al., 1993; Suzuki et al., 1968). The biological applications of the nonribosomal 
peptides have made the machinery that produces them an intriguing research topic 
through the possibility to discover compounds with novel or enhanced biological 
activities. Especially in the modern world where the number of bacterial strains resistant 
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to known antibiotics is increasing, there is an urgent need for novel antimicrobial 
compounds. 
1.4.2 Non-Ribosomal peptide synthetases  
The broad spectrum of biological activities displayed by the nonribosomal 
peptides has made their mechanism of biosynthesis and the enzyme responsible for it, the 
non-ribosomal peptide synthetase an attractive target for the scientific research. The non-
ribosomal synthesis of peptides is mainly encountered in soil-inhabiting microorganisms, 
such as members of the Gram-positive Actinomycetes and Bacilli but also in eukaryotic 
filamentous fungi and in other bacterial species including cyanobacteria (Mootz et al., 
2002). Several bacterial and fungal operons that encode the large modular enzymes for 
nonribosomal synthesis have been analyzed using DNA sequencing in order to get 
information about the molecular architecture of these enzymes (Marahiel, 1997; Marahiel 
et al., 1997). In bacteria, several distict synthetases, encoded in separate gene operons, are 
usually involved in forming the final peptide product. An example of this is the synthesis 
of bacitracin in Bacillus lichenifomis, where three separate synthetases, BA1 (5 modules, 
598 kDa), BA2 (2 modules, 297 kDa) and BA3 (5 modules, 723 kDa) are required to 
assemble the fully functional peptide. The fungal NRPSs on the other hand are usually 
formed by one large polypeptide, which is encoded in a single gene. For example the 
synthesis of the immunosuppressive drug Cyclosporin A is catalyzed by one large 
enzyme, Cyclosporin synthetase (1600 kDa) from Tolypocladium niveum (Marahiel, 
1997).  
Despite of the high structural diversity of their end products, most of the 
Nonribosomal peptide synthetases employ a common mode of synthesis known as the 
multienzyme thiotemplate mechanism (Kleinkauf & von Döhren, 1990; Stein et al., 1996; 
 35 
Marahiel et al., 1997). This mechanism describes the formation of peptide bond in the 
peptide synthetase as a two-step process where the amino acid is first activated through 
the formation of aminoacyl adenylate intermediate, followed by a transfer of the activated 
su strate to the 4’-phosphopantheine thiol in a separate domain for the subsequent chain 
elongation. The basis of the synthesis mechanism lies in the modular organization that 
replaces the need for a specific template to define the sequence of the peptide product. 
The nonribosomal peptide synthetases consist of modules, each of which is responsible 
for recognition and activation of a specific monomeric residue, and the elongation of the 
growing peptide through condensation of the activated residue with the one of the 
adjacent module. Each module in turn consists of domains that form functionally 
independent enzymes carrying out a specific step in the peptide synthesis.  
The basic module of NRPS proteins consists of three core domains that are the 
adenylation (A) domain, thiolation/peptide carrier protein (PCP) domain and the 
condensation (C) domain (Figure 3) (Strieker et al., 2010). These are found from each 
elongation module and catalyze the key reactions in the elongation phase of the peptide 
synthesis. The first and last module of each NRPS, referred to as initiation and 
termination module, differ from the elongation module in that the former lacks the C 
domain and the latter contains an additional termination (TE) domain that is responsible 
for releasing the ready peptide. The growing peptide can also be subjected to variety of 
modifications to achieve specific chemical or biological properties, thus further 
increasing the diversity of these compounds. These modifications can take place either 
during synthesis or after release of the peptide. Specific domains within the certain 
modules are responsible for the alterations during synthesis, and include examples like 
the epimerase (E), cyclization (Cy), methyltransferase (MT) and oxidation (Ox) domains 
(Hur et al., 2012). Modifications that occur after the release of the peptide are catalyzed 
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by separate enzymes and include glycosylation, halogenation and oxidative cross-linking 
(Hur et al., 2012). 
 
 
Figure 3. The modular architechture of Non-ribosomal peptide synthetases. One module contains all the 
necessary enzymatic units for recognition and activation of the amino acid substrate and for its 
incorporation to the growing peptide chain. These enzymatic units include the adenylation (A) domain, 
peptide carrier protein (PCP) and condensation (C) domain. Additionally the last module in the NRPS 
contains a termination (TE) domain that is responsible for the release of the peptide product.  
  
The adenylation (A) domain is the enzymatic unit of about 550 amino acids in 
length that is responsible for the recognition and activation of its cognate monomeric 
residue from the pool of available substrates (Konz & Marahiel, 1999). The activation of 
the target molecule occurs through adenylation, in which the carboxyl group of the 
substrate reacts with the pyrophosphoryl group of ATP, releasing inorganic 
pyrophosphate to drive the reaction forward (Figure 4) (Novelli, 1967). Due to its 
important role in defining the substrate specificity in each module, the A domain is 
possible the most extensively studied unit in the NRPS system.  Engineering the substrate 
specificity of A domains provides the means to design new peptide products (Marahiel et 
al., 1997).  
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Figure 4. Activation of amino acid by 
adenylation. The A domain catalyzes the 
adenylation reaction, which results in 
formation of aminoacyl adenylate. It involves a 
formation of phosphodiester bond between the 
aminoacid and AMP molecule derived from 
hydrolysis of ATP.  
 
 
 
 
Insights into the substrate binding of A domains was achieved when the first 
crystal structure was solved for the phenylalanine adenylation subunit of Gramicidin S 
synthetase 1 (PheA) in the presence of both AMP and L-phenylalanine (Figure 5A) 
(Conti et al., 1997). Although the structure was obtained in the presence of L-isoform, the 
PheA enzyme is able to activate both stereoisomers of its phenylalanine substrate 
(Stachelhaus & Marahiel, 1995). Based on the structural information from PheA and 
sequence alignment of PheA with other adenylation domains, the ATP-binding appeared 
to be conserved and mediated by shared sequence motifs (Stachelhaus et al., 1999). The 
residues involved in forming the binding pocket for the amino acid substrate were found 
to locate within a stretch of 100 amino acids (Stachelhaus et al., 1999). Combined 
information from sequence alignment between PheA and 160 other adenylation domains 
and from the available PheA structure led to the identification of 10 residues that were 
important for the binding specificity of the A domains (Figure 5B) (Stachelhaus et al., 
1999). This so-called specificity conferring code was proposed and also shown to be 
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useful tool in predicting or altering the substrate specificity of adenylation domains 
(Stachelhaus et al., 1999, Eppelmann et al., 2002).  
 
Figure 5. The first solved A domain structure. A) The crystal structure for the phenylalanine adenylation 
subunit of Gramicidin synthetase 1 (PheA, PDB code: 1AMU) represented the structural organization of A 
domains (Conti et al., 1997). The structure exhibits a two-domain organization consisting of a larger N-
terminal domain (dark green) and a smaller C-terminal domain (yellow), connected to eachother with a 
flexible linker. The N- and C-terminus are marked in the image. B) The binding specificity of 
phenylalanine is conferred by a set of 10 residues that surround the amino acid substrate.  The residues in 
corresponding positions in other adenylation domains form the specificity conferring code, which can be 
used to predict and modify the substrate specificity of the adenylating enzyme (Stachelhaus et al., 1999). 
 
The central domain in the mediating the nonribosomal peptide synthesis is the 
small peptidyl carrier protein (PCP), also known as thiolation (T) domain, consisting of 
roughly 80 – 100 amino acids (Marahiel et al., 1997; Lai et al., 2006; Hur et al., 2012). 
The PCP domain is located between the adenylation and condensation domain to which it 
is fused from its N- and C-termini, respectively (Koglin et al., 2006). After the carboxylic 
acid containing residue has been activated as adenylate intermediate, a nucleophilic attack 
 y a rea tive thiol group in 4’phosphopantheine  ofa tor of PCP domain is followed. This 
results in tethering of the monomeric substrate to the PCP domain as a thioester. The 
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4’phosphopantheine lin er functions like a swinging arm, transferring the activated 
residue from the adenylation domain to the condesation domain for the peptide bond 
formation.  
The 4’phosphopantheine prosteti  group is derived from Coenzyme A (CoA) and 
is attached to a conserved serine residue in the PCP domain in Mg
2+
-dependent reaction 
that is catalyzed by Sfp-type phosphopanthetheinyl transferase (PPTase) (Hur et al., 
2012). The action of PPTase is needed to convert the inactive apo-PCP into its active 
holo-form (Koglin et al., 2006; Lai et al., 2006; Hur et al., 2012). The structural studies 
using Nuclear Magnetic Resonance (NMR) spectroscopy on the PCP domain from the 
third module of tyrocidine A synthetase revealed that both the apo and the holo form of 
the enzyme were able to maintain two different conformational configurations (Koglin et 
al., 2006). Furthermore it was concluded that two of these four conformations represented 
the individual apo and holo forms whereas the remaining two were virtually identical and 
was considered to be common state between the apo and holo form. The three individual 
conformational states were termed A, A/H and H state (Koglin et al., 2006) (Figure 6). 
The A and H state represent the individual apo-PCP and holo-PCP forms of TycC3-PCP, 
whereas the A/H conformation is the shared one between the two forms. The canonical 
four-helix bundle, which is observed in many carrier proteins, is found from the structure 
of the TycC3-PCP in A/H state whereas the A and H state part of the helical structure 
unravels (Koglin et al., 2006; Hur et al., 2006). Further experiments showed that the shift 
from A/H to H conformation results in movement of the 4’-phosphopantheine cofactor 
from N-terminal to C-terminal end of the holo-TycC3-PCP, thus supporting the swinging 
arm mechanism for the transfer of the activated residue from adenylation domain to 
condesation domain in the peptide synthesis process (Hur et al., 2006). It was also shown 
that the PPTase prefers the A  onformation when loading the PCP domain with the 4’-
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phosphopantheine cofactor whereas another interaction partner of PCP domains, the type 
II thioesterase (TEII) only interacts with the H-PCP (Koglin et al., 2006). The TEII is an 
en yme required for the regeneration of PCP if mispriming of the 4’-phosphopantheine 
with incorrect adenylate intermediate occurs (Schwarzer et al., 2002). 
 
 
Figure 6. The NMR structures of TycC3-PCP domain in three different conformations. A) The A state 
(PDB code: 2GDY) is only seen for the inactive apo-form of the enzyme. B) The A/H state (PDB code: 
2GDW) is proposed to be the intermediate state between the apo- and holo-forms. C) The H-state (PDB 
code: 2GDX) corresponds the active holo-form. The conformational changes are mediated by the three core 
heli es, αI ( lue), αII (yellow) and αIII (red). In the A/  state, an additional α-helix (αIV) appears resulting 
in the formation of canonical four-helix bundle, observed in many carrier proteins among others. 
 
The step leading to the elongation of the chain is the formation of the peptide 
bond, which is catalyzed by the condensation (C) domain.  Like the A and PCP domains, 
the C domain is required in each module, with the exception of the initiation module, and 
is located between two adjacent activating units in the same peptide synthetase 
polypeptide (Marahiel et al., 1997). In some modules the C domain is replaced by Cy-
domain, which catalyzes the formation of oxazoline or thiazoline through either 
intermolecular condensation or intramolecular heterocyclization reaction (Keating et al., 
2002).  The C domain contains a donor site, dedicated for the peptide attached to the PCP 
 41 
domain of the preceeding module, and an acceptor site for the monomeric residue 
attached to the PCP domain in the same module (Challis & Naismith, 2004). The reaction 
in the C domain pro eeds through a nu leophili  atta   of the α-amino group of the 
substrate in the acceptor site onto the thioester group of the substrate in donor site, 
followed by the amide bond formation (Marahiel & Essen, 2009). Since the growth of the 
peptide chain progresses unidirectionally from N-terminus to C-terminus, the entire 
peptide is transferred from the upstream donor site to the downstream acceptor site after 
the peptide bond is formed. The acceptor site has shown to be more substrate specific and 
even discriminating between different enantiomers whereas the donor site as the binding 
site for the growing peptide exhibits less strict specificity towards its substrates (Belshaw 
et al., 1999; Linne & Marahiel, 2000). 
Insight into the structural characteristics of C domain has been obtained through 
the crystal structures of VibH, a stand-alone condensation domain from Vibrio cholerae 
vibrioactin synthetase (Figure 7), and of the didomain PCP-C from modules 5 and 6 of 
tyrocidine synthetase TycC (Keating et al., 2002; Samel et al., 2007). In both structures 
the enzyme consists of N-terminal and C-terminal domains that form a V-shaped fold 
with the active site at the junction of the two domains. The two subdomains are 
structurally very similar and based on their sequnce are related to enzymes of the acetyl 
coenzyme A dependent acetyl transferase superfamily, such as chloroamphenicol acetyl 
transferase (CAT) (Keating et al., 2002; Samel et al., 2007; Challis & Naismith, 2004). 
The domains exhi it a αβα sandwi h  onformation where one of the β-strands from each 
domain contributes to  omplete a β-sheet in the other (Keating et al., 2002). The active 
site was found to rather be a canyon-like formation than two distinct pockets as was 
expected (Keating et al., 2002; Samel et al., 2007). The opposite faces of the canyon 
would serve as the acceptor and donor sites so that their substrates point towards a highly 
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concerved catalytic histidine motif, HHxxxDG, which contains a catalytically important 
histidine residue (Marahiel et al., 1997; Keating et al. 2002; Samel et al., 2007; Marahiel 
& Essen, 2009). This histidine is proposed to function as a general base and deprotonate 
the α-aminogroup for the nucleophilic attack. 
 
Figure 7. The crystal structure of VibH from Vibrio cholerae (PDB code: 1L5A) as a representative of the 
C domain in NRPS system (Keating et al. 2002). The enzyme adopts a V-shaped conformation with the 
active site located in the canyon-like formation between the N-terminal (blue) and C-terminal (purple) 
domains. The two domains are connected with 56-residue helical linker, which is depicted here in red. 
 
After the synthesized peptide has reached its final length, it is released from the 
NRPS machinery. The release of the peptide is usually catalyzed by a dedicated domain 
at the C-terminal module of the peptide assemply line, known as the TE domain (Sieber 
& Marahiel, 2005). The TE domain cleaves the peptide product from the 
4’phosphopantheneyl  ofa tor of PCP of the terminal module in a two-step process that 
leads into linear (penicillin precursor ACV), cyclic (e.g. tyrocidine) or branched-cyclic 
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(e.g. bacitracin) products. The first step is the transfer of the peptide to the highly 
conserved serine residues, located within the GXSXG signature motif of TE domain 
(Konz & Marahiel, 1999; Shen et al., 2004). In this step the hydroxyl group of the serine 
acts as a nucleophile and attacks the thioester bond between the peptide and the 
4’phosphopantheneyl  ofa tor, resulting in the formation of peptidyl-O-TE intermediate 
(Lautru & Challis, 2004; Marahiel & Essen, 2009). The second step results in the release 
of the peptide either through hydrolysis to produce a linear peptide or through 
intramolecular macrocyclization to create a cyclic end product (Marahiel & Essen, 2009; 
Hur et al., 2012). The latter one is more commonly employed by the TE domains in most 
NRPS systems and results from the attack of internal nucleophile, such as a hydroxyl – or 
aminogroup in the peptidyl chain, leading to a cyclic lactone or lactam, respectively 
(Shen et al., 2004; Hur et al., 2012). The function of the TE domain can be replaced by 
the activity of NADPH-dependent reductase (R) domain, which catalyzes the release of 
linear aldehydes or alcohols (Konz & Marahiel, 1999; Marahiel & Essen; 2009). This 
type of peptide release mechanism has been encountered for example in the biosynthesis 
of linear Gramicidin A in Bacillus brevis (Sieber & Marahiel, 2005).  
1.4.3 Structural features of adenylating enzymes 
Adenylation is a chemical reaction where a carboxylic acid group, usually arising 
from an amino acid moiety, is converted into more reactive phosphodiester group through 
condensation with ATP (Novelli, 1967). The released pyrophosphate functions as the 
driving force in this reaction where one mole of water is produced as a byproduct. The 
resulting phosphodiester linkage between the amino acid and AMP is very reactive and 
usually the aminoacyl adenylate is used in secondary reactions either by the same enzyme 
or a different one (Gulick, 2009; Schmelz & Naismith, 2009). There are a number of 
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enzymes capable of adenylation, arising also from very different functional backgrounds. 
These comprise the adenylation subunit of Non-Ribosomal peptide synthetases, acyl- and 
aryl-CoA synthetases, luciferase oxidoreductases, aminoacyl-tRNA synthetases and 
enzymes involved in NRPS-independent siderophores (NIS) synthesis (Schmelz & 
Naismith, 2009). The common feature of these enzymes is that they all activate their 
carboxylic acid containing substrate through adenylation. However, already before 
structural information was available a sequence-based analysis showed that the 
adenylation subunit of NRPS proteins, acyl- and aryl-CoA synthetases, and luciferases 
belong to a same enzymatic superfamily on the basis of the numerous shared concerved 
sequence motifs (McElroy et al., 1967; Babbitt et al., 1992; Turgay et al., 1992a; Turgay 
et al., 1992b). Together these three enzymes form the superfamily of adenylating 
enzymes that in addition of shared sequence motifs, possess common structural 
characteristics.  
In both adenylation subunit of NRPS and in acyl-or aryl CoA synthetases the 
activation via adenylation is followed by thioester-forming reaction where the adenylated 
molecule is attached to a pantheine thiol group (Gulick, 2009). However, in the NRPS 
machinery the thioester formation requires the transfer of the adenylate intermediate from 
the A domain to the PCP domain, whi h  ontains the required 4’-phosphopantheine thiol 
prostetic group. This differs from the acyl-CoA synthetases, which catalyze both 
adenylation and the thioester formation to produce acetyl-CoA (Gulick, 2009). The 
follow-up reaction after adenylation catalyzed by luciferases differs from the ones of its 
enzymatic family members. The lyciferyl-adenylate first goes through an oxidative 
decarboxylation after which the resulting intermediate decomposes within the active site 
to produce a photon of light.  
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The first crystal structure from the family of adenylating enzymes was obtained 
for the firefly luciferase from Photinus pyralis (Figure 8) (Conti et al., 1996). The protein 
consists of two domains, a larger N-terminal domain and a smaller C-terminal one, which 
are linked to each other by a flexible linker.  The N-terminal domain is further divided 
into three subdomains, which include two β-sheet su domains and a β-barrel subdomain 
(Conti et al., 1996). The two β-sheet subdomains form together a five-layered sandwich-
like αβαβα tertiary fold where two helices lie in the middle of the sandwich surrounded 
by the two eight-stranded β-sheets with the remaining heli es pa  ed against the β-sheets. 
The C-terminal domain on the other hand consists of two-stranded antiparallel β-sheet 
and central three-stranded β-sheet that is surrounded  y three α-helices. The overall 
extended conformation of the unliganded enzyme indicated that it represented the 
enzymatic state prior to substrate binding and that conformational changes would occur 
upon substrate binding to enclose the putative active site. 
 
Figure 8. The crystal structure of P. pyralis (firefly) luciferase (PDB code: 1LCI, Conti et al., 1996). The 
structure of firefly luciferase was solved in absence of bound substrate and was the first representative for 
the superfamily of adenylating enzymes. The basic architecture of adenylating enzymes comprises a larger 
N-terminal domain (in gray) linked to a smaller C-terminal domain (in yellow) with a flexible loop.  
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The firefly luciferase structure provided information about the general structural 
organization of the adenylating enzymes. However, in the absence of substrate and a 
structural comparison from the same superfamily of enzymes, the functional mechanism 
of these enzymes remained elusive. This was until the structure of the phenylalanine 
adenylation subunit of Gramicidin synthetase A (PheA) became available (Conti et al., 
1997). The PheA structure was the first solved A domain structure and more intriguingly 
represented the enzyme in its substrate-bound state, which enabled characterization of the 
active site (discussed in detail in the previous chapter). Despite the low sequence identity 
with firefly luciferase (16%), the tertiary fold of the two proteins was highly similar. As 
with the luciferase structure, the PheA also consisted of two domains, a larger N-terminal 
and smaller C-terminal one with the active site in the cleft between the domains. It was 
noticed however that the C-terminal domain of the PheA had rotated about 140° in order 
to form the binding site for the substrates. This observation led later to a hypothesis that 
the different conformational states would represent the steps in the reaction mechanism.  
Currently several crystal structures for the members of the adenylating enzyme 
superfamily have been obtained both in the absence and presence of substrates. These 
include the crystal structures for the stand-alone 2,3-dihydroxybenzoate (DHB)-activating 
adenylation domain DhbE from Bacillus subtilis (May et al., 2002), for the acetyl-CoA 
synthase (Acs) from Salmonella enterica (Gulick et al., 2003), and for the D-Alanine 
carrier protein ligase DltA from both Bacillus subtilis (Yonus et al., 2008) and from 
Bacillus cereus (Du et al., 2008). These enzymes exhibit very similar domain 
organization with the firefly luciferase and PheA. However, depending on the absence or 
presence of ligand/substrate or on the reaction state (i. e. if the adenylation reaction has 
been completed or not), the orientation of the C-terminal domain changes in relation to 
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the N-terminal one. At least three different conformational states have been observed: an 
open conformation with the unliganded firefly luciferase structure as an example, an 
intermediate conformation of which PheA is an example, and finally a so-called closed 
conformation, represented by S. enterica Acs in complex with adenosine-5’-
pyrophosphate and CoA (Gulick, 2009). The two conformational states mentioned last 
have also been termed as the adenylation and thioester-forming conformation, 
respectively. This nomenclature arises from the reaction that these conformations are 
proposed to presede. It has been postulated that the three different conformations would 
mediate the steps in the adenylation reaction mechanism. The open conformation would 
represent a state prior to substrate binding and the binding of the substrate would cause a 
shift to the adenylation conformation, which would be the reactive state of the enzyme, 
and would finally be followed by the closing of the active site to give rise to the thioester-
forming conformation (Figure 9) (Yonus et al. 2008; Gulick, 2009). This theory is, 
however, based on structural information from separate enzymes, and does not for 
example correlate with the information gained from the DhbE structures. The adenylation 
domain DhbE, which is a stand-alone enzyme responsible for the activation of the aryl 
acid DHB as the initial step in the synthesis of bacillibactin, was crystallized in 
unliganded form, together with DHB and AMP, and finally in complex with adenylated 
DHB (May et al., 2002). No conformational change between the three structures was 
observed, in contrast with the proposed model. Therefore the authors proposed that the 
binding and activation of the substrate by adenylation would rather involve local changes 
in the active site.   
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Figure 9. The proposed adenylation domain reaction cycle. The conformational changes in the C-terminal 
domain (shown in brown) of adenylating enzyme have been proposed to reflect the different steps in the 
adenylation reaction. The open conformation is reperesented by the structure of unliganded firefly 
luciferase (PDB code: 1LCI), the adenylation conformation by the structure of PheA and the closed 
conformation (also termed as thioester conformation) by the structure of DltA (PDB code: 3E7W). The N-
terminal domain is depicted in pink and the bound substrate as yellow sphere model. Image adopted from 
Yonus et al. (2008) and Strieker et al. (2010).  
 
1.5 Aim of the work 
The main aim of the thesis work is the structural characterization of two 
Arabidopsis thaliana proteins, ETR1 and EDR1, both of which are involved in the plant 
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defense response signaling in ethylene-dependent manner. The most ambitious goal is the 
expression and purification, and ultimately crystallization of the full-length ETR1, an 
initiator and regulator of the ethylene-signaling pathway. The structure of the full-length 
receptor would help to answer questions about the signal relay from the membrane-
embedded ligand-binding domain to the cytosolic domains. Since membrane protein 
expression and purification possess several challenges and a construct without the 
membrane domain is studied in parallel. A combination of X-ray crystallography and 
Small Angle X-ray scattering (SAXS) are used for the structural characterization of this 
ETR1-ΔTM  onstru t. ETR1-ΔTM has already  een studied in the group using SAXS  ut 
the presence of non-detergent sulfobetaine (NDSB) compound in the buffer was found 
not to be ideal for these measurements. Since the NDSB is required for the stabilization 
of the protein in solution, the aim is to improve the purification conditions of the protein 
in order to make the protein sample more compatible with SAXS. A stable protein is also 
expected to be more amenable for crystallization. 
In addition to the work on the ethylene receptor, structural studies on another A. 
thaliana protein EDR1 are conducted. EDR1 is known to be involved in plant immune 
responses and also in the regulation of ethylene-induced senescence. It also shares high 
similarity with CTR1, which makes it interesting target for structural studies in the light 
of previous work in the group. The structural knowledge of proteins that take part in the 
plant defense response signaling pathways is important for elucidating the mechanisms by 
which they regulate their activity or the activity of other proteins in the same or related 
pathways. Additionally, it could give information needed to genetically modify and thus 
create plant cultivars more resistant to certain pathogens. 
Concerning the proteins that are involved in responses to environmental and biotic 
stress, another interesting but bacterial enzyme is studied as part of the thesis work. The 
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target enzyme, ApnA A1 is the first adenylation domain in the initiation module of the 
Anabaenopeptin synthetase (a non-ribosomal peptide synthetase) from cyanobacterium 
Planktothrix agardhii strain PCC7821. ApnA A1 PCC7821 is a bi-specific enzyme that 
activates both L-tyrosine and L-arginine. As a part of the Anabaenopeptin synthetase, the 
bi-specificity of ApnA A1 enables the formation of two different Anabaenopeptins as 
final peptide products. The possible pharmaceutical applications for the synthesis 
products of these enzymes make them an interesting topic for structural studies. 
Knowledge about the residues that define the substrate specificity of the enzyme could 
help to modify its activity. Enzyme with engineered specificity could be further used in 
synthesis of new compounds with antimicrobial activity. 
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2. MATERIALS AND METHODS 
2.1 List of online tools 
The table 1 summarizes the online tools and their use in this thesis work. The NetPhos 2.0 
Server was used only for EDR1 kinase domain construct. 
 
Table 1. Online tools used in the thesis work. 
Name Function Reference 
NetPhos 2.0 Server Prediction of phosphorylation 
sites 
Blom et al., 1999 
ProtParam Calculation of variety of 
physicochemical properties 
(molecular mass, isoelectric 
point and extinction coefficient) 
for proteins  
Gasteiger et al., 2005 
PDBePISA Interfaces, surfaces and 
assemblies from 3D structures 
Krissinel & Henrick, 2007 
DALI server Search for similar 3D structures Holm & Rosenstrom, 2010 
MATTPROB Calculation of Matthews 
coefficient 
Matthews, 1968; 
Kantardjieff & Rubb, 2003 
 
2.2 Constructs 
The work on plant defense signaling molecules focused on the full-length ETR1 
(NCBI accession no. NP_176808) and on the structural characterization of its cytosolic 
part, referred as ETR1-ΔTM. The latter one comprised GAF domain, histidine kinase 
domain with dimerization histidine phosphotransfer (DHp) and catalytic ATP-binding 
(CA) subdomains, and receiver (RR) domain. In addition to ETR1, structural 
characterization of another plant defense signaling protein, the Enhanced Disease 
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Resistance 1 (EDR1, NCBI accession no. NP_563824) was conducted. The main 
construct comprised the catalytic domain of A. thaliana serine/threonine kinase EDR1 
(EDR1-kd, residues 655-933). In addition to the wild type catalytic domain, three kinase 
domain variants were studied. These included a catalytically inactive and two G-helix 
mutants.  
Apart from the work on plant signaling molecules, structural studies were 
conducted with ApnA A1 PCC7821, which is the first adenylation domain in the initiation 
module of Anabaenopeptin synthetase from Planktothrix agardhii strain PCC7821. In 
addition to the structural studies on the wild type enzyme, several active site mutants 
were produced in order to alter the substrate binding specificity of the enzyme. The 
plasmid containing the wild type ApnA A1 PCC7821 was obtained from a collaboration 
partner G. Christiansen (University of Innsbruck).  
The main constructs for ETR1, EDR1 and ApnA A1 PCC7821 are listed in the 
table 2 and the mutants of these proteins, if applicable, are shown in the table 3. The 
primers needed for the PCR amplifications of the target genes are listed in appendix 1. 
The nucleotide sequence for the ApnA A1 PCC7821 construct is shown in appendix 2. 
 
Table 2. The protein constructs of ETR1, EDR1 and ApnA A1 that were included into the thesis work. 
Construct ID Protein Domain(s) Molecular 
weight (kDa) 
FL ETR1 ETR1 Full-length protein 82.6 
ETR1-ΔTM ETR1 GAF++DHp+CA+RR 64.6 
EDR1-kd EDR1 Kinase domain 32.0 
ApnA A1 PCC7821 ApnA A1 PCC7821 Adenylation domain 61.2 
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Table 3. The list of EDR1-kd and ApnA A1 PCC7821 mutants. 
Construct Mutated residue(s) Mutated into 
EDR1-kd D792 N 
EDR1-kd V876 E 
EDR1-kd F881 E 
EDR1-kd V876/F881* E/E 
ApnA A1 PCC7821 E204 G 
ApnA A1 PCC7821 E204/S243 G/E 
ApnA A1 PCC7821 S243 C, D, E, G, H, I, K, L, M, N, P, Q, R, T, 
V, W, Y 
ApnA A1 PCC7821 A307 C, D, E, F, G, H, I, K, L, M, N, P, R, T, 
V, W, Y 
ApnA A1 PCC7821 K415 A 
ApnA A1 PCC7821 K500 A 
ApnA A1 PCC7821 K415/K500* A/A 
* A double mutant. 
 
2.3 Polymerase Chain Reaction (PCR) 
Polymerase chain reaction was used to amplify target genes from suitable DNA 
source prior to cloning but also to verify the existence of correct clone in bacterial colony 
(colony-PCR). For this purpose, primers that bind to flanking regions of the target gene 
were needed. In site-directed mutagenesis PCR was used to introduce a desired mutation 
into the target gene and consequently to the corresponding protein. Both standard PCR 
amplifications of target gene and site-directed mutagenesis PCR experiments were 
conducted using a high-fidelity version of Phusion DNA polymerase (New England 
Biolabs GmbH, Frankfurt am Main, Germany). In the case of colony-PCR a polymerase 
with a very low error rate is not necessary and therefore OneTaq polymerase (New 
England Biolabs GmbH, Frankfurt am Main, Germany) was preferred. The reaction set 
up for Phusion HF polymerase is shown in table 4 and for OneTaq polymerase in table 5.  
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Table 4. PCR reaction set up for Phusion HF polymerase. 
Reagent Amount 
5XPhusion HF or GC reaction buffer 10 µl 
2 mM deoxy-nucleotide solution 5 µl 
Forward primer (10 pmol/µl) 1.5 µl 
Reverse primer (10 pmol/µl) 1.5 µl 
DNA template (50 – 150 ng/µl) 1 µl 
Phusion HF Polymerase (2 U/µl) 0.7 µl 
Milli-Q H2O To total volume of 50 µl 
 
Table 5. PCR reaction mixture for OneTaq polymerase as used in the colony-PCR. A sample of the 
bacterial colony with the target plasmid was added to the solution to provide the DNA template. 
Reagent Amount 
5XOneTaq standard reaction buffer 5 µl 
2 mM deoxy-nucleotide solution 2.5 µl 
Forward primer (10 pmol/µl) 1.0 µl 
Reverse primer (10 pmol/µl) 1.0 µl 
OneTaq DNA polymerase 0.1 µl 
Milli-Q H2O To total volume of 25 µl 
 
For the colony-PCR the primers were chosen so that one was specific for the 
vector and the other for the gene insert. Since the E. coli expression vectors used in this 
thesis work contained T7 promoter site, a commercially available T7 forward primer 
(Eurofins MWG Operon, Ebersberg, Germany) complementary to the nucleotide 
sequence of the promoter was used in combination with insert specific reverse primer.  
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The thermocycling conditions for both polymerases were chosen according to 
manufa turer’s proto ol unless mentioned otherwise. In a standard PCR run the annealing 
temperature was set up to be 5°C below the melting temperature (Tm) of the primer with 
the highest Tm-value. The amplified insert was purified after PCR by either using gel 
extraction or QIAquick PCR Purification kit (Qiagen GmbH, Düsseldorf, Germany) 
according to manufactors protocol. For gel extraction the insert DNA was first run on 
agarose gel, the band corresponding to the insert excised from the gel and finally purified 
using QIAquick Gel Extraction kit (Qiagen GmbH, Düsseldorf, Germany). 
2.4 Site-directed mutagenesis 
The EDR1 kinase domain mutants as well as the ApnA A1 PCC7821 mutants were 
produced using site-directed mutagenesis. A modified protocol from QuickChange® Site-
Directed Mutagenesis Kit (Agilent Technologies, Waldbronn, Germany) was used to 
introduce the desired mutations. This involved the replication of both strands of the 
plasmid using oligonucleotide primers with the desired mutation included. The primers 
were designed so that they were complementary to opposite strands of the plasmid. The 
primers are extended in a PCR reaction to create a plasmid that contains the mutated 
target gene. The plasmid from the site-directed mutagenesis PCR contains a nick, which 
is repaired in E. coli after the plasmid is transformed into a suitable E. coli strain. Prior to 
transformation the product from the site-directed mutagenesis PCR is treated with DpnI 
to digest the parental plasmid. This digestion is based on the ability of the DpnI enzyme 
to degrade hemimethylated DNA, which is the case with plasmid DNA that has been 
isolated from E. coli.  
In the site-directed mutagenesis of EDR1 kinase domain mutants Phusion High-
Fidelity DNA polymerase were used in the PCR reaction. The wild type kinase domain of 
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EDR1 in pMCSG7 vector (Eschenfeldt et al., 2009) was used as the template. The 
thermocycling conditions differed from the standard Phusion HF DNA polymerase 
protocol in that the number of cycles was reduced to 18. Additionally, instead of the 
recommended 1kb/min, a doubled extension time of 2kb/min was used to ensure the 
synthesis of the entire plasmid. For the site-directed mutagenesis of both ApnA A1 
PCC7821 and ETR1-ΔTM Pfu Ultra  igh Fidelity DNA polymerase (Agilent 
Technologies, Waldbronn, Germany) was used. The reaction set up for Pfu Ultra HF 
DNA polymerase is shown in the table 6 and the thermocycling conditions in table 7. 
 
Table 6. PCR reaction set up for ApnA A1 PCC7821 mutants using Pfu Ultra HF DNA polymerase. 
Reagent Amount 
10XPfu Ultra Turbo reaction buffer 5 µl 
2 mM dNTPs 5 µl 
Template DNA  5 µl 
10 pmol forward primer 1 µl 
10 pmol reverse primer 1 µl 
Pfu Ultra HF DNA polymerase 1 µl 
Milli-Q H2O 32 µl 
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Table 7. PCR thermocycling conditions for the ApnA A1 PCC7821 mutants. 
Step Temperature Time Repeats 
Initial Denaturation 95°C 2 min 1 
Denaturation 
Annealing 
Extension 
95°C 
59°C 
72°C 
35 s 
35 s 
15 min 
18 
18 
18 
Final Extension 72°C 18 min 1 
 
After the PCR reaction, the formed product was treated with DpnI (New England 
Biolabs GmbH, Frankfurt am Main, Germany) to degrade the parental plasmid, which 
does not have the desired mutation. The DpnI digestion was done according to the 
manufa turer’s protocol using CutSmart buffer (New England Biolabs GmbH, Frankfurt 
am Main, Germany). To ensure the completion of the DpnI digestion the reaction mixture 
was incubated overnight at 37°C. 5 µl of the overnight incubation product was used to 
transform high-efficiency and chemically competent E. coli D 5α  ells a  ording to the 
standard transformation protocol. From the colonies growing on the plate a subset was 
chosen to set up pre-cultures for the subsequent plasmid preparation. The correct 
mutation in the plasmid was verified by DNA sequencing.  
2.5 Restriction endonuclease cloning method 
The full-length ETR1 was cloned from both cDNA and from pUC57 vector 
containing the E. coli codon-optimized synthetic gene of ETR1 (GenScript USA Inc., 
Piscataway, NJ, USA) using restriction endonuclease based method. The gene 
amplification was conducted using standard PCR setup with Phusion DNA polymerase 
(New England Biolabs GmbH, Frankfurt am Main, Germany) according to 
 58 
manufa turer’s protocol. The ETR1 gene was cloned into pET15b and pETM-11-
SUMO3GFP E. coli expression vectors using forward primers with NdeI and NcoI and 
reverse primers with BamHI recognition site, respectively. Both vectors add an N-
terminal His6-tag to the construct and but the latter one also a C-terminal Green 
Fluorescence Protein (GFP) as a fusion protein. Prior to the ligation step the PCR 
amplified insert and the target vector were digested with the appropriate enzymes. The 
inserts as well as the pETM11-SUMO3GFP vector were digested in one step. The 
pET15B vector was digested in two consequent steps due to the near location of the NdeI 
and BamHI sites in the vector sequence to ensure the efficient binding of the enzymes to 
their cutting sites. The basic digestion reaction set up is shown in table 8 using the 
NcoI/BamHI double digestion as an example. All the enzymes were purchased from New 
England Biolabs (New England Biolabs GmbH, Frankfurt am Main, Germany) and with 
the exception of NdeI were the high-fidelity (HF) versions. The pET15b vector was 
digested for 3 h at 37°C with one enzyme prior to the addition of the second enzyme. 
After this, the incubation was continued for another 3 h at same temperature. 
 
Table 8. Restriction enzyme digestion reaction for the ETR1 insert for pET15b vector. 
Compound V(stock solution) Final concentration/amount 
NcoI-HF  1 µl 0.4 U/µl 
BamHI-HF  1 µl 0.4 U/µl 
10NEBuffer 4 5 µl 1X 
Insert or vector DNA* x µl 1.0 µg 
MilliQ H2O 38 µl - 
*The amount of vector or insert DNA stock solution dependent on the stock concentration. 
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After the completion of the reaction both the insert and the vector were purified using 
Qiaquick Gel Extraction kit (Qiagen GmbH, Düsseldorf, Germany). The purified 
products were used for the subsequent ligation reaction. 
2.6 Ligation in restriction endonuclease cloning 
The ligation of the ETR1 gene, both synthetic and cDNA derived, into both 
pET15b and pETM11-SUMO3GFP vectors was conducted by T4 DNA ligase-dependent 
method. The T4 DNA ligase is an enzyme that catalyzes the formation of a 
phosphodiester bond between juxtaposed 5' phosphate and 3' hydroxyl termini in duplex 
DNA or RNA and can be used to join both blunt end and cohesive end termini.  
The ligation reaction was performed with an enzyme from New England Biolabs 
(New England Biolabs GmbH, Frankfurt am Main, Germany) according to the 
manufacturer's protocol. The insert and the vector were added to the reaction mixture 
roughly in 7:1 molar ratio. The reaction set up is shown below (Table 9). 
 
Table 9. The ligation reaction set up in restriction endonuclease cloning. 
Reagent Amount 
10XT4 ligase buffer 2 µl 
Vector DNA* 50 ng 
Insert DNA** 110 ng 
T4 DNA ligase 1 µl 
Milli-Q H2O 4 µl 
 *The size of pET15b is 5708 bp and pETM11-SUMO3GFP 6290 bp. 
**ETR1 insert size is 2217 bp.  
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2.7 Ligation Independent Cloning 
Ligation Independent cloning or LIC cloning was used to produce two of the main 
ETR1 constructs. The LIC vectors as well as the cloning protocol were developed at 
EMBL Hamburg (courtesy of A. Geerlof). The full-length ETR1 was cloned to the 
pETM-11/LIC, which introduces an N-terminal His6-tag to the protein. The ETR1-ΔTM 
had been previously cloned into pET-GB-1a/LIC vector (Mayerhofer, 2011), which adds 
the β-subunit of protein G as a solubility improving phusion tag to the N-terminus of the 
target protein.  
In LIC cloning the use of restriction enzymes is not required instead it is based on 
annealing of the complementary overhangs between the insert and the LIC vector. The 
suitable overhangs are created to the insert by PCR using primers that contain the specific 
extensions complementary to the LIC-vector. The overhangs needed for insertion of the 
target gene into EMBL LIC-vectors are as shown here: 
Forward primer CAGGGCGCCATG-gene of interest 
Reverse primer GACCCGACGCGGTTA-gene of interest 
Additionally both the vector and the insert are treated with T4 DNA Polymerase to create 
poly-A (insert) or poly-T (vector) extension to improve the annealing.  
The EMBL LIC-vectors contain the gene for enhanced Green Fluorescence 
Protein (eGFP), which was removed prior to T4 treatment.  Two BsaI cutting sites flank 
the eGFP gene, which allows its removal by an enzymatic digestion reaction. To 
complete this digestion the reaction mixture shown in the table 10 was incubated at 50°C 
for an hour. The enzyme and the buffer were obtained from New England Biolabs (New 
England Biolabs GmbH, Frankfurt am Main, Germany). 
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Table 10. The reaction components for BsaI digestion of the LIC-vector. 
Reagent Amount 
10XNew England Biolabs buffer 3 5 µl 
LIC vector DNA 5 µg* 
BsaI (10 units/µl) 2.5 µl 
Milli-Q H2O To the total volume of 50 µl 
*Usually the amounts of DNA from gel extraction were relatively low and due to this vector DNA was 
added to fill the reaction volume to 50 µl thus excluding the addition of Milli-Q H2O. 
 
After the BsaI-digestion the linearized vector was purified using gel extraction. To this 
end, the sample was run on a 0.8% agarose gel at 100 V for an hour and the band 
corresponding to the vector was extracted from the gel using the QIAquick Gel Extraction 
kit according to manufa turer’s protocol and subsequently treated with T4 DNA 
polymerase. The reaction set up for the T4 DNA Polymerase (New England Biolabs 
GmbH, Frankfurt am Main, Germany) is shown in the table 11. 
 
Table 11. The components required for T4 DNA Polymerase treatment of the LIC-vector. 
Reagent Amount 
2XNew England Biolabs buffer 2 2 µl 
BsaI-digested vector  600 ng 
100 mM dTTP  0.5 µl 
100 mM DTT  1 µl 
100XBSA  0.2 µl 
T4 DNA Polymerase (3 units/µl) 0.4 µl 
Milli-Q H2O To total volume of 20 µl 
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To complete the reaction the reaction mixture was incubated for 30 minutes at room 
temperature and subsequently the polymerase was inactivated by incubating the reaction 
mixture at 75°C for 20 minutes.  
The insert for the LIC-cloning was amplified using standard PCR reaction and 
primers with the LIC-cloning extensions and following the protocol for Phusion HF DNA 
polymerase (New England Biolabs GmbH, Frankfurt am Main, Germany). The PCR 
amplification was followed by the purification of the insert according to instruction in the 
used Qiagen PCR Purification kit. The insert was then also treated with T4 DNA 
polymerase in a similar manner as the vector but using dATP to form complementary 
overhang with the vector. For the ligation reaction, T4 polymerase treated insert DNA 
and vector DNA was mixed in 2:1 ratio. The subsequent mixture was first incubated at 
room temperature for 5 minutes followed by addition of 1 µl of 25 mM EDTA, and the 
incubation was continued for at least another 5 min but up to 1 hour at room temperature 
to complete the reaction. The product of the annealing reaction was finally transformed to 
E. coli D 5α  ells to seal the nicks and form an intact plasmid.  The bacterial colonies 
growing on the antibiotic containing agar plate were further screened for the correct 
insertion by colony-PCR. The sequence of the plasmid was verified by DNA sequencing 
(Eurofins MWG Operon, Ebersberg, Germany). 
2.8 DNA gel electrophoresis 
Gel electrophoresis is a method for separating macromolecules such as DNA 
according to their size and charge. The molecules are placed into an electrical field where 
they migrate towards the positive or negative pole depending on their charge. Due to the 
phosphate backbone DNA molecule is negatively charged and travels towards the 
positively charged pole. Therefore the separation of DNA fragments is based on their size 
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and the velocity of their migration is dependent on the density of the matrix. The most 
commonly used matrix for DNA applications consists of agarose, a polysaccharide 
originally extracted from seaweed. Depending on the size of DNA fragments to be 
separated the concentration of the agarose can vary between 0.7 % and 2.0 %. The 
sieving range of agarose gel can be from few hundred bases to several kilobases (kb).  
DNA electrophoresis was used for both qualitative analysis and purification of 
DNA molecules from mixtures of differently sized fragments. The agarose concentration 
used dependent on application of the method. For purification of DNA inserts after PCR 
and both vectors and inserts after enzymatic digestion was done on a 1.0 % agarose gel. 
The gel was prepared by mixing 2.5 g of agarose (Serva Electrophoresis GmbH, 
Heidelberg, Germany) in powder form to 250 ml of 1Tris-borate-EDTA (TBE) 
electrophoresis buffer, diluted from a commercially available 10TBE stock solution 
(Carl Roth GmbH & Co. KG, Karlsruhe, Germany). The mixture was made homogenous 
by heating it up in the microwave for up to 3 min at full power (900 W), occasionally 
gently mixing by swirling. Prior to casting of the gel ethidium bromide (0.025% solution, 
Carl Roth GmbH & Co. KG, Karlsruhe, Germany) was added for visualization of the 
DNA fragments by using UV-light. Prior to loading the samples to the gel mixed with 
6Xloading dye in sample to loading dye ratio of 5:1. The samples were loaded into the gel 
together with either a 100 bp DNA ladder (Fermentas/Thermo Fisher Scientific – 
Germany GmbH, Schwerte, Germany) if the DNA fragment size was smaller than 500 bp 
or with a 1kb DNA ladder (Fermentas/Thermo Fisher Scientific – Germany GmbH, 
Schwerte, Germany) if the fragment size exceeded 500 bp. Typically the gel was run at 
100 V for 1 hour submerged in 1TBE buffer.  
For analyzing the success of digestion or PCR reaction both after site-directed 
mutagenesis and colony-PCR, a lower agarose gel concentration of 0.8% in combination 
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with 1Tris-acetate-EDTA (TAE) buffer was used. The preparation of the 50TAE buffer 
is hown in the table 12. The sample handling and choice of DNA ladder was as 
previously described in the case of DNA purification from 1% agarose gels. The gel was 
however run at lower energy of 50 V for 80 min to avoid the melting of the gel.   
 
Table 12. The preparation of 50TAE buffer. The chemicals were purchased from Roth (Carl Roth GmbH 
& Co. KG, Karlsruhe, Germany). 
Reagent Final concentration 
TRIS 
Glacial acetic acid 
EDTA 
2.0 M 
1.0 M 
50 mM 
 
2.9 Plasmid preparation 
The plasmid containing the gene for the target protein was transformed to E. coli 
D 5α strain a  ording to standard proto ol. Colony from the agar-plate was used to 
inoculate 5 ml of Luria Bertani (LB) medium (see table 13 for recipe) with suitable 
antibiotics and grown overnight at 37°C. The cells were then harvested the next day by 
centrifugation at 4000 rpm for 10 min at 4°C. The pellet was used for the plasmid 
purification, which was conducted using the Qiaprep Spin Miniprep kit (Qiagen GmbH, 
Düsseldorf, Germany) according to the protocol supplied by the manufacturer. The 
plasmids were eluted to 32 µl Milli-Q water and their concentration was measured using 
Nanodrop ND-1000 spectrophotometer (NanoDrop Technologies, Inc., Wilmington, 
USA).  
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Table 13. The components of LB-medium. The chemicals were purchased from Roth (Carl Roth GmbH & 
Co. KG, Karlsruhe, Germany). 
Compound Final concentration 
Tryptone 
Yeast Extract 
NaCl 
10 g/l 
5 g/l 
5 g/l 
 
2.10 Transformation 
The plasmid DNA containing the target gene was introduced into the suitable 
chemically competent E. coli strain by heat-shock transformation method. When 
transformation was performed after cloning experiments the amount of ligation mixture 
added to the thawed competent cells was between 4 and 10 μl whereas for standard 
plasmid transformation 0.5 - 1 μl of plasmid solution was normally sufficient. After this 
the cells were incubated 30 minutes on ice and then heated for 45 seconds in 42°C water 
bath in order to the bacterial membrane become porous and take the target plasmid in. 
The heat-shocked E. coli cells were then incubated additional 2 minutes on ice to reduce 
the damage on the cells followed by the addition of 80 µl SOC (Super optimal broth with 
catabolite repression) medium (see Table 14 for recipe) and incubation for 1 hour at 
37°C. Finally the cells were plated on LB-agar containing the suitable antibiotic and 
colonies were allowed to grow during the overnight incubation period at 37°C. 
 
 66 
Table 14. The components included in the SOC medium. 
Component Final concentration 
Yeast extract 
Tryptone 
NaCl 
KCl 
MgCl2 
MgSO4 
0.5 % (w/v) 
2.0 % (w/v) 
10 mM 
2.5 mM 
10 mM 
10 mM 
 
2.11 Expression in E. coli 
The expression of ETR1-ΔTM with the deca-His-tag was done as previously 
described for the His6-tagged protein (Mayerhofer, 2011). For this purpose the plasmid 
containing the His10-tagged construct was transformed to the E. coli Rosetta 2 (DE3) 
strain and colony from the kanamycin-containing agar-plate was used to inoculate 
overnight LB-culture. 1 L of Terrififc Broth (TB, see table 15 for recipe) culture medium 
was in turn inoculated with 10 ml of the overnight pre-culture and the cells were allowed 
to grow at 37ºC with 200 rpm shaking (Infors HT Multitron 25, Infors GmbH, Einsbach, 
Germany) until OD600-value of 1.0 – 1.5 was reached. At this point, the cultures were 
induced with isopropyl-β-D-thiogalactopyranoside (IPTG), which was added to final 
concentration of 40 µM. Culturing was then continued at lower temperature of 25ºC for 
another 18 hours. The cells were harvested by centrifugation at 4500 rpm for 45 minutes 
at 4ºC and the resulting pellet stored at -20ºC until the day of use.  
 
 67 
Table 15. The preparation of the TB-media for E. coli cultures. The chemicals were purchased from Roth 
(Carl Roth GmbH & Co. KG, Karlsruhe, Germany). 
Component Final concentration 
Casein 
Yeast Extract 
K2HPO4 
KH2PO4 
12 g/l 
24 g/l 
12.5 g/l 
2.3 g/l 
 
The EDR1 kinase domain constructs were transformed and expressed in E. coli 
strain BL21 cells co-expressing chaperones DnaK, DnaJ, GrpE, ClpB, GroEL and GroES 
(CC4 cell lines, courtesy of A. Geerlof, Helmholtz Zentrum München, Munich, 
Germany). The pre-cultures were prepared by inoculating 5 ml of LB-medium containing 
100 µg/ml ampicillin with a single colony from a plate of freshly transformed cells. The 
pre-cultures were incubated overnight at 37ºC in shaking incubator (160 rpm, Infors HT 
Multitron 25) and used the next day to inoculate 1 L of auto-induction medium (Studier, 
2005). The components of the auto-induction medium are shown in table 16. The 1 L 
cultures were first incubated at 37ºC with 200 rpm shaking speed until an OD600 between 
0.6 and 0.8 was reached. After this point the cultures were cooled down and incubation 
was continued for another 18 h at a lower temperature of 21ºC. IPTG addition was not 
needed sin e the α-lactose in the medium functions as the inducer and starts to act after 
the bacteria has consumed all the available glucose. Finally, the cells were harvested by 
centrifugation at 5500 rpm in a Sorvall RC26 centrifuge (Thermo Fisher Scientific 
Inc./Thermo Electron LED GmbH, Langenselbold, Germany) equipped with JLA-8.1000 
rotor (Beckmann Coulter, Inc., Brea, CA, USA) for 25 min at 4ºC. 
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Table 16. The components of the ZYM-5052 auto-induction medium used for large-scale cultures. 
Component Concentration 
Trype 
Yeast Extract 
1 % 
0.5 % 
Na2HPO4 25 mM 
KH2PO4 
NH4Cl 
Na2SO4 
25 mM 
50 mM 
5 mM 
Glycerol 
Glucose 
α-lactose 
0.5 % 
0.05 % 
0.2 % 
MgSO4 2 mM 
1000Trace elements* 0.2x 
*This solution contains 50 mM FeCl3, 20 mM CaCl2, 10 mM MnCl2, 10 mM ZnSO4 and CoCl2, CuCl2, 
NiCl2, Na2MoO4, Na2SeO3 and H3BO3 each in concentration 2 mM. 
 
The expression protocol for the ApnA A1 PCC7821 mutants was obtained from a 
collaboration partner Prof. Dr. Andrea Rentmeister (University of Münster). For 
expression the plasmid containing the gene for the ApnA A1 PCC7821 mutant was first 
transformed into E. coli strain BL21(DE3). The pre-cultures were set up by inoculating 6 
ml of LB-medium containing 50 µg/ml kanamycin with a single colony from LB-agar 
plate. These cultures were then grown overnight in shaking incubator (160 rpm, Infors 
HT Multitron 2) at 37°C and used next day to inoculate 400 ml of LB-medium containing 
kanamycin in same concentration than in the pre-cultures. The main cultures were first 
incubated at 37ºC until suitable cell density was reached, indicated by the OD600-value 
between 0.2 and 0.5. The expression of the target protein was then induced by the 
 69 
addition of IPTG to 0.16 mM final concentration. The culturing was then continued at 
23ºC for 5 h after which the cells were harvested at 4°C at 6000 rpm (Sorvall RC26 
centrifuge with JLA-8.1000 rotor) for 15 min. The cell pellets were stored at -20ºC prior 
to use. 
2.12 Virus preparation for insect cell culturing 
The expression in insect cells was conducted using MultiBac expression system 
developed in Berger lab at EMBL Grenoble (Berger et al., 2004; Fitzgerald et al., 2006; 
Bieniossek et al., 2008). The target gene was inserted to pFastBac HTa vector by 
restriction enzyme based cloning method and transformed into E. coli DH10EMBacY 
cells. This cell strain contains the baculoviral genome as bacterial artificial chromosome 
to which the target gene is integrated by Tn7 transposition. It also contains the helper 
plasmid for Tn7 transposon enzyme and YFP reporter gene in the virus backbone for 
quantitative analysis of protein expression. Additionally the DH10EMBacY strain has 
resistance to kanamycin, tetracycline and chloramphenicol. The transformed cells were 
plated on an agar plate, which contained in addition to the listed three antibiotics also 
gentamycin in standard concentrations, 1 mM IPTG and 40 µg/ml 5-bromo-4-chloro-3-
indolyl-beta-D-galactopyranoside (X-Gal, Invitrogen™, Life Te hnologies Gm  , 
Darmstadt, Germany). A dilution series of 1:1, 1:10, 1:100 and 1:1000 was made from 
the transformed cells to optimize the cell density on the agar plates. The plates were then 
treated according to standard transformation protocol. The positive integration of the 
target gene was confirmed by blue-white screening since the baculoviral genome also 
contains a LacZα gene that becomes disrupted upon the insertion of the target gene. The 
colonies with the correct clone were distinguishable by their white color. Two of these 
white colonies were picked to inoculate separate 2 ml LB-cultures. 
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The isolation of the baculoviral DNA with the target gene was conducted 
according to a modified protocol from Qiagen Spin Miniprep kit using the buffers from 
the kit. The overnight LB-culture was centrifuged at 4000 rpm for 10 min using a bench-
top centrifuge (Eppendorf 5810R, Eppendorf AG, Hamburg, Germany Diagnostics) to 
harvest the cells. The cells were first re-suspended to 300 µl of P1 buffer followed by 
addition of 300 µl of P2 buffer and gentle mixing of the suspension by turning the tube 4-
6 times upside down. To this 300 µl of N3 buffer was then added and the suspension was 
mixed gently in a similar manner as in previous step. To remove all E. coli debris, the 
solution was first centrifuged at room temperature for 10 minutes at 13,400 rpm 
(Eppendorf Minispin, Eppendorf AG, Hamburg, Germany) followed by the transfer of the 
supernatant to a fresh, sterile tube and an additional centrifugation for 3 minutes. The 
bacmid was then isolated from the supernatant using isopropanol precipitation. To this 
end, 700 µl of 100% isopropanol was added and the solution was centrifuged for 10 min 
at 13,400 rpm at room temperature. The resulting pellet washed with 70% ethanol. After 
this step the work was continued in sterile conditions to avoid any contamination from E. 
coli. The remaining residual amounts of 70% ethanol were removed from the DNA pellet 
by drying it in sterile hood. This was followed by addition of filter-sterilized water to 
dissolve the pellet. The bacmid was prepared for transfection by first adding 200 µl serum 
free insect cell medium (HyClone SFM4 Insect, Thermo Fisher Scientific – Germany 
GmbH, Schwerte, Germany) to 20 µl of the re-suspended baculoviral DNA and then 
mixing the resulting solution with 100 µl of transfection reagent solution. The 
transfection reagent solution was prior to this prepared by mixing 100 µl of insect cell 
media with 10 µl of transfection reagent (X-Treme GENE HP, Roche Diagnostics GmbH, 
Mannheim, Germany).  
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Prior to transfection a stock culture of Spodoptera frugiperda Sf21 cells was 
grown in the serum free insect cell medium to cell density of 0.5 – 1.0 Million/ml and this 
stock was used to seed wells of a 6-well tissue culture plate leaving one well empty for 
medium control. The wells were supplemented with the insect cell medium to total 
volume of 3 ml. The prepared baculoviral DNA is sufficient to transfect two wells leaving 
one seeded well un-transfected for cell control. After transfection the cells were grown at 
27°C for 60 hours followed by harvesting of the supernatant. The supernatant contains the 
initial virus or V0 and was used to infect fresh cells for virus amplification. 
2.13 Virus amplification and expression in insect cells 
The virus amplification was conducted according to the Multibac protocol 
(Bieniossek et al., 2008). The infected cells were monitored in 24-hour intervals by 
counting the cells. If the cell count exceeded 1.5 Mio, the culture was divided in two 
halves and to both equal amounts of culture medium was added. The cells infected with 
ETR1 gene-containing virus usually doubled only once 24 hours after the infection. After 
48 hours the cells stopped doubling and therefore reached the day of proliferation arrest 
(dpa). To monitor the expression level of the protein 1.0 million cell (Mio) aliquots were 
withdrawn starting from the dpa and then in 24-hour intervals. 60 hours after dpa the cell 
suspension was transferred to 50 ml falcon tubes and centrifuged at 150 rcf for 3 minutes 
to harvest the amplified virus or V1 virus in the supernatant. The cell pellet was 
resuspended to media according to the protocol and culturing was continued till 96 hours 
after dpa. At the 96
th
 hour after infection the cells were harvested by gentle centrifugation 
at 150 rcf for 3 min and stored in -20°C. In order to evaluate the protein expression, the 
cell probes that were taken on dpa and on 24-hour intervals after dpa were analyzed on 
SDS-PAGE gel.  
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Prior to protein production in large-scale baculovirus infected insect cell (BIIC) 
stocks were prepared. For this purpose 50 ml of cells in density 1 Mio cells/ml were 
infected with 6 ml of V1 and maintained in this density until dpa was reached. Freezing 
media containing 90% of HyClone insect cell media, BSA in concentration 10 g/l and 
10% of DMSO (v/v) was prepared and filter-sterilized. 100 ml of cell culture was 
centrifuged at 150 rcf for 10 minutes, gently re-suspended to the sterile freezing solution 
to final density of about 10
7
 cells/ml and finally divided to 1 ml aliquots into sterile 
cryovials. These aliquots were either used directly to infect expression cultures or 
optionally stored at -20°C.   
The protein production was done in 1 L cultures, which were infected using the 
prepared BIIC stocks. To this end, one BIIC aliquot was thawed rapidly at 37°C water 
bath, then diluted quickly to 100 ml with the culture media (HyClone) and finally added 
to 900 ml of uninfected cells at a density of about 0.9*10
6
 cells/ml. The cells were 
incubated at 27°C and kept at a density of 10
6
 cells/ml until the day of proliferation arrest. 
The protein expression levels were monitored by taking samples every 24 hours as 
described in the V1 virus preparation section.  
2.14 Membrane protein isolation 
The full-length ETR1 was expressed in insect cell strain Sf21 and as a membrane 
protein was assumed to insert to the cell membranes. Subsequently, the purification of 
ETR1 required a protocol adapted for membrane proteins. A protocol for membrane 
protein isolation from E. coli was obtained from Dr. Preben Morth (Centre for Molecular 
Medicine Norway (NCMM), Blindern, Oslo, Norway). It was slightly modified to be 
better suited for the isolation from insect cells. The initial isolation experiments were 
carried out using the buffers listed in the table 17. The ultracentrifugations and the 
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isolation steps in between were performed at Biozentrum Klein Flottbek (Hamburg 
University, Klein Flottbek, Hamburg) by Ulrike Peters. From each individual isolation 
step, a small sample was taken for analysis on SDS-PAGE gel and for Western blot. 
 
Table 17. The  uffers that were used in the initial mem rane isolation experiment for ETR1. The β-
mercaptoethanol, protease inhibitor PMSF and DNase were always added fresh to the stock solutions that 
contained rest of the components. 
Lysis buffer Membrane wash buffer Membrane resuspension buffer 
50 Mm Tris-HCl pH 7.6 
100 mM NaCl 
5% (V/V) Glycerol 
5 mM β-mercaptoethanol 
3 mM PMSF 
1 µg/ml DNase 
20 mM Tris-HCl pH 7.6 
100 mM NaCl 
5% (V/V) Glycerol 
1 mM PMSF 
20 Mm Tris-HCl pH 7.6 
200 mM NaCl 
10% (V/V) Glycerol 
5 mM β-mercaptoethanol 
1 mM MgCl2 
1 mM PMSF 
 
Prior to cell lysis the insect cells were thawn on ice and washed twice with cold 
lysis buffer to carefully remove residuals of the insect cell media. For the wash step the 
pellet wash gently resuspended to 5 ml of the lysis buffer and centrifuged at 1250 rpm for 
5 min at 4°C. The washed pellet (m = 1 g) was then resuspended to 8 ml of cold lysis 
buffer and sonicated for 30 s on ice using 0.5s/0.5s ON/OFF pulsation mode and 45% 
amplitude. This procedure was repeated once with one minute break in the between. The 
sonicated suspension was centrifuged for 20 minutes at 18000 rpm at 4°C to remove cell 
debris, inclusion bodies and DNA. The membrane fraction with the protein should remain 
in the supernatant, which was transferred on ice to Biozentrum Klein Flottbek for the 
subsequent isolation steps. To isolate the membranes with the protein attached, the 
supernatant from the previous centrifugation step was subjected to ultracentrifugation 
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(45Ti rotor, Beckmann Coulter, Inc., Brea, CA, U.S.A). The ultracentrifugation was 
performed at 4°C using 45 000 rpm rotational speed for 75 minutes. This resulted in 
small, soft membrane pellet that was washed by resuspending the pellet to 9 ml of ice-
cold membrane wash buffer with Dounce homogenizer and repeating the 
ultracentrifugation. The wash step was followed by the membrane protein solubilization 
step. To this end, the washed pellet was resuspended to 3 ml of ice-cold membrane 
resuspension buffer and a solubilization detergent DDM was added to final concentration 
of 1% (W/V). For efficient solubilization, the solution was incubated overnight at 4°C 
with gentle agitation. The isolation process was completed the next day by 
ultracentrifugation. The success of the isolation and solubilization was evaluated using 
SDS-PAGE and Western blot.  
The effect of pH and salt concentration was also studied to obtain soluble protein. 
To this end, two different pH-values (6 and 8) in combination with two different NaCl 
concentrations (20 mM and 500 mM) were tested. The buffers for these experiments were 
prepared as described in tables 18 and 19. Apart from the modification of the buffers, the 
isolation was conducted as described above. 
 
Table 18. The low pH buffers for ETR1 isolation experiments.  
Lysis buffer Membrane wash buffer Membrane resuspension buffer 
50 Mm MES pH 6 
20 or 500 mM NaCl 
5% (V/V) Glycerol 
5 mM β-mercaptoethanol 
3 mM PMSF 
1 µg/ml DNase 
20 mM MES pH 6 
20 or 500 mM NaCl 
5% (V/V) Glycerol 
1 mM PMSF 
20 Mm MES pH 6 
20 or 500 mM NaCl 
10% (V/V) Glycerol 
5 mM β-mercaptoethanol 
1 mM MgCl2 
1 mM PMSF 
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Table 19. The high pH buffers for ETR1 isolation experiments. 
Lysis buffer Membrane wash buffer Membrane resuspension buffer 
50 Mm Tris-HCl pH 8 
20 or 500 mM NaCl 
5% (V/V) Glycerol 
5 mM β-mercaptoethanol 
3 mM PMSF 
1 µg/ml DNase 
20 mM Tris-HCl pH 8 
20 or 500 mM NaCl 
5% (V/V) Glycerol 
1 mM PMSF 
20 Mm Tris-HCl pH 8 
20 or 500 mM NaCl 
10% (V/V) Glycerol 
5 mM β-mercaptoethanol 
1 mM MgCl2 
1 mM PMSF 
 
2.15 Protein isolation from E. coli cells 
The isolation of the soluble protein from the E. coli cells was conducted in similar 
manner for the ETR1-ΔTM and EDR1  onstru ts. The pellets from the large-scale E. coli 
cultures were first thawed on room temperature water path then re-suspended to lysis 
buffer (see table 20) to final volume of 50 ml. The re-suspension of the pellet was 
conducted by 250 rpm mixing with magnetic stirrer at 4°C. To break the cells the cell 
suspension was subjected to sonication, which is a method that employs sound energy at 
ultrasonic frequencies to disrupt the cell membrane. Typically the cell sample was 
sonicated on ice with ultrasonic homogenizer (Sonopuls HD 3200, Bandelin electronic 
GmbH&Co. KG, Berlin, Germany) for 4 minutes in 0.4 s/0.9s ON/OFF pulsation mode 
and this treatment was repeated once. The suspension was then centrifuged at 19 000 rpm 
for 45 - 60 min at 4°C to remove cell debris. For this purpose SS-34 fixed angle rotor 
(Thermo Fisher Scientific, Inc.) in combination with Sorvall RC26 centrifuge (Thermo 
Fisher Scientific, Inc.) was used. The clear lysate was transferred to a fresh 50 ml falcon 
and filtered using 45 µm membrane prior to Ni-NTA affinity chromatography 
purification step. 
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The cell lysis and purification protocol for ApnA A1 PCC7821 was obtained from 
Prof. Andrea Rentmeister (University of Münster). As with EDR1, the cell pellet was first 
thawed on RT water bath after which 10 ml of the lysis buffer described in table 20 was 
added to resuspend the pellet. The resuspended pellet was then sonicated three times for 3 
minutes at 30% amplitude level and having 2 minute break between the sonication 
rounds. The sonication was followed by centrifugation at 4000 rpm for 20 min at 4°C to 
remove the cell debris. The lysate was filtered using 0.22 µm membrane for the 
subsequent NiNTA purification step.  
 
Table 20. The cell lysis buffers for the EDR1 kinase domain and the ApnA A1 PCC7821 constructs. 
Construct Lysis buffer composition 
EDR1 kinase domain 
(WT and mutants) 
50 mM Hepes pH 7.5, 400 mM NaCl, 5% glycerol, 5 mM 
MgSO4, 0.1% CHAPS, 1xEDTA-free protease inhibitor 
tablet, 10 µg/ml DNase 
ApnA A1 PCC7821 50 mM Tris pH 8.0, 300 mM NaCl, 5 mM Imidazole 
 
2.16 NiNTA purification 
Ni-affinity chromatography is a well-known and most widely used version of 
immobilized metal affinity chromatography (IMAC) and was performed as a first 
purification step for all the constructs in this thesis work. The isolation of the target 
protein from the crude cell extract in this purification step was based on the presence of 
an N-terminal hexa-histidine tag, which was included in the N-terminus of every 
construct. For the EDR1 kinase domain Ni-NTA agarose beads (2 ml for WT kinase 
domain and for the D792N mutant, and 1 ml for the G-helix mutants) in gravity flow 
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column were used for this purpose whereas the corresponding purification step for ETR1-
ΔTM and for ApnA A1 PCC7821 was conducted in commercially available NiNTA 
superflow cartridge columns. For ETR1-ΔTM 5 ml NiNTA superflow  artridge  olumn 
(Qiagen GmbH, Düsseldorf, Germany) and for ApnA A1 PCC7821 1 ml His60 Ni-
Superflow cartridge (Invitrogen™, Life Te hnologies Gm  , Darmstadt, Germany) was 
used. The basic steps of the Ni-affinity purification were the same for the different 
proteins consisting of repeated washes and eluting the protein with an imidazole gradient. 
The main differences arose from the buffer compositions and amounts of wash and/or 
elution steps, and also in the amounts of buffers used in these steps. The compositions of 
the two basic buffers used in the wash and elution steps are listed in the table 21. For 
EDR1 these buffers are later referred as buffer A and B, respectively. 
 
Table 21. Compositions of the basic wash and elution buffers used in the NiNTA purification. 
Protein Washing buffer* Elution buffer** 
EDR1 50 mM Hepes pH 7.0, 400 mM 
NaCl, 5 % Glycerol, 5 mM 
MgSO4 
50 mM Hepes pH 7.0, 400 mM 
NaCl, 5 % Glycerol, 5 mM 
MgSO4, 500 mM Imidazole 
ETR1-ΔTM 20mM Tris 8.8, 150mM NaCl, 
3mM β-Mercaptoethanol, 0.1% 
(w/v) CHAPS, 5% glycerol 
20mM Tris 8.8, 150mM NaCl, 
3mM β-Mercaptoethanol, 5% 
glycerol, 300 mM Imidazole 
ApnA A1 
PCC7821 
50 mM Tris pH 8.0, 300 mM 
NaCl, 5 mM Imidazole 
50 mM Tris pH 8.0, 300 mM 
NaCl, 250 mM Imidazole 
*Referred as buffer A for EDR1. **Buffer B for EDR1. 
 
Prior to loading the filtered cell lysate to the column or onto the beads, the Ni-
NTA matrix was equilibrated with 10 column volumes (CV) of wash buffer or buffer A in 
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the case of EDR1. After the lysate was loaded the column, the wash steps followed. For 
EDR1, the beads were first washed with 10 CV of buffer A with 6% buffer B followed by 
5 CV of buffer A with 10 % of buffer B. The protein was eluted in four consecutive steps, 
first with 15 %, 20% and 60% of buffer B in buffer A and finally with buffer B (75 mM 
to 500 mM imidazole). 2CV of buffer was used in each elution step.  
For the ETR1-ΔTM the  olumn was washed after lysate loading by increasing 
linearly the elution buffer concentration to 17% in a 5 CV range. This was followed by 
elution gradient from 17 % to 100 % of elution buffer in 9 CV range. To ensure that all of 
the protein eluted out, elution buffer was run through the column until a plateau in 
absorbance at 280 nm was reached.  
The lysate loading for ApnA A1 PCC7821 was followed by a two-step column 
wash, first with 7 CV of washing buffer then with 7CV of 10 % elution buffer in washing 
buffer. The protein was eluted in a 20 CV linear gradient where the elution buffer 
concentration from 10 to 100 %. Finally 8 CV of elution buffer was run through the 
column to elute any remaining protein. 
2.17 TEV-cleavage and 2
nd
 NiNTA 
The EDR1 constructs were all with an N-terminal His6-tag whereas the ETR1-
ΔTM  ontained an N-terminal His10-tag and also an N-terminal GB1-tag. The expression 
vectors used for these constructs contained a TEV-protease cleavage site between the 
target protein and the tag enabling an easy removal of the tag. After NiNTA purification 
step the His6 – or His10-tag was not needed and was therefore removed by TEV-protease 
treatment. This was conducted during an overnight dialysis step at 4°C. The components 
of the dialysis buffers for both ETR1-ΔTM and EDR1  inase domain  onstructs are listed 
in the table 22.  
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Table 22. Dialysis buffers for the EDR1 and ETR1-ΔTM  onstru ts. 
Dialysis buffer for EDR1 constructs ETR1-ΔTM dialysis buffer 
50 mM Hepes pH 7.0 
400 mM NaCl 
5% Glycerol 
5 mM MgSO4 
1 mM EGTA 
1 mM DTT 
30 mM Tris pH 8.8 
100 mM NaCl 
3 % Glycerol 
6 mM β-mercaptoethanol 
 
For the TEV treatement the suitable elution fractions from Ni-affinity purification step 
were combined and to this TEV-protease in concentration 2 mg/ml were added in 1:10 
molar ratio. The resulting protein solution was dialyzed overnight in a dialysis bag 
(Spectra/Por® 1 Dialysis Membranes, MWCO 6000 to 8000, Spectrum® Laboratories) 
against 2 liters (ETR1-ΔTM) or 5 liters (EDR1) of dialysis buffer.  
The overnight tag-removal step was followed by a second Ni-affinity purification 
to remove the His-tagged TEV-protease and uncleaved protein material. To this end, the 
dialyzed sample was loaded onto Ni-beads in gravity flow column and flow through was 
collected. 1 CV of dialysis buffer was added to the beads to elute the remaining tag-free 
protein out of the column. After this the material bound to the beads was eluted with 2 
CV of elution buffer and collected to a separate falcon tube for analysis of the protease 
treatment efficiency by SDS-PAGE.  
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2.18 Size-Exclusion Chromatography 
The purification of EDR1 kinase domain constructs was finalized with size-
exclusion chromatography (SEC), which is a method that separates proteins according to 
their molecular weight. The SEC purification was conducted in Hiload 16/60 Superdex 
G75 column (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). The matrix of this 
column consists of cross-linked agarose and carbohydrate dextran, and it is suitable for 
separating proteins in molecular range from 3000 Da to 70 000 Da. The tag-free 
monomeric EDR1 kinase domain has a molecular weight of 32 kDa and fits into the 
separating range of this SEC column.  
Prior to the SEC run the tag-free protein material was concentrated to volume of 
about 500 µl using Corning Spin-X UF centrifugal concentrator with a 10 kDa cut-off 
(Corning Incorporated Life Sciences, Tewksbury, USA) and filtered through a 0.22 µm 
membrane. The sample was then applied to the column equilibrated with SEC buffer (50 
mM HEPES pH 7.5, 400 mM NaCl, 5 % Glycerol and 5 mM MgSO4). Based on the 
measured absorbance at 280 nm (NanoDrop ND-1000 spectrophotometer, NanoDrop 
Technologies, Wilmington, DE), protein-containing fractions were analyzed on SDS-
PAGE and the fractions with monomeric protein were pooled together. The amount of the 
obtained protein was determined by measuring the absorbance at 280 nm with NanoDrop 
ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). An extinction 
coefficient of 1.38 was used to calculate the correct sample concentration from the 
measured absorbance reading. 
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2.19 SDS-PAGE and Western blot 
The purity of the protein samples was analyzed using sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE), which is a very widely used and 
popular discontinuous buffer system and is also known as the Laemmli method. Bio-Rad 
Mini-PROTEAN® Tetra Cell was used as the electrophoresis system together with self-
made Tris-minigels in 1 mm thickness. Since discontinuous buffer system was utilized, 
the gel composed of two separate layers of stacking and resolving gel. The recipes for the 
resolving gels in the three most commonly used densities are listed in the table 23 and the 
preparation of the stacking gel in table 24. 
  
Table 23. The components of the resolving gel for the self-made Tris-buffer based SDS-PAGE gel. The 
amounts are optimized for casting two gels in 1 mM thickness for Mini-Protean system. 
Reagent Amount 
7.5 % 10 % 12 % 
4Tris pH 8.8 2.5 ml 2.5 ml 2.5 ml 
Milli-Q H2O    
10 % SDS 100 µl 100 µl 100 µl 
40 % Acrylamide (Roth) 2.0 ml 2.7 ml 3.2 ml 
20 % APS 50 µl 50 µl 50 µl 
Temed (Roth) 10 µl 10 µl 10 µl 
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Table 24. The components of the stacking gel for the self-made Tris-buffer based SDS-PAGE gel. The 
amounts are optimized for casting two gels in 1 mM thickness for Mini-Protean system. 
Reagent Amount 
4Tris pH 6.8 1.25 ml 
Milli-Q H2O 3.14 ml 
10 % SDS 50 µl 
40 % Acrylamide (Roth) 0.53 ml 
20 % APS 25 µl 
Temed (Roth) 5 µl 
 
Prior to loading the samples onto the gel, 7.5 µl of protein sample was mixed with 
2.5 µl of 4NuPAGE® LDS sample  uffer supplied with β-mercaptoethanol, the sample 
was then boiled for 5 minutes at 75°C and finally centrifuged shortly. The whole 10 µl 
sample was loaded onto the well of the gel. The EDR1 constructs were always run on 
12% gels whereas the ETR1 constructs and cell pellet samples from expression tests were 
run on gels with density between 7.5 and 10% for more optimal separation. All SDS-
PAGE gels were run at constant voltage of 200 V for 48 – 60 minutes depending on the 
length of the construct. For longer constructs longer run times were usually chosen to 
better separation at higher molecular weight range. 
For the immuno-detection the samples were first loaded onto SDS-PAGE gel and 
then transferred onto nitrocellulose membrane (Protran - Schleicher & Schuell) using 
Bio-Rad Mini Trans-Blot cell (Bio-Rad Mini-PROTEAN® Tetra Cell). During the 
transfer the blotting cell was cooled down on ice and the transfer was performed using 
constant voltage of 100 V for 1 hour. The membrane was subsequently incubated in PBS-
T buffer containing 5% (w/v) milk powder to block unspecific binding of the primary 
antibody. Prior to this step the membrane had been rinsed with PBS-T buffer for 15 min. 
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For the blotting mouse antibodies against His6-tag from EMBL Heidelberg were used as 
primary marker (1:2000 dilution) and Goat anti-mouse-HRP from Pierce as secondary 
antibody (1:5000 dilution). Detection of ETR1 was carried out by luminescence reaction 
with Super Signal West Pico Chemiluminescent Substrate (Pierce) as the reagent. The 
reaction was followed using Bio-Rad GelDoc system. 
2.20 SEC-LS/UV/RI 
Several methods exist to determine the oligomerization state of the protein 
sample. The oligomerization state of wild type EDR1 kinase domain and the D792N 
mutant were evaluated using the Malvern system (Malvern Instruments Ltd, Malvern, 
UK), which contained light scattering, refractive index and optical UV detectors. For a 
non-glycosylated protein (as with E. coli expressed protein) the molecular mass of the 
eluted sample can be calculated from the measured light scattering intensity, (LS) and 
refractive inde signal, (RI) using the following formula: 
M = K’(LS)/(RI), 
where K’ = KRI/[KLS(dn/dc)] (Wen et al., 1996). KRI and KLS are the instrument 
calibration constants for the refractive index and light scattering, respectively, and are 
determined using protein standard. The refractive index increment, dn/dc is for protein 
solution 0.185.  
For the analysis the protein samples were concentrated to 1 – 4 mg/ml 
concentration using Spin Concentrators with 10 kDa cut-off (Corning® Spin-X® UF 
20mL Centrifugal Concentrator, 10,000 MWCO Membrane, Corning Incorporated) and 
filtered with spin filters (0.22 µm membrane, Millipore). A 100 µl sample was injected to 
the system equipped with an analytical grade size-exclusion column (Superdex 75 10/300 
GL, GE Healthcare Bio-Sciences AB, Uppsala, Sweden).  
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2.21 Thermofluor 
The stability and monodispersity of the protein in soluble form is critical for many 
applications used to study these macromolecules. Especially in structural studies with x-
ray crystallography, obtaining a crystalline sample remains still as one of the main 
bottlenecks and is usually hampered by the availability of pure and stable sample. 
Thermofluor is a fluorescence-based thermal-shift assay that can be used to examinate the 
stability of the protein in various different buffer conditions and in presence of additives 
in a high-throughput manner. The method is based on measuring the temperature-
dependent unfolding of the protein through the binding of the hydrophobic fluorophore to 
the exposed hydrophobic areas of the unfolding protein.  
The thermofluor assays were performed at EMBL Hamburg SPC facility using 
96-well thin-wall PCR plates and real-time PCR machine (MyiQ™ Single-Color Real-
Time PCR Detection system, Bio-Rad) equipped with a charge-coupled device (CCD) 
detector for the fluorescence imaging (Boivin et al., 2013). For the thermofluor analysis 
the studied protein was diluted to a concentration between 20 - 100 µM. SYPRO Orange 
(Invitrogen) was used as a fluorescence dye. This dye is stored as 5000concentrated 
solution in DMSO and was diluted to 62.5concentration with distilled water prior to 
use. For the buffer screen (see Appendix 3) 5 µl of 5buffer solution was mixed in a 
reservoir of the 96-well plate with sufficient amount of water to reach final volume of 25 
µl after addition of the protein and the dye. For the additive screen (Appendix 3), 5 µl of 
suitable 5 additive solution was added. The protein and dye were added last to the wells. 
The volume of both was 2 µl in order to reach final concentrations of 1.6 – 8.0 µM for the 
protein and 5 concentration for the dye. After the addition of the protein and the dye the 
plate was sealed with highly transparent optical-clear quality sealing tape (Greiner Bio-
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one) to avoid evaporation and spun down at 4°C at 4000 rpm for 30 s to properly mix the 
reaction components and to remove airbubbles. The RT-PCR machine was programmed 
to equilibrate the plate for 5 min at 25°C before the start of the experiment. The plate was 
subsequently heated from 5°C to 95°C using a temperature ramp of 1°C/min. The 
fluorescence readings were followed during the temperature ramping by using excitation 
and emission values of 485/20 nm and 530/30 nm, respectively. These values are 
optimized for the chosen SYPRO Orange dye. 
2.22 Mass Spectrometry 
Mass Spectrometry (MS) is a technique that is used to analyze the atomic or 
molecular components of a sample. The ionized atoms or molecules produce spectra 
where their abundance and composition can be obtained based on the mass-to-charge 
ratio (m/z). Mass Spectrometry is a widely used technique in proteomics where it can be 
employed to analyze the primary sequences, post-translational modifications and protein-
protein interactions even from more complex protein samples thus gaining knowledge of 
the function of the protein (Aebersold, R. et al. 2003).  
The basic elements of MS instrument include an ion source, a mass analyzer for 
measuring the mass-to-charge ratio of the ionized particles and a detector to register the 
ions at each m/z-value and the number of these ions. There are several ways to ionize the 
sample but in proteomics the two most commonly used techniques are electrospray 
ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI).  
The accurate mass of the EDR1 kinase domain and its inactive version (EDR1-
D792N) were analyzed with ESI-MS. Additionally a peptide-fingerprinting analysis with 
MALDI-TOF was performed for the wild type EDR1 kinase domain to identify the 
putative phosphorylation sites.  For the analysis the protein samples were concentrated to 
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approximately 5 mg/ml concentration using Spin Concentrators with 10 kDa cut-off 
(Corning® Spin-X® UF 20mL Centrifugal Concentrator, 10,000 MWCO Membrane, 
Corning Incorporated). The MS analysis of the EDR1 samples was conducted by Stephan 
Leicht at the Proteomics Core facility of EMBL Heidelberg outstation. The protocol for 
the MS analysis including sample handling, data acquisition and data analysis are shown 
in appendix 4. 
2.23 Kinase assay 
The kinase activity of EDR1 constructs was evaluated using the coupled kinase 
assay originally developed by Cook et al. (1982). In this assay the consumption of ATP to 
produce ADP is coupled with the formation of pyruvate from phosphoenolpyruvate (PEP) 
and subsequent NADH-dependent reduction of pyruvate to lactate by lactic 
dehydrogenase (Figure 10).  
 
Figure 10. The principle of the coupled kinase assay. The reaction for the studied EDR1 kinase domain is 
shown as example. 
 
The measurement buffer consisted of 50 mM Hepes at pH7.5, 350 mM NaCl, 10 
mM MgCl2, 1 mM DTT, 1% glycerol, 1 mM NADH, 2 mM PEP and 2.2 U/1.5 U lactic 
dehydrogenase/puryvate kinase (Sigma). Also the enzyme was added to the buffer in 
enzymatic concentration of 250 nM. The reaction were started by adding ATP to 2 mM 
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concentration to one of the wells and then making a serial dilution from this well, having 
the final ATP concentrations between 0.03125 mM and 2 mM. The measurements were 
performed in 96well plates using Tecan Infinite M1000 microplate reader (Tecan Group 
Ltd., Männedorf, Switzerland) set up to measure the absorbance at 340 mm wavelength. 
The absorbance value was measured on 30 second intervals for a total of one hour. For 
the linear part of the obtained absorbance curve the standard Michealis-Menten kinetics 
calculations were performed using GraphPad Prism 5 software (GraphPad Software, Inc., 
La Jolla, USA). 
2.24 Hydroxylamine-trapping assay 
The activity of ApnA A1 PCC7821 was examined using a hydroxylamine-trapping 
assay, which is based on the protocol published by Kadi&Challis (2009) to study the 
substrate specificity of NRPS-independent Siderophore (NIS) synthetases. The original 
assay was created in 1950s as a colorimetric method to detect acyl phosphates through 
their reaction with hydroxylamine (Lipmann & Tuttle, 1945). The reaction between acyl 
phosphates and hydroxylamine results in formation of hydroxamic acid, which in the 
presence of trivalent iron (Fe
3+
) forms colorful complexes with absorption maxima 
between 540 nm and 480 nm (Figure 11).  
 
Figure 11. The overall reaction mechanism in the hydroxylamine-trapping assay. In the presence of 
hydroxylamine the formation of adenylate intermediate is followed by formation of hydroxamic acid. The 
subsequent reaction between the hydroxamic acid and trivalent iron leads to colorful complex that can be 
detected by measuring its absorbance at 540 nm.  
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The hydroxylamine trapping assays were conducted by Stephan Schiefelbein 
(University of Münster). The activity of wild type ApnA A1 PCC7821 and the enzyme 
variants were tested against the 20 canonical aminoacids, excluding the 
selenomethionine. Additionally the wild type enzyme and the specific mutants were 
tested against two unnatural amino acids, 4-Azido-phenylalanine (Az) and 4-Fluoro-
phenylalanine. All protein samples were diluted to a concentration of 40 µM with the 
assay buffer that contained 50 mM TRIS at pH 8 and 30 mM MgCl2. The reaction 
mixture was prepared in a reservoir of a 96-well plate by mixing 2.3 µL of the protein 
solution with 3.5 µL hydroxylamine (NH2OH) solution at concentration 2 M (freshly 
prepared aqueous solution) and 35.2 µL of 3.88 mM amino acid solution. To iniate the 
reaction, 4.5 µL of 30 mM ATP solution was added to the reaction mixture. The final 
reaction mixture contained 25 mM TRIS at pH 8, 15 mM MgCl2, 2.0 µM enzyme, 150 
mM NH2OH, 3 mM ATP and 3 mM amino acid.  The plate was then incubated for 4 h at 
25°C with gentle shaking.  Prior to the absorbance measurements, the reaction was 
stopped by addition of stopping solution, which contained 10% (w/v) FeCl3*6H2O and 
3.3% trichloroacetic acid (TCA) in 0.7 M HCl. The absorption was measured at 
wavelength of 540 nm using Tecan Infinite® M1000 PRO microplate reader (Tecan 
Group Ltd., Männedorf, Switzerland). 
2.25 Crystallization 
The initial crystallization trials were conducted at the high-throughput 
crystallization facility at EMBL Hamburg (Müller-Dieckmann et al., 2006) using 
commercial screens from Qiagen. All initial screens were performed using the sitting-
drop vapour-diffusion method at 292K in 96-well Greiner or iQ plates (TTP Labtech Ltd, 
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Melbourn, UK). In the default experimental set up the drop contained 300 nl protein 
solution mixed with an equal volume of reservoir solution, and was equilibrated against 
50 µl of reservoir solution. Based on the obtained lead conditions, manual optimization 
was performed at 292 K using 24-well Linbro plates (Molecular Dimensions Limited, 
UK) and hanging drop vapor diffusion method. For the inactive kinase domain of EDR1 
(EDR1-D792N) 5 mM AMP-PNP, a non-hydrolyzable analog of ATP was added to 
protein sample at 10 mg/ml concentration prior to the crystallization experiments. This 
protein produced well-diffracting crystals from solution containing 1.2 M LiSO4, 10% 
Polyethylene glycol (PEG) 3350 and 0.1 M HEPES at pH 7.8 and these crystals were 
used for the data collection.  
The manual crystallization trials for ApnA A1 PCC7821 were conducted by 
Sandra Kozak (Sample Preparation and Characterisation Facility, EMBL Hamburg). For 
ApnA A1 PCC7821 the protein concentrations of 5, 10 and 13 mg/ml were used for the 
manual crystallization trials. Well-diffracting crystals were obtained in several conditions 
and with all tested protein concentrations. However, for data collection and soaking 
experiments crystals from conditions containing 24-30% Polyethylene glycol 3350 and 
either 0.1 M MES or 0.1 M BIS-TRIS buffer in pH 5.5 to 6.5 were used. 
2.26 Data Collection and Processing 
The data collection was conducted at PETRA III beamlines P13 and P14 at EMBL 
Hamburg, Germany. P13 is a tunable beam line with energy range between 6 and 15 keV 
and is equipped with MD2 type diffractometer with mini-kappa goniostat. P14 on the 
other hand is a beam line especially suited for very small crystals due to the availability 
of micro-beam with a beam-size of 5 x 10 micron
2
 and beam-divergence below 0.3 mrad. 
Additionally the beam line provides a possibility to use an unfocused beam with a 
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maximum size of 150 micron for larger crystals. The diffractometer at P14 is type MD3. 
Both beam lines are equipped with PILATUS 6M detectors enabling shutter-less 
oscillation data collection.  
Prior to data collection the protein crystals were soaked in suitable cryo-solution 
containing glycerol as cryo-protectant and then flash-cooled to 77 K in liquid nitrogen. 
The cryo-solution for EDR1-D792N crystals contained in addition to the original 
crystallization solution, 15 % glycerol and 10 mM AMP-PNP. From the best diffracting 
crystal a data set of 800 images was collected with an oscillation range of 0.1° at beam 
line P13.  
The basic cryo-solution for the ApnA A1 PCC7821 crystals contained the original 
crystallization solution with 5% higher PEG3350 concentration, 10% glycerol as 
additional cryo-protectant and also 4 mM MgCl2. To obtain the structure with the 
substrate or adenylation reaction product bound, the crystals of the native protein were 
soaked for 5 to 10 seconds in a cryo-solution containing the suitable substrate or 
substrates as listed in the table 25. The data for the adenylate complex structures were 
collected at beam line P13 whereas the data for the AMP-PNP containing structures were 
collected at beam line P14. From the crystal soaked in AMP-PNP alone a data set of 300 
images were collected at oscillation range 0.5° and the same oscillation range but with 
total rotation range of 180° was used for the crystal soaked in AMP-PNP and L-arginine 
containing solution. Both the crystal soaked in ATP and L-Tyrosine containing cryo-
solution as well as the one incubated in ATP and L-Arginine containing cryo-solution 
was used to collect a data set of 1800 images but with oscillation ranges of 0.1° and 0.2°, 
respectively.  
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Table 25. The additives used in the soaking experiments for ApnA A1 PCC7821. 
Complex structure ID Additives in soaking solution 
Complex 1 2 mM AMP-PNP 
Complex 2 2 mM AMP-PNP and 50 mM L-Arginine 
Complex 3 2 mM ATP and 50 mM L-Arginine 
Complex 4 2 mM ATP and a few milligram of powdery L-Tyrosine 
 
The data for both EDR1-D792N and for P. agardii ApnA A1 PCC7821 were indexed and 
integrated using XDS (Kabsch, 2010) and scaled with SCALA (Collaborative 
Computational Project, Number 4, 1994). 
2.27 Structure determination and validation 
The structure determination was performed for both EDR1-D792N and for ApnA 
A1 PCC7821 using automated molecular replacement and program MOLREP 11.0 
(Vagin&Teplyakov, 1997). The initial model was refined against the native dataset using 
REFMAC 5.7 (Murshudov et al., 1997) as part of CCP4 Program Suite 6.3.0 (Potterton et 
al., 2003). This was followed by iterative cycles of manual model building and 
refinement using programs COOT 0.7 (Emsley et al., 2010) and REFMAC 5.7, 
respectively.   
The tyrosyl adenylate and arginyl adenylate in the ApnA A1 PCC7821 complex 
structures were created with JLigand (Lebedev et al., 2012) using existing restrains from 
the standard Refmac library to define the link between the monomeric units.  The L-
arginine (PDB Ligand code: ARG) and AMP-PNP (PDB Ligand code: ANP) were 
readily available from COOT monomer library. The final models were validated through 
analysis with MolProbity (Chen et al., 2010). The structure images were created with the 
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program PYMOL (The PyMOL Molecular Graphics System, Version 1.6.x, Schrödinger, 
LLC). 
2.28 Small Angle X-ray Scattering 
SAXS measurements were performed at PETRA III beamline P12 (EMBL/DESY, 
Hamburg, Germany)(Roessle et al., 2007). The beamline is equipped with a Pilatus 2M 
detector (Dectris). For the ETR1-TM
 
construct, the dialyzed protein sample was 
concentrated to suitable concentration using Corning Spin Concentrators with 30 kDa cut-
off (Corning® Spin-X® UF 20mL Centrifugal Concentrator, 30,000 MWCO Membrane, 
Corning Incorporated) and filtered with a prewashed spin filter (0.22 µm membrane, 
Millipore). Due to the high aggregation tendency of the sample, measurements were 
conducted at lower protein concentrations (0.3 – 1.4mg/ml). The sample concentrations 
were measured using the NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies, Wilmington, DE) and an extinction coefficient of 0.502 for the absorbance 
value at 280 nm. Each measurement consisted of twenty 50 ms frames, which were 
averaged using a sample volume of 30 µl at a temperature of 10 °C. A sample-detector 
distance of 3.1 m was used to cover the momentum transfer range 0.008 Å
-1
 < s < 0.47 Å
-
1
 (s = 4π sin(θ)/λ where 2θ is the scattering angle and λ=1.24 Å is the X-ray wavelength). 
A solvent blank was measured prior to and following each sample exposure to enable 
background substraction.  
The data were processed using standard procedures, corrected for buffer 
contribution, scaled for solute concentration and extrapolated to infinite dilution using the 
program PRIMUS (Konarev et al., 2003). The radius of gyration Rg and forward 
scattering intensity I(0) were determined from the scattering profile using Guinier 
approximation (Guinier, 1938). This relies on the assumption that at very small scattering 
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angles (s ≤ 1.3/Rg) the intensity is represented as I(s)=I(0)exp((sRg)
2
/3). As a mean to 
validate the obtained Rg and I(0) values, they were also independently calculated using 
the indirect Fourier transform of the scattering curve with program GNOM (Svergun, 
1992). The resulting interparticle distance distribution function P(r) was also used to 
determine the maximum particle dimension Dmax. The interpolated forward scattering 
from a reference bovine serum albumin (BSA) sample (calculated molecular mass 
66kDa) was used as comparison to calculate the molecular mass (MMSAXS) of the 
construct. Another molecular mass estimation was derived from the small angle region of 
the data (s < 0.25 Å
-1
) using the Porod equation (Porod, 1982). This gives the excluded 
volume of the hydrated particle Vp (Å), which is for globular protein about 1.7 times of 
the molecular mass in Da (Petoukhov et al., 2012). Available high-resolution structures 
were used to calculate the scattering pattern of the SAXS model and define its fit to the 
experimental data using the program CRYSOL (Svergun et al., 1995). The dis repan y χ
2
 
between the measured and calculated SAXS profiles is described by the following 
equation:   
 
where N is the number of experimental points, c is a scaling factor, Icalc(sj) and Iexp(sj) are 
the calculated and experimental scattering intensity and σ(sj) experimental error at the 
momentum transfer sj. 
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4. RESULTS 
4.1 Full-length ETR1 
4.1.1 Cloning 
The gene for the full-length Ethylene Receptor 1 of A. thaliana (ETR1, residues 1-
738) was originally amplified by PCR from a cDNA library obtained from the 
Arabidopsis Biological Research Center at Ohio State University (Kieber et al., 1993). 
This gene was cloned into pETM-11/LIC using LIC-cloning and into pET15b with 
restriction endonuclease dependent method. To make the expression of the full-length 
receptor more feasible in E. coli, a synthetic gene codon-optimized specifically for this 
expression system was ordered from Genscript. The synthetic ETR1 gene was obtained 
both in pUC57 vector and baculovirus vector Fastbac HTa. The ETR1 gene in pUC57 
was amplified by PCR and sub-cloned into pETM-11/LIC, pETM11SUMO3GFP and 
pET15b vectors. All three vectors contain N-terminal His6-tag. In pETM11SUMO3GFP 
the cloning sites, namely NcoI and BamHI, were chosen so that a C-terminal GFP fusion 
was added to the construct. Cloning experiments were conducted in the E. coli strain 
DH5 (Life Technologies GmbH, Darmstadt, Germany). The correct position and 
sequence of the insert in the target vectors was verified by sequencing (Eurofins MWG 
Operon, Ebersberg, Germany).  
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4.1.2 Expression trials in E. coli 
The expression of the full-length ETR1 was attempted according to the published 
protocol from Voet-van-Vormizeele & Groth (2003). To this end, the gene in the pET15b 
vector was transformed to both C41(DE3) and C43(DE3), which are E. coli strain 
optimized for membrane protein expression (Miroux & Walker, 1996). Additionally, the 
expression in C43(DE3) cells were tested for the pETM-11/LIC and 
pETM11SUMO3GFP constructs. The expression tests were conducted in small-scale 
cultures of both 5 and 50 ml using 2YT media. The cultures were grown at 37°C to 
OD600-value of 0.4 – 0.6 after which they were induced with 0.5 mM IPTG. The 
culturing was then continued at 25 or 30°C for 6 hours since according to the paper by 
Vormizeele & Groth, at the 6
th
 hour the expression of the protein was at its peak. Un-
induced cultures were grown in parallel for comparison. To analyze the expression of the 
target protein, 100 μl samples were ta en immediately  efore indu tion and then every 2 
hours from both induced and un-induced cultures. These samples were centrifuged at 
4000 rpm for 2 min at room temperature and remaining pellet re-suspended in 60 μl of 
standard SDS-PAGE sample buffer (see materials and methods) with β-mercaptoethanol 
as reducing agent.  
To evaluate the expression of the FL ETR1, the cell culture samples were run on 
SDS-PAGE (10% Bio-Rad Mini gel). They were also analyzed by Western blotting using 
antibodies against the His6-tag. No expression was detected for the target protein with 
either of the tested cell strains. Since the ETR1 expression was tested in parallel in 
baculovirus-insect cell expression system and led to successful production of the protein, 
the expression in E. coli was not continued further. Figure 12 shows the SDS-PAGE and 
Western blot analysis of ETR1 expression samples from C43(DE3) cells 6 hours after 
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induction for the three chosen vectors. Culture samples from insect cells were used as a 
positive control. 
 
 
Figure 12. The summary of the E. coli expression trials of ETR1. The conditions in the trials were based on 
the published protocol by Voet-van-Vormizeele & Groth (2003). The samples in the lanes are as following: 
1) FL ETR1 in pET15b, un-induced 2) FL ETR1 in pET15b, induced 3) FL ETR1 in pETM-11/LIC, un-
induced 4) FL ETR1 in pETM-11/LIC, induced 5) FL ETR1 in pETM11SUMO3GFP, un-induced 6) FL 
ETR1 in pETM11SUMO3GFP, induced 7) Roti®-Mark 10-150 plus protein marker (Carl Roth GmbH & 
Co. KG, Karlsruhe, Germany) 8) and 9) Cell culture samples from insect cells expressing FL ETR1 as a 
positive control 10) As in the lane 7 11) PageRuler Plus Prestained protein ladder (Fermentas/Thermo 
Fisher Scientific – Germany GmbH, Schwerte, Germany). 
 
4.1.3 Expression in insect cells 
The plasmid for the insect cell was ordered from Genscript and contained the E. 
coli codon-optimized synthetic gene for the full-length ETR1 (residues 1 – 738) in 
pFastBac HTa vector. The preparation of the bacmid and the initial transfection of Sf21 
cells on a 6well-plate were performed as stated in the materials and methods. The V0 
virus that was harvested 60 h after the transfection was used to infect fresh batch of Sf21 
cells for preparation of the V1 virus. These V1 cultures were split to keep optimal cell 
density of 0.5 – 1.0 Mio/ml until the cells stopped dividing and thus had reached the day 
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of the proliferation arrest (dpa). The samples taken on dpa and on 24-hour intervals after 
dpa were analyzed for protein expression. To this end, the cell samples were thawn gently 
on ice and resuspended to 500 µl of PBS buffer. The resuspended cells were sonicated for 
10 s with 25 % amplitude (Bandelin Sonopuls2200, Bandelin electronic GmbH & Co. 
KG, Berlin, Germany). A small aliquot of the lysate was set aside for analysis on SDS-
PAGE gel. The remaining lysate was spun for 3 min at 13,400 rpm (Eppendorf Minispin, 
Eppendorf AG, Hamburg, Germany) at room temperature. From the supernatant YFP 
fluorescence was measured using an excitation wavelength of 488 nm and an emission of 
wavelength of 520 nm with TECAN Infinite M1000 microplate reader (Tecan Group 
Ltd., Männedorf, Switzerland). YFP was expressed simultaneously with the target protein 
and its levels should correlate with the amount of protein expressed, i.e. the YFP 
fluorescence should reach a plateu when the maximum level of expression is reached. 
However, the expression tests for ETR1 in insect cells did not seem to show the expected 
pattern for YFP. Instead, a peak of YFP signal was reached 24 hours after dpa and after 
this point the signal appeared to decrease significantly (Figure 13). Furthermore, 48 hours 
after dpa the YFP signal had dropped below the signal at the beginning (at dpa). Based on 
the YFP fluorescence measurements, the sonicated cell samples from dpa, 24 hours after 
dpa and 48 hours after dpa were analyzed by SDS-PAGE and Western Blot. A band 
corresponding to the molecular mass of ETR1 monomer was observed, which confirmed 
the successful expression of the protein (Figure 14). Furthermore, it was found that the 
ETR1 expression level did not show a similar decrease as was observed for YFP. As a 
possible explanation for the observed difference, it was postulated that the insertion of the 
overexpressed receptor to the insect cell membrane had caused breakage of the membrane 
and the release of the soluble YFP to the culture media. The cell samples taken from the 
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later stages of expression thus presumably contained more broken cells with the receptor 
still attached but very little YFP since it had been lost in the media. 
 
  
Figure 13. The measured fluorescence signal for YFP (excitation at 488 nm, emission at 520 nm) in the 
ETR1 expression samples after the day of proliferation arrest (dpa). YFP is expressed simultaneously with 
the target protein. The decrease in the YFP signal indicated that the insect cells had started to break due to 
insertion of ETR1 to the membrane thus resulting in release of the YFP to the culture media.  
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 Figure 14. The results of the SDS-PAGE (on the left) and Western blot (on the right) for ETR1 V0 insect 
cells cultures. Samples taken at dpa (0), 24 hours and 48 hours after dpa were analyzed from two cultures 
grown in parallel. In SDS-PAGE gel the protein band for ETR1 (MW 82.6 kDa) appeared above the 70 kDa 
marker band and in the Westerb blot between the 60 kDa and 70 kDa marker bands. The protein markers 
used were PageRuler Color Plus Prestained protein ladder (M2, Fermentas/Thermo Fisher Scientific – 
Germany GmbH, Schwerte, Germany) for SDS-PAGE and Roti®-Mark 10-150 plus protein marker (M1, 
Carl Roth GmbH & Co. KG, Karlsruhe, Germany) for Western blot.  
 
The V1 cultures were harvested at 96
th
 hour after dpa by centrifugation at 800 rpm 
at 4°C. The supernatant contained the V1 virus, which was further used to produce the 
BIIC stocks according to the protocol obtained from Berger lab at EMBL Grenoble and 
as described in the materials and methods. The prepared BIIC stocks were used for 
protein production. To this end, one aliquot of the BIIC stocks were diluted to 100 ml 
with HyClone culture media and added to 900 ml of Sf21 cells at cell density of 
approximately 0.9 Mio/ml. As with the V1 cultures, the cultures were kept at the 
recommended density of about 1 Mio/ml until they stopped dividing (dpa reached) and 
started the protein expression. Due to the cell damage caused by ETR1 expression and 
assumed membrane localization, the cultures were harvested at 48th hour after dpa. The 
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cell pellet was stored at -20°C until further use. Samples were taken and handled in a 
similar manner than for the V1 cultures. Both the pellet and the supernatant from the 
sonicated and centrifuged cell suspension were analyzed using SDS-PAGE and 
immunoblotting with antibodies agaist the N-terminal His6-tag. A sample from an 
uninfected culture was used as a control. The results are summarized in figure 15. 
 
 
Figure 15. The results of the large-scale expression of full-length ETR1 in insect cells. The samples on the 
lanes correspond to the pellet and supernatant of the sonicated and centrifuged culture samples, which were 
taken at dpa (0), 24 hours after dap and 48 hours after dpa. A sample from the uninfected culture provided 
the cell control (CC). The SDS-PAGE is shown in the left panel and the western blot in the right one. The 
band below the 100 kDa marker band (M2, PageRuler Color Plus Prestained protein ladder, 
Fermentas/Thermo Fisher Scientific – Germany GmbH, Schwerte, Germany) in the SDS-PAGE gel for the 
pellet samples correspond to ETR1. Similarly, a protein band corresponding to a molecular mass of 
approximately 80 kDa is seen in the pellet fractions on the Western blot. 
4.1.4 Isolation from the membrane 
The next step after the successful expression of ETR1 in insect cells was its 
isolation from the membrane. A protocol from Dr. Morth (Centre for Molecular Medicine 
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Norway (NCMM), Blindern, Oslo, Norway) was used as a base for the isolation and 
purification tests of ETR1. A schematic representation for the steps in the protocol is 
shown in the figure 16 (for more in detail describtion, see materials and methods). As in a 
standard isolation of a soluble protein, also in the membrane protein isolation the target 
protein should remain in the cleared lysate after the first centrifugation step (18,000 rpm 
rotational speed). However, membrane proteins are not readily soluble but remain 
attached to small membrane drafts, which are subsequently pelleted using high-speed 
centrifugation (i.e. ultracentrifugation). The resulting soft pellet is washed to remove 
residual impurities from the cells and from the culture medium. After the pellet wash 
step, the target protein is solubilized with a suitable detergent, which functions by 
breaking the remaining cell membranes and forming a protecting layer around the 
hydrophobic, membrane-embedded parts of the protein. As the task of the detergent is to 
mimic the native lipid environment of the protein, they usually have lipid-like structure 
and consist of hydrophilic head group and hydrophobic tail. Most commonly non-ionic 
detergents, such as octyl-β-D-glucopyranoside (OG), decyl-/dodecyl-β-D-
maltopyranoside (DM/DDM) are used in initial solubilization step as they have a good 
solubili ation  apa ity  ut don’t  ause denaturation or ina tivation of the protein. Other 
important requirements for the detergent include a suitable critical micelle concentration 
(CMC) and micelle size. The CMC-value of the detergent defines the concentration above 
which the detergent forms micelles. As in the standard solubilization experiment a 
detergent concentration above CMC is used, detergents with lower CMC values are 
preferred. The concentration of the detergent is in the later purification steps decreased 
below CMC to avoid formation of micelles, which can interfere with the subsequent 
characterization methods. For the further use of the protein in applications downstream of 
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the membrane protein isolation and purification, detergents with small micelle sizes are 
usually preferred. 
 
 
Figure 16. Schematic representation for the ETR1 isolation from insect cell membrane. Prior to cell lysis 
step the cell pellet wash additionally washed twice with lysis buffer. Sonication was used to break the cells 
in the cell lysis step. 
 
The samples taken from the different isolation steps of ETR1 were analyzed with 
SDS-PAGE and Western blot using antibodies against the His6-tag in order to evaluate 
the success of the isolation process. In the first isolation trial, 0.5 % DDM (CMC = 
0.008%, Sigma-Aldrich) was used in the solubilization step. The chosen solubilization 
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conditions were insufficient to bring the protein in soluble form since all the protein 
remained in the pellet after the overnight solubilization and final ultracentrifugation steps. 
The results of this trial are shown in the figure 17. 
 
 
Figure 17. The results of the first isolation trial of ETR1. The samples in the lanes are as following: 1) 
Pellet washes 2) Crude lysate 3) Cleared lysate 4) Cell debris and inclusion bodies 5) Supernatant after 1
st
 
ultracentrifugation (UC) 6) Supernatant after 2
nd
 UC 7) Membrane before solubilization 8) Insoluble 
material after 3
rd
 UC 9) Soluble fraction 10) As in lane 9 11) - 12) - 13) - 14) Roti®-Mark 10-150 plus 
protein marker (Carl Roth GmbH & Co. KG, Karlsruhe, Germany) 15) PageRuler Color Plus Prestained 
protein ladder (Fermentas/Thermo Fisher Scientific – Germany GmbH, Schwerte, Germany). 
 
As an attempt to improve the solubilization of the receptor, the composition of the 
isolation buffers was modified. To this end, the pH and the NaCl concentration was 
varied. In the initial isolation trial, TRIS buffer at pH 7.6 was used in combination with 
100 Mm NaCl, with the exception of the membrane resuspension buffer where the NaCl 
concentration was 200 mM.  For the buffer optimization trials, TRIS buffer at pH 8 and 
MES buffer at pH 6 was tested both in combination with lower (20 mM) and higher (500 
mM) NaCl concentration. Additionally, the concentration of the detergent was increased 
from 0.5% to 1.0% in the solubilization step. DDM was used as the detergent as in the 
initial trial. To evaluate the success of the isolation, selected samples were analyzed in a 
similar manner than in the initial isolation trial (Figure 18). The change of the pH and 
NaCl concentration appeared to have an effect only when low salt concentration was 
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combined with higher pH (pH 8) or vice versa (high salt, pH 6). Selected soluble fractions 
from these two isolation trials were re-analyzed on SDS-PAGE and Western blot to avoid 
possible contaminant effect from the pellet fractions (Figure 19). It was found that 
solubilization was still hampered although more protein was recovered in cell lysis step. 
Due to the limited access to the equipment required for membrane protein isolation, more 
solubilization trials were not performed. As the solubilization step appeared to be the 
biggest bottleneck in the ETR1 isolation from the insect cell membrane, future work 
would require the testing of other detergents. 
 
 
Figure 18. SDS-PAGE gel and Western blot of the selected samples from ETR1 isolation steps with low 
NaCl concentration at pH 6 and at pH 8 (abbreviations L6 and L8, respectively) or with high NaCl 
concentration at pH 6 and at pH 8 (H6 and H8). The lanes in the gel and Western blot are as follows: 1) L6 
crude lysate 2) L6 cleared lysate (UC) 3) L6 soluble material after overnight solubilization 4) L8 crude 
lysate 5) L8 cleared lysate 6) L8 soluble material after overnight solubilization 7) H6 crude lysate 8) H6 
cleared lysate 9) H6 soluble material after overnight solubilization 10) H8 crude lysate 11) H8 cleared 
lysate 12) H8 soluble material after overnight solubilization 13) Roti®-Mark 10-150 plus protein marker 
(Carl Roth GmbH & Co. KG, Karlsruhe, Germany) 14) PageRuler Color Plus Prestained protein ladder 
(Fermentas/Thermo Fisher Scientific – Germany GmbH, Schwerte, Germany). 
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Figure 19. Re-analysis with SDS-PAGE and Western blot for the selected samples from ETR1 isolation 
steps with low NaCl concentration at pH 8 (L8) and high NaCl concentration at pH 6 (H6). The lanes in the 
gel and Western blot are as follows: 1) L8 cleared lysate 2) L8 supernatant after 1st ultracentrifugation 
(UC) 3) L8 resuspended membrane after 2
nd
 UC 4) L8 supernatant after 2nd UC 5) L8 sample after 
solubilization 6) L8 soluble material (supernatant from 3
rd
 UC) 7) L8 insoluble material after 3rd UC 8) 
Roti®-Mark 10-150 plus protein marker (Carl Roth GmbH & Co. KG, Karlsruhe, Germany) 9) H6 cleared 
lysate 10) H6 supernatant after 1st UC 11) H6 soluble material (supernatant from 3
rd
 UC) 12) H6 insoluble 
material after 3rd UC 13) Same as lane 8 14) PageRuler Color Plus Prestained protein ladder 
(Fermentas/Thermo Fisher Scientific – Germany GmbH, Schwerte, Germany). 
 
4.2 ETR1-ΔTM 
4.2.1 Cloning, expression and purification 
The cytosolic part of the main ethylene receptor ETR1 was expressed and purified 
for structural studies with both X-ray crystallography and Small Angle X-ray scattering 
method. This ETR1-ΔTM  onstru t  onsisted of the C-terminal residues 158 – 738 and 
included the GAF domain, DHp and CA subdomains as part of the HK domain and 
finally the RR domain (Figure 20). 
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Figure 20. Schematic representation of the ETR1-ΔTM domain organi ation. The residues that define the 
domain borders are shown in numbers. 
 
The ETR1-ΔTM had already  een previously studied using SAXS and also 
crystallization trials had been performed, and therefore established expression and 
purification protocol was available (Mayerhofer, 2011). The plasmid containing ETR1-
ΔTM gene from A. thaliana in pET-GB-1a/LIC vector was also obtained from H. 
Mayerhofer. Site-directed mutagenesis was used to introduce four additional histidines to 
the already existing His6-affinity tag. This was done in order to improve the binding of 
the protein to the Ni-affinity matrix, resulting in very pure protein material already after 
NiNTA purification step and eliminating the need to for SEC step.   
The ETR1-ΔTM was expressed in E. coli strain Rosetta 2 (DE3) using 1 L culture 
volume and TB-media. The expression was induced by addition of IPTG to final 
concentration of 50 µM. The cultures were harvested after 18 h at 20°C by centrifugation. 
For purification the cell pellet was resuspended to lysis buffer and the cells were lysed by 
sonication on ice. The resulting lysate was centrifuged at 19000 rpm (SS-34 rotor, 
Sorvall), filtered through 0.45 µm membrane and loaded to 5 ml NiNTA column (Qiagen 
NiNTA Superflow cartridge column), which had been pre-equilibrated with washing 
buffer. The beads were then washed using imidazole gradient to 17% of elution buffer in 
washing buffer (51 mM Imidazole). The protein was eluted in imidazole gradient from 
17% to 100% elution buffer (from 51 mM to 300 mM imidazole). The protein eluted 
mainly with imidazole concentration higher than 150 mM resulting in very pure protein 
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material. The different NiNTA purification fractions were analyzed using SDS-PAGE, 
based on which the fractions containing the target protein were pooled together. The 
NiNTA purification results for ETR1-ΔTM are summarized in the figure 21. 
 
 
Figure 21. The NiNTA purification graph of ETR1-ΔTM and the  orresponding purification fractions 
shown on SDS-PAGE gel. The fractions A2 - A7 corresponded to the wash gradient (up to 51 mM 
imidazole) while the fractions A8 – A12 and B12 – B7 comprised the elution gradient (to 300 mM 
Imidazole). The elution at imidazole concentration 300 mM was continued until a plateau in UV signal at 
280 nm was reached. Based on the SDS-PAGE results fractions containing pure protein (C1 – C12 and D12 
– D9) were combined. The PageRuler Unstained Protein Ladder (Lane M, Fermentas/Thermo Fisher 
Scientific – Germany GmbH, Schwerte, Germany) was used as size standard for the SDS-PAGE. 
 
It was observed that upon clevage of the N-terminal GB1-fusion tag together with 
the His10-tag the protein became highly unstable and began to aggregate. Previously, the 
stability of the protein had been improved through addition of a non-detergent 
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sulfobetaine (NDSB) compound 3-(1-Pyridinio)-1-propanesulfonate prior to the SEC run. 
However, this chemical (referred later simply as NDSB) was found to contribute to the 
scattering in SAXS measurements, which led to mismatch at the higher angles after 
solvent substraction. Since thermofluor had been previously successfully employed to 
find stabilizing compounds for the ETR1-ΔTM  onstru t (Mayerhofer, 2011), a 
thermofluor experiment was conducted using the Buffer screen of EMBL Hamburg 
(Boivin et al., 2013). The obtained results indicated that increase in NaCl concentration 
could provide additional stabilization (Figure 22). However, it did not result in more 
stable protein in the purification trials. Since glycerol has been suggested to prevent 
protein aggregation (Vagenende et al., 2009), addition of this compound in 5% 
concentration to the dialysis buffer was tested. This appeared to have the desired effect 
since no visible aggregation formed after TEV treatment. In the test SAXS experiments, it 
was observed that 5% glycerol also had a minimal effect on the scattering. This problem 
was solved by reducing the amount of glycerol in the final buffer to 3%. The SDS-PAGE 
analysis of the ETR1-ΔTM sample before and after TEV-cleavage is shown in the figure 
23. The TEV-treated and dialyzed sample was run through Ni-affinity matrix to remove 
the His-tagged TEV-protease.  
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Figure 22. The best buffer conditions for ETR1-ΔTM indentified from the thermofluor experiment. The 
Buffer screen of EMBL Hamburg (Boivin et al., 2013) was used in this experiment. 
 
 
Figure 23. The TEV-treatment results of ETR1-ΔTM. The samples in the lanes are as follows: 1) – 2) 
Combined NiNTA fraction (before TEV treatment and dialysis) 3) TEV cleaved sample (before 2nd Ni 
affinity) 4) TEV cleaved diluted sample after 2nd Ni-affinity step 5) As in lane 4 but without dilution 6) 
Material bound to the Ni-beads after the 2nd Ni-affinity step. Lane M contains the PageRuler Color Plus 
Prestained protein ladder (Fermentas/Thermo Fisher Scientific – Germany GmbH, Schwerte, Germany). 
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4.2.2 Crystallization trials 
The crystallization trials of ETR1-ΔTM were  ondu ted at the  Tx-facility of 
EMBL Hamburg (Mueller-Dieckmann, 2006). These trials were performed at 19°C for a 
protein sample with and without the GB1-tag at concentration 4 mg/ml. Higher 
concentrations could not be tested since the protein became instable and started to 
precipitate. Four commercial screens (Qiagen Classic I and II, PEGs I and II) were 
chosen for the initial screening.  owever, the initial s reens didn’t result in any 
promising conditions for further optimization.  The main problem appeared to arise from 
protein aggregation at the concentrations, which are required for crystallization. Since the 
structural characterization with SAXS does not necessary require high protein 
concentration, the studies on the ETR1-ΔTM  onstru t were focuzed on the SAXS 
studies. 
4.2.3 Structural characterization by SAXS 
Previously the ETR1-ΔTM had  een studied using SAXS in the presen e of the 
NDSB compound (Mayerhofer, 2011). The molecular weight estimates calculated from 
the SAXS scattering curve in these experiments indicated existence of dimeric protein 
molecule. Furthermore, the ab initio and ridig body modeling showed that the two ETR1-
ΔTM monomers form together an overall dumbbell shaped dimer. However, due to the 
presence of the NDSB compound accurate determination of the protein concentration was 
hampered, which consequently lead to unreliable MMSAXS – value. This molecular weight 
estimation is calculated from the I(0)-value (the scattering intensity at zero angle) using 
known protein standard (BSA) as comparison  and relies on the accurate protein 
concentration value. Additionally, the scattering of the NDSB caused problems in the 
background substraction and subsequently resulted in poor fit between the calculated and 
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experimental scattering curve at higher angles. Although this did not affect the modeling 
as the information for the overall shape of the molecule is derived from the scattering at 
lower angles, it reduced the overall quality of fit. 
To overcome the negative effect of NDSB on SAXS measurements, other means 
to stabilize the protein were attempted. As a first attempt, SAXS measurements for the 
protein with the GB1-fusion tag attached was conducted. Prior to the measurements the 
sample was concentrated to 4.6 mg/ml and filtered to remove any aggregated protein that 
would influence the data quality. The concentration was measured using absorbance at 
280 nm and the calculated extinction coefficient of 0.502. A dilution series of the protein 
sample was measured where the lowest concentration was 0.46 mg/ml. Although the 
SAXS data collected at higher sample concentrations showed signs of protein 
aggregation, the quality of the data was not affected. Furthermore, there was no buffer 
mismatch at the higher angles of the SAXS scattering curve as observed in the presence 
of the NDSB. The obtained data was used to calculate the SAXS parameters, which are 
shown in table 26. The radius of gyration, Rg and the scattering intensity at zero angle, 
I(0) were calculated using Guinier approximation while the maximum particle dimension, 
Dmax was obtained from the interatomic distance distribution function, P(r). The 
interpolated forward scattering from the BSA standard was used as a comparison to 
obtain an estimated molecular mass (MMSAXS) for the measured ETR1-ΔTM  onstru t. 
Another molecular mass estimation was obtained using the Porod equation, which gives 
the excluded volume of the hydrated particle, Vp (Porod, 1982). The molecular mass of 
the particle can be derived from Vp-value in Å
3
, as it is approximately 1.7 times the MM 
in Da (Petoukov et al., 2012).  
The I(0) and Rg showed a concentration-dependent behaviour by increasing 
slightly upon the increase in the sample concentration, which indicated a concentration-
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dependent oligomerization. Also the MMSAXS-value appeared to depend on the 
concentration to some extend. At concentrations below 3.0 mg/ml, it varied between 61 
and 85 kDa, which is close to the MM of the monomeric ETR1-ΔTM with the GB1-
fusion tag (the calculated molecular weight: 67.7 kDa). At the highest used protein 
concentration (4.2 mg/ml), the MMSAXS-value was slightly higher (~100 kDa) than 
expected for a monomer. This indicated the existence of monomer-dimer equilibrium. 
However, the molecular mass estimates from the Porod volumes seemed to vary between 
244 kDa (~4 times the MM of the monomer) and 417 kDa (~6 times the MM of the 
monomer), which would correlate with higher order oligomers. Possible reason for the 
observed difference between the MM estimations from independent methods could be 
inaccuracies in the concentration measurement. This affects especially the determination 
of the MMSAXS-value. Additionally, the flexibility of the system causes problems in the 
calculation of Vp and thus provides an additional source of error for the estimation of the 
MM. Attempts to perform structural modeling were hampered mainly due to the 
increased degrees of freedom, which resulted from the additional rigid body, namely the 
GB1-fusion tag. Therefore it was decided to find purification conditions that would allow 
SAXS data collection in the absence of both NDSB and the fusion tag.  
 
Table 26. The SAXS parameters for the ETR1-ΔTM with the GB1-fusion tag. 
c (mg/ml) Rg (Å) I(0) Dmax (Å) MMSAXS Vp (Å
3
) 
0.5 49.0 74.08 171 71 415,000 
0.8 53.0 88.94 185 85 426,000 
0.9 51.9 82.55 181 79 295,000 
1.1 52.1 63.43 182 61 323,000 
2.1 58.2 78.47 199 75 523,000 
2.1 61.1 84.53 209 81 401,000 
3.0 59.6 73.52 204 70 359,000 
4.2 70.0 104.90 246 101 710,000 
4.2 64.6 97.89 226 94 650,000 
4.2 70.2 107.80 234 103 401,000 
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As described in the previous chapter, addition of 3 % glycerol was found to have a 
stabilizing effect on the studied ETR1-ΔTM  onstru t. For the SAXS data collection 
several protein concentrations up to 3.0 mg/ml were tested. However, the final data was 
obtained using protein samples at concentration between 0.5 mg/ml – 1.4 mg/ml as at 
higher sample concentrations the protein aggregation created problems regarding data 
analysis. The data collection statistics together with the SAXS parameters derived from 
the scattering curve are summarized in the table 27. 
For the structural modeling a previously constructed homology model of ETR1-
ΔTM (Mayerhofer, 2011) was used. The model was built using the DHp domain structure 
of ERS1, the structures of the CA and receiver domain of ETR1 (PDB code 1DCF, 
Müller-Dieckmann et al., 1999) and a bacterial GAF domain from Deinococcus 
radiodurans (PDB code 2O9B, Wagner et al., 2007). The residues of the DHp domain 
and the GAF domain were mutated to the corresponding ones in ETR1 sequence. The 
position of the GAF domain in the model was based on the overlapping region with the 
N-terminus of the DHp. The relative orientation of the DHp and CA domains to one 
another was defined using the structure of the histidine kinase domain from Thermotoga 
maritima sensor histidine kinase protein TM0853 as a template. The short but flexible 
linkers between the GAF and DHp domains, and the DHp and CA domains allowed some 
movement in the otherwise rigid core structure. The receiver domain was attached to this 
core with a 15-residue linker. 
The ridig body modeling was performed using the program CORAL (Petoukhov 
& Svergun, 2005). The known dimeric organization of the DHp domains was defined as a 
core around which the GAF, CA and receiver domains were modeled. The linker regions 
between the domains were treated as flexible random polypeptide chains. The calculated 
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scattering curve from the obtained model correlated well with the experimental data 
 ased on the χ
2
 value of 1.2. In comparison to the results from the SAXS measurements 
in the presence of NDSB, a better fit also at higher scattering angles were obtained for the 
new data in the absence of the NDSB compound (Figure 24). This didn’t, however have a 
significant effect on the overall shape of the ETR1-ΔTM SAXS model as the information 
about the size and the shape of the particle is mainly derived from the lower angle 
scattering range. The model of ETR1-ΔTM exhi ited the previously o served dimeri  
arrangement where the DHp domains form the central four-helix bundle with the GAF 
domains attached to top and the CA and the receiver domains to the bottom part of this 
helical bundle (Figure 25A). However, in the absence of the NDSB compound, ETR1-
ΔTM appeared to  e more flexible based on the larger Dmax –value (190 Å) in comparison 
to the Dmax-value (158 Å) of the model from the SAXS data in the presence of NDSB. 
The main source of flexibility appeared to be the 15-residue linker between the CA and 
the receiver domain, which allowed the movement of the latter domain in relation to the 
rest of the molecule.  
As another modeling approach, the ab initio bead-model of the protein was 
constructed using program DAMMIN (Svergun, 1999). The program uses simulated 
annealing to create a shape envelope for the target particle that fits to the experimental 
data. Since the particle is represented as finite volume elements (beads/dummy atoms), 
contraints for compactness and connectivity are required in order to create a physically 
and biologically reasonable model. For ETR1-ΔTM additional P2 symmetry constrain 
was applied based on the observed symmetry-relation between the DHp domains in the 
crystal structure. The obtained ab initio model of ETR1-ΔTM agreed with the dimeri  
rigid body model from CORAL as shown with the overlay of the two models in figure 
25B.   
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Figure 24. Structural modeling of ETR1-ΔTM against the SAXS data. The fit of the CORAL model with 
the experimental data is shown for the data both with NDSB (above, circles) and without NDSB (below, 
squares). The collection and intepretation of the SAXS data in the presence of NDSB has been previously 
described (Mayerhofer, 2011) and is shown here for comparison. The overall fit of the calculated scattering 
curve to the experimental one was better in the absence of the NDSB due to the lack of buffer mismatch at 
the higher angles. 
 
 116 
 
Figure 25. The SAXS models of ETR1-ΔTM in the a sen e of NDSB. The ab initio model from 
DAMMIN and rigid body model from CORAL for ETR1-ΔTM. A) The ridig body refinement with 
CORAL resulted in the expected dumbbell shape. B) The shape and size of the ab initio bead model (in 
grey) correlated well with the rigid body model (dark blue cartoon representation) as shown with the 
alignment. 
 
As the receiver domain in the ETR1-ΔTM model was not very tightly pa  ed 
against the dimer core, it was expected to exhibit more flexible movement. To analyze the 
flexibility mediated by the 15-residue linker between the CA and receiver domains, 
recently developed ensemble optimization method (EOM, Bernado et al., 2007) was 
employed. The program RANCH (Bernado et al., 2007) was used to produce 10 000 
random configurations by allowing the movement of the receiver domains in relation to 
the rest of the protein. From the created pool of possible conformations, an ensemble of 
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conformations that provided the best fit to the scattering curve was selected using a 
generic algorithm. The results were represented as a distribution of Rg –values. The 
original pool covered a broader Rg range whereas the best-fitted models had an average 
Rg of about 54 Å, which correlated well with the Rg of about 56 Å calculated for the 
CORAL model. Additionally, a more compact protein species were observed with an Rg 
of about 51 Å. This indicated movement between extended and compact conformations 
mediated by the receiver domain. The results from the EOM analysis are summarized in 
the figure 26. 
  
 
Figure 26. The results from the flexibility analysis of ETR1-ΔTM using EOM approa h. A) The fit of the 
selected ensemble of conformations from EOM analysis to the scattering data. The fitted curve is shown in 
black line and the scattering curve in grey squares. B) The Rg distribution in the ensemble of conformations 
fitting the experimental data using EOM. The Rg of the models in the original pool of structures has a broad 
distribution (shown with dotted line) while the ensemble of the selected structures (shown with solid line) 
has an average peak at ~ 54 Å and a smaller side peak at ~ 51 Å. 
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Table 27. SAXS Data Collection and Scattering Derived Parameters.   
Data collection parameters 
Instrument 
 
Beam geometry (mm) 
Wavelength (Å) 
s-range (Å
-1
) 
Exposure time (ms) 
Concentration range (mg ml
-1
) 
Temperature (K) 
 
 
P12, PETRAIII (EMBL, Hamburg, 
Germany) 
0.2 x 0.12 
1.24 
0.008 – 0.47 
50 
0.66 – 4.16 
283 
Structural parameters* 
I(0) (arbitrary units) (from P(r)) 
Rg (Å) (from P(r)) 
I(0) (arbitrary units) (from Guinier) 
Rg (Å) (from Guinier) 
Dmax (Å) 
Porod volume estimate (Å
3
) 
Dry volume calculated from sequence (Å
3
) 
 
 
1175 ±10 
59 ± 6 
1164 ± 40 
55 ± 11 
190 ± 5 
274000 ±  4200 
78367 
Molecular mass determination* 
Contrast (Δρ x 1010  m
-2
) 
Molecular mass Mr (from I(0)) 
Molecular mass Mr (from Porod volume) 
Calculated monomeric Mr from sequence 
 
 
3.047 
53000 ± 5000 
 161200 ± 24000  
64771.3 
Software employed 
Primary data reduction 
 
Data processing 
Ab initio analysis 
Validation and averaging 
Rigid body modelling 
Computation of model intensities 
3D graphics representations 
 
Automated radial averaging 
(Petoukhov et al., 2007) 
PRIMUS 
DAMMIN 
DAMAVER 
CORAL, EOM 
CRYSOL 
PYMOL 
*Reported for 0.66 mg ml
-1
 measurement 
 
4.3 EDR1 
4.3.1 Production of the protein material 
The plasmid for the wild type kinase domain of Enhanced Disease Resistance 1 
(EDR1) was received from S. Panneerselvam. This plasmid comprised the C-terminal 
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residues 655-933 of EDR1 cloned into the expression vector pMCSG7 (Eschenfeldt et al., 
2009). The target gene had been amplified by PCR from a cDNA library obtained from 
the Arabidopsis Biological Research Center at Ohio State University (Kieber et al., 
1993). The expression vector introduced an N-terminal His6-tag followed by a TEV 
cleavage site to the target protein. Due to cloning, 3 additional amino acids (SNA) 
remained at the native N-terminus after digestion with TEV protease. The correct 
insertion of the target gene was verified by DNA sequencing.  
The wild type EDR1 kinase domain containing plasmid was used as template to 
produce four variations of the enzyme using site-directed mutagenesis. These variants 
comprised the catalytically inactive enzyme and three interface mutants targeting on the 
conserved G-helix in the enzyme. In order to produce a catalytically inactive kinase 
domain, a conserved and catalytically important aspartate residue (D792) was substituted 
with asparagine. The three interface mutants were made based on the solved crystal 
structure of the inactive EDR1 kinase domain, which implicated that the residues in the 
conserved G-helix motif are participating in protein-protein interactions at the ES-
complex interface. The two substituted residues were valine (V876) and phenylalanine 
(F881) of the G-helix, both of which were mutated to glutamate. The third interface 
mutant was the combination of the two, V876E/F881E. The sequence of the four 
plasmids was verified by DNA sequencing.  
The EDR1 kinase domain constructs were expressed in E. coli strain BL21 cells 
co-expressing chaperones DnaK, DnaJ, GrpE, ClpB, GroEL and GroES (CC4 cell lines, 
courtesy of A. Geerlof, Helmholtz Zentrum München) as described in methods section. 
The isolation of the protein from the cell lysate was conducted using Ni-NTA affinity 
chromatography followed by TEV protease cleavage to remove the His-tag and finally 
size exclusion chromatography (SEC). For the first purification step the cell lysate was 
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loaded onto Ni-NTA Agarose beads (Invitrogen™, Life Te hnologies Gm  , Darmstadt, 
Germany) pre-equilibrated with buffer A (see materials and methods) and washed in two 
steps with 30 mM and 50 mM imidazole containing buffers, respectively. The protein was 
eluted in four consecutive steps (elutions 1 to 4) with increasing imidazole concentration, 
first with 75 mM, then with 100 mM and 300 mM, and finally with 500 mM imidazole 
using 2CV of buffer in each step. The NiNTA purification fractions were analyzed using 
SDS-PAGE (Figure 27). Small fraction of the protein material were lost in the 2
nd
 wash 
step but most were found from the four elutions that were therefore combined for the 
subsequent purification steps. 
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Figure 27. The SDS-PAGE analysis of the NiNTA fractions for the EDR1 kinase domain constructs. The 
abbreviations used: L = lysate, FT = Flow through, W1 = 1
st
 wash, W2 = 2
nd
 wash, E1 – E4 = The four 
elution steps with increasing imidazole concentration, M = PageRuler Color Plus Prestained protein ladder 
(Fermentas/Thermo Fisher Scientific – Germany GmbH, Schwerte, Germany). The results for WT are 
shown in A, for D792N mutant in B, for F881E mutant in C, for V876E in D and for the V876E/F881E 
double mutant in E. 
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The NiNTA purification was followed by the removal of the His6-tag using TEV 
protease treatment and subsequent removal of the protease using an additional NiNTA 
step. Size exclusion chromatography (SEC) was performed as the last purification step for 
the cleaved protein to yield a pure protein. 
The SEC elution profile and the corresponding SDS-PAGE analysis of the wild 
type EDR1 kinase domain is shown in figure 28. Two distinct peaks were observed in the 
SEC graph. Based on the SDS-PAGE analysis, the material that eluted nearly at the void 
volume of the column (V0 = 42 ml, HiLoad 16/60 Superdex 75 prep grade, GE Healthcare 
Bio-Sciences AB, Uppsala, Sweden) contained mainly aggregated target protein but also 
protein contaminants with molecular masses larger than 70 kDa. The presumably 
monomeric protein eluted separately with an elution volume of about 70 ml. The SDS-
PAGE analysis of the monomeric fraction revealed that the obtained protein material was 
not homogenous. Instead, two protein bands near the 35 kDa molecular weight standard 
band were observed. The molecular mass of both observed protein species corresponded 
roughly to the calculated molecular mass of EDR1 kinase domain (32 kDa). 
Phosphorylation was considered as possible explanation for the observed heterogeneity as 
the mass spectrometry analysis of the protein indicated existence of multiple 
phosphorylation sites and multiple protein species (results shown in detail in chapter 
4.3.2.2). To obtain more homogeneous sample, a kinase inactive mutant was produced. 
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Figure 28. The SEC curve and the corresponding SDS-PAGE analysis of WT EDR1 kinase domain. The 
lanes in the gel are designated by the corresponding elution fraction from the SEC purification. The first 
peak in the SEC elution profile corresponded to aggregated target protein and higher molecular weight 
impurities according to SDS-PAGE analysis shown here for the elution fraction B12. The elution fraction 
of the presumed monomeric protein (fractions C6, C9 and D11 on gel) appeared to be heterogeneous, 
presumably due to phosphorylation. PageRuler Color Plus Prestained protein ladder (Fermentas/Thermo 
Fisher Scientific – Germany GmbH, Schwerte, Germany) was used as protein marker (lane M). 
 
The catalytically inactive variant of EDR1 kinase domain seemed to have a 
slightly altered SEC profile when compared to the wild type (Figure 28). Altough the 
SEC profile of EDR1-D792N contained two peaks, significantly less protein came out in 
the aggregate fraction. Additionally, the SDS-PAGE analysis confirmed that elution 
fractions with the target protein (elution volume of about 68 ml) contained only one 
protein species with molecular weight slightly below 35 kDa. This correlates well with 
the calculated molecular mass of EDR1-D792N, which is 32 kDa. The fractions that 
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contained the pure monomeric protein were pooled together and concentrated to about 10 
mg/ml prior to use.  
 
 
Figure 29. The SEC graph and corresponding SDS-PAGE analysis for EDR1-D792N. The fractions 
corresponding to the second peak with elution volume of about 68 ml in the SEC profile, containing the 
pure, monomeric protein (MW = 32 kDa) were pooled together. M = PageRuler Color Plus Prestained 
protein ladder (Fermentas/Thermo Fisher Scientific – Germany GmbH, Schwerte, Germany). 
 
The SEC results of the EDR1 kinase domain G-helix mutants were very similar to 
the EDR1-D792N, also based on the SDS-PAGE analysis (Figure 29). The final protein 
sample consisted of monomeric protein and no additional protein species were observed 
according to SDS-PAGE. The SEC purification step of the three G-helix mutants resulted 
in pure protein samples, which were concentrated to roughly 5 mg/ml prior to use in the 
activity assays. 
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Figure 30. The SEC purification profiles and SDS-PAGE analysis results of the three EDR1 kinase domain 
G-helix mutants. A) The SEC profile of the EDR1-F881E mutant showed two peaks at elution volumes of 
about 46 ml and 70 ml, latter one of which contained the pure monomeric protein according to SDS-PAGE 
analysis. B) Based on the SEC graph of EDR1-V876E, the sample contained more aggregated or larger 
oligomer of the protein compared to the other two G-helix mutants. Despite of this, highly pure protein was 
obtained. C) The G-helix double mutant had a similar SEC profile with the D792N and F881E mutants. The 
fractions of the pure monomeric protein, eluting out at volume of about 70 ml, were pooled together. 
 
4.3.2 Biophysical characterization of EDR1 kinase domain 
4.3.2.1 Thermofluor for the EDR1-D792N 
The D792N mutant was despite of being homogenous compared to the wild type 
kinase domain, not at the beginning very amenable for crystallization. To find either more 
suitable buffer condition or optionally an additive that would stabilize the protein, 
thermofluor experiment using both buffer and additive screen (Boivin et al. 2013) was 
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performed. The protein concentration used in both screens was 100 µM, which is the 
upper limit of recommendable protein concentration in thermofluor experiment. From the 
buffer screen significantly improving conditions were not identified. The results for 
buffer screen are summarized in figure 31. 
 
 
Figure 31. The results of the thermofluor experiment for EDR1-D792N using the buffer screen. No 
significant stabilizing effect on the protein with the standard buffer components was observed. Not 
surprisingly, very acidic or basic pH however showed strong de-stabilizing effect. 
 
In search of additives that could have positive effect on the thermostability of the 
EDR1-D792N, the protein was subjected to the thermofluor analysis with additive screen. 
This screen included compounds with various different chemical properties, such as 
chaotropic and dissociating reagents, salts, mono- and multivalent ions, reducing agents, 
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polyamines, detergents, alcohols, amino acids, sugars and nucleotide cofactors. 
Additionally three custom chemicals were included, which were the generic kinase 
inhibitor staurosporin in concentration 0.5 mM and the non-hydrolyzable analog of ATP, 
AMP-PNP in two different concentrations, 5 mM and 10 mM. Staurosporin was chosen 
since it was successfully used as additive to crystallize CTR1 (Mayerhofer et al., 2012) 
while AMP-PNP mimics the natural ATP substrate of EDR1.  
A modest stabilizing effect was seen with various compounds from different 
chemical subgroups. Out of the tested salts, both sodium and potassium dihydrogen 
phosphates had a clear positive effect on the thermostability of the protein. Both 
increased the melting temperature by 7°C. Similarly a slight increase in the melting 
temperature was observed with all the tested polyamines (100mM Trimethylamine, 1mM 
Spermidine and 1 mM Spermidine-HCl) and with glycerol when used in 10 or 20 % 
concentration. The increase was in this case in 5 to 6°C range. The additives with only a 
very weak stabilizing effect on the EDR1-D792N included NH4Cl, NaBr, the detergent 
Octyl-β-D-Glucoside, taurine and amino acids, such as L-Histidine and in high 
concentration (500mM) L-arginine when combined with L-Glutamate. These chemicals 
shifted the Tm-value by 3°C on average. 
The most remarkable increase in the melting temperature and was observed when 
either ATP or its non-hydrolyzable analog, AMP-PNP was added to the protein solution. 
In the case of ATP an increase from 37°C to 57.3°C was measured whereas with AMP-
PNP only slightly lower increase, namely from 37°C to 54.3°C was seen. The effect of 
AMP-PNP appeared to be independent of the concentration since the increase from 5 mM 
to 10 mM concentration didn’t show any shift in the measured Tm-value. Also the 
addition of generic kinase inhibitor, staurosporin had a noticeable positive effect on the 
thermostability of the protein, increasing the melting temperature from 37°C to 50.1°C. 
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Based on these results, the presence of ATP, AMP-PNP and staurosporin was considered 
to have desired effect on making EDR1-D792N more amenable for crystallization. The 
results for the chemical included by default in the thermofluor additive screen are shown 
in figure 32. The results for the customized screening of thermostability improving 
compounds are shown in figure 33.  
 
Figure 32. The effect of several different additives with various chemical properties was tested for the 
EDR1-D792N. From the chemical included in the thermofluor additive screen, there were several that 
showed a modest stabilizing effect on the protein. These were some salts, such as dihydrogen phosphates, 
Mn
2+
 of the multivalent ions, all three polyamines included in the screen, the detergent Octyl-β-D-
Glucoside, glycerol in concentration 10 or 20 % and some amino acids, such as L-Histidine and 
combination of L-Arginine and L-Glutamate in concentration 50 mM. The strongest effect on the 
thermostability of the EDR1-D792N was observed with nucleotide cofactors, especially with the natural 
substrate molecule ATP, which increased the melting temperature of the protein with 20°C. 
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Figure 33. The effect of staurosporin and AMP-PNP on the thermostability of EDR1-D792N. Both 
stabilized the protein significantly based on the roughly 20°C increase in melting temperature. 
 
4.3.2.2 Phosphorylation sites 
The crystallization of the wild type EDR1 kinase domain proved to be a highly 
challenging task presumably due to the unability to produce material that was 
homogeneous enough. This was accounted to be the result of multiple phosphorylation 
sites in the protein. Based on a NetPhos 2.0 Server prediction, EDR1 kinase domain was 
estimated to contain 9 phosphorylation targets, out of which 6 were serine and 3 threonine 
residues (Figure 34). This program uses artificial neural network method to score the 
individual putative phosphorylation sites and the residues with highest score are 
considered to be the most probable sites for phosphorylation (Blom et al., 1999). To get a 
more comprehensive view of the possible phosphorylation targets within EDR1, peptide-
fingeprinting analysis with LC-MS/MS was performed to identify phosphorylation 
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containing peptide fragments from both trypsin and chymotrypsin containing samples. 
The results from the MS/MS analysis were analyzed using MASCOT version 2.2.03 
(Matrix Science Limited, London, UK). Also the peptide-fingerprinting analysis indicated 
that the enzyme contained 9 putative phosphorylation sites, although only the 
phosphorylation of Thr787 could really be confirmed with certainty. This threonine 
located two residues upstream from the catalytic HRD motif. It was also observed that 
majority of the pshosphorylation sites concentrated on the activation segment region, 
which is marked by DFG and APE tripeptide sequences at the N- and C-terminus of this 
region, respectively. The position of the putative phosphorylation sitesin the EDR1 kinase 
domain sequence is shown in the figure 34. 
 
Figure 34. The putative phosphorylation sites of EDR1 kinase domain. The results from the peptide-
fingerprinting analysis using trypsin and chymotrypsin digested fragments are shown in the upper and 
middle panel while the predicted sites from NetPhos are shown in the lower panel.  
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To examine the number and mass of the different protein species in the final 
purification fraction, ESI-MS analysis was conducted. As expected the sample for the 
wild type EDR1 kinase domain appeared to be heterogeneous based on the separate mass 
species in the ESI-MS spectrum. Three separate protein entities were observed with 
molecular weights of 32248 Da, 32328 Da and 32408 Da (Figure 35). These correlate 
very well with the 3-, 4-, and 5-fold phosphorylation of the protein since the calculated 
molecular weight for the unphosphorylated protein is 32008 Da to which each phosphoryl 
group adds an additional 80 Da. Furthermore, when the same MS analysis was performed 
to the kinase inactive mutant of EDR1, the most abundant mass entity had the molecular 
weight of the unphosphorylated EDR1 kinase domain (Figure 36). These results 
confirmed that the wild type protein has multiple phosphorylations and furthermore is not 
homologously phosphorylated. The substitution of the catalytically important aspartate 
(Asp792) with asparagine renders the enzyme inactive and results in unphosphorylated 
protein. 
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Figure 35. The ESI-MS analysis results for the wild type EDR1 kinase domain (courtesy of S. Leicht, 
Proteomics Core Facility of EMBL Heidelberg). As expected the sample was heterogeneous and contained 
multiple protein species in different phosphorylation states. The main forms of the protein appeared to 
possess 3, 4 or 5 phosphorylated residues based on the obtained mass values. 
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Figure 36. The high accuracy molecular mass analysis was performed for EDR1-D792N mutant using ESI-
MS (courtesy of S. Leicht, Proteomics Core Facility of EMBL Heidelberg). The most abundant mass 
species corresponded to the non-phosphorylated form of the enzyme. 
 
4.3.2.3 The kinase activity of EDR1-kd and EDR1-D792N 
The coupled kinase assay was used to study the activity of the wild type EDR1 
kinase domain and confirm that the inactive state of EDR1-D792N. In this assay the 
enzymatic activity of the target protein is the only source for ADP, which is required for 
the reaction catalyzed by puryvate kinase to produce ATP and Pyruvate from 
phosphoenolpuryvate (PEP). The formed puryvate in turn is reduced to lactate by LDH in 
expence of NADH oxidation. NADH has absorption maxima at 540 nm thus providing 
the means to measure its consumption. A dilution series of ATP (from 1 mM to 0.016 
mM) was used and for each protein sample three replicates were measured 
simultaneously. 
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The linear part of the raw data curve (A540-values versus time in minutes) for the 
different ATP concentrations was used to calculate the reaction velocity for each 
replicate. The reaction velocity (mOD/min) was obtained from the slope of the curve. The 
mean mOD/min value from the three replicates was then plotted agaist the ATP 
concentration (µM) and from the obtained curve (Figure 37), the standard enzyme 
kinetics parameters were calculated according to Michaelis-Menten kinetics. Only the 
wild type enzyme showed activity with a maximum reaction velocity (Vmax) value of 6.7 
± 0.3 mOD/min and a Michaelis constant (Km) of 60 ± 8.9 µM. 
 
 
Figure 37. The kinetics curve from the coupled kinase assay for both the wild type kinase domain of EDR1 
and for the D792N mutant. The mutation of the catalytically important aspartate residue (D792) renders the 
enzyme inactive. The error bars represent the standard deviation of the reaction velocity for the three 
replicates at each data point.  
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4.3.2.4 Oligomerization state of EDR1 WT and D792N by SEC-
LS/UV/RI 
The oligomerization state of wild type and D792N mutant of EDR1 kinase 
domain were studied using SEC-LS/UV/RI to investigate whether EDR1 shows similar 
dimerization dependent behaviour as CTR1. CTR1 was shown to form dimers when 
active and inactive mutants of the enzyme appeared to mainly exist as monomers 
(Mayerhofer et al., 2012). Since CTR1 is the closest homolog of EDR1, it was speculated 
whether the kinase activity of EDR1 would also be dimerization dependent. Both the wild 
type enzyme and the D792N variant were tested at two concentrations. The Malvern 
instrument was used at this work to measure the UV absorbance at 280 nm, refractive 
index (RI) and the right angle light scattering (RALS) of the sample, which eluted out 
from the SEC column. The measured values for reference BSA sample were used to 
obtain the calibration constants for the equipment. Based on the calibration constants 
from the BSA standard and the measured RI and LS signals for the studied protein, the 
molecular mass of the latter one was calculated.  
The UV-absorption based elution profile of the wild type EDR1 kinase domain 
consisted of one main peak at approximate elution volume of 15.5 ml with both 4.5 and 
7.3 mg/ml protein concentration (Figure 38 A and B). The calculated molecular mass for 
the corresponding protein species was 30.4 kDa at concentration 4.5 mg/ml and 36.9 kDa 
at concentration 7.3 mg/ml, both of which are roughly the molecular mass of a monomer. 
Similar results were obtained for the kinase inactive mutant at the tested concentrations of 
1.7 mg/ml and 3.5 mg/ml (Figure 39 A and B). Therefore the analysis with SEC-
LS/UV/RI indicated that the kinase domain of EDR1 exist mainly as a monomer in 
solution independent of its activation state. 
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Figure 38. The results for the wild type EDR1 kinase domain from the SEC-LS/UV/RI analysis. The 
measured UV absorbance at 280 nm is represented with the blue curve, RI with red curve and RALS with 
green curve. The molecular weight of the main protein species corresponded to the monomeric form of the 
enzyme, both at concentration 4.5 mg/ml (A) and 7.3 mg/ml (B). 
 
  
Figure 39. The SEC-LS/UV/RI analysis results for EDR1-D792N. The protein appeared as a single peak in 
the UV-absoprtion based elution profile (blue curve). Only monomeric form of the enzyme was detected 
based on the molecular mass estimation. The figure shows the UV absorption at 280 nm (blue curve), the 
measured RI (red curve) and the measured RALS (green curve) for the samples at concentration 1.7 mg/ml 
(A) and 3.5 mg/ml (B).  
 
4.3.3 Crystallization trials on the wild type EDR1 kinase domain  
The purification of the wild type EDR1 kinase domain resulted always in a 
heterogeneous material based on the observed double band in the SDS-PAGE gel after 
the SEC purification step. MS/MS peptide fingerprinting analysis using both trypsin and 
chymotrypsin additionally showed that the protein contained several phosphorylation 
sites and was not uniformly phosphorylated based on accurate mass analysis with ESI-
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MS. Instead at least three protein species were observed in 4-, 5- and 6-phosphorylated 
forms, respectively. Despite of the heterogeneity, crystallization was attempted both in 
the presence of generic kinase inhibitor staurosporin and the non-hydrolyzable ATP 
analog AMP-PNP, which were added to the protein solution to final concentration of 0.5 
mM and 5 mM, respectively. The crystallization trials were carried out using commercial 
screens (Qiagen Classic I and II, PEGs I and II and AmSO4 Suite) at the EMBL Hamburg 
high-throughput crystallization facility (Mueller-Dieckmann, 2006). This resulted in one 
initial hit from a condition that contained 0.1 M Magnesium chloride, 0.1 M MES pH 6.5 
and 30% PEG 400 (PEGs II Suite no. 10). In the corresponding drop clusters of very thin 
needle crystals grew after a couple of days (Figure 40) but due to their dimensions, they 
were challenging to test at the X-ray source and also eventually did not produce a 
diffraction. The subsequent manual reproduction and optimization trials unfortunately 
also failed. The reason for this was presumably in the variations in the phosphorylation 
state of the protein resulting in heterogeneity not only within the sample but also between 
different purification batches. Therefore a kinase inactive form of the protein was 
produced and eventually successfully crystallized. 
Figure 40. The needle-like initial crystals of 
EDR1 kinase domain. The crystals grew in a 
drop containing 0.1 M Magnesium chloride, 
0.1 M MES pH 6.5 and 30% PEG 400. These 
crystals could not be reproduced, most likely 
due to phosphorylation-dependent 
heterogeneity between the different protein 
purification batches.  
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4.3.4 Obtaining the EDR1-D792N structure  
The crystallization of the inactive EDR1 protein kinase domain, EDR1-D792N 
was performed in the presence of AMP-PNP, a non-hydrolyzable analog of ATP, which 
was added to the protein solution to a final concentration of 5 mM. Crystallization trials 
were also conducted to protein material with 0.5 mM staurosporin, a generic kinase 
inhibitor added, but no crystals were obtained from these trials. Initial crystallization 
experiments were carried out with 5 commercial crystallization screens (Qiagen Classic I 
and II, PEGs I and II and AmSO4 Suite) at the EMBL Hamburg high-throughput 
crystallization facility (Müller-Dieckmann, 2006). All initial screens were performed 
using the sitting-drop vapour-diffusion method at 292K in 96-well Greiner plates. 300 nl 
protein solution was mixed with an equal volume of reservoir solution and equilibrated 
against 50 µl of reservoir solution. Thin, needle-like crystals were growing in several 
conditions after only few days but the most promising one was with 1.6 M Ammonium 
sulphate and 0.1 M Bicine pH 9.0 (Qiagen AmSO4 Suite, solution No. 60) (Figure 41A). 
Rod-like crystals that diffracted to 2.5 Å were obtained from optimization screen with 
hanging drop vapor diffusion method. These crystals appeared after one week in a drop 
that contained 1.2 M Lithium sulphate, 10% PEG3350 and 0.1 M Hepes pH 7.8 (Figure 
41B). 
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Figure 41. The results from the crystallization trials of EDR1-D792N. A) The initial crystallization 
experiments with EDR1-D792N produced thin needle-like crystals in condition that contained 1.6 M 
Ammonium sulphate and 0.1 M Bicine pH 9.0. B) Optimization trials led into slightly thicker rod-like 
crystals that grew in approximately one week in a drop containing 1.2 M Lithium sulphate, 10% PEG3350 
and 0.1 M Hepes pH 7.8. 
 
Prior to data collection, a single crystal of EDR1kd-D792N grown in the presence 
of AMP-PNP was soaked for about 5s in mother liquor augmented with 15% glycerol as a 
cryoprotectant and 10 mM AMP-PNP. Out of the best diffracting crystal a total of 800 
images were collected with an oscillation range of 0.1º at the PETRA-III beamline P13, 
EMBL Hamburg, Germany. The data were indexed and integrated using XDS (Kabsch, 
2010) and scaled with SCALA (Collaborative Computational Project, Number 4, 1994).  
The crystals of the EDR1-D792N belonged to the trigonal space group P3221 with 
unit cell parameters a = b = 90.57 and c = 185.90 (α = β = 90°, γ = 120°). The phases 
were obtained through automated molecular replacement using program MOLREP 11.0 
as part of CCP4 Program suite 6.3.0 (Collaborative Computational Project, Number 4, 
1994) and the crystal structure of the inactive A. thaliana CTR1 protein kinase domain 
(PDB code: 3P86, Mayerhofer et al., 2012) as a search model. The asymmetric unit 
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contained two molecules with a calculated solvent content of 64.24 % and Matthews 
coefficient Vm = 3.44 Å
3
/Da (Matthews, 1968). The calculation of Matthews coefficient 
indicated the possibility of third molecule in the asymmetric unit with corresponding Vm 
– value of 2.29 and solvent content 46.36 % but attempts to obtain phase solution for 
three molecules per a.u. failed. Therefore the dimeric packing of the molecules was 
considered to be correct. The initial model was refined against the native dataset with 
program REFMAC 5.7 (included in CCP4 program suite 6.3.0) to obtain interpretable 
electron density maps for manual model building in COOT 0.7 (Emsley et al., 2010). A 
large section of unassigned density was identified in the putative active site of each 
monomer enabling the modeling of one AMP-PNP molecule (PDB Ligand code: ANP) 
per monomeric protein unit. The final model with R-factor of 0.191 and Rfree of 0.249 
resulted from iterative cycles of manual model building and refinement using the 
programs REFMAC 5.7 and COOT 0.7. The data quality and refinement statistics are 
shown in table 28. 
 
 141 
Table 28. Data collection and refinement statistics for EDR1-D792N structure. Values in the parenthesis 
are for the high resolution shell. 
 EDR1-D792N 
Data collection 
 
X-ray source 
Wavelength (Å) 
Space group 
Cell dimensions 
a, b, c (Å) 
α, β, γ (°) 
Resolution (Å) 
Rmerge 
I / σI 
Completeness (%) 
Redundancy 
 
Refinement 
 
Resolution (Å) 
No. reflections 
Rwork / Rfree 
No. atoms 
  Protein 
  Ligand/ion 
  Water 
B-factors 
  Protein 
  Ligand/ion 
  Water 
r.m.s. deviations 
  Bond lengths (Å) 
  Bond angles (°) 
 
 
P13, PETRA III 
1.3858 
P3221 
 
90.57, 90.57, 185.9 
90.0, 90.0, 120.0 
92.93–2.55 (2.69-2.55) 
9.5 (73.0) 
8.6 (2.0) 
97.5 (96.4) 
3.3 (3.2) 
 
 
 
78.45 – 2.55 
29,533 
19.1/24.9 
 
4,305 
130 
6 
 
68.1 
76.9 
89.6 
 
0.02 
1.9 
 
 
4.3.4 Structural characterization 
4.3.4.1 EDR1-D792N structure 
The crystal structure for EDR1-D792N was obtained in the presence of the ATP 
analog AMP-PNP with two protein molecules per asymmetric unit. As expected, the 
inactive kinase domain of EDR1 adopted the characteristic protein kinase domain fold as 
described first for the catalytic subunit of cyclic adenosine monophosphate-dependent 
protein kinase (PKA-Cα) (Knighton et al., 1991). The structure of EDR1-D792N 
 142 
consisted of two lobes: N-terminal one (residues 655 – 744) and larger C-terminal one 
(750 – 933) connected to eachother with a short linker (residues 745 – 749) (Figure 42). 
The first 6 N-terminal residues appeared to be disordered based on the lack of 
interpretable electron density. Additionally, the last or the last two C-terminal residue(s) 
were missing in the protomers B and A, respectively. As in the canonical kinase core 
structure, the N-terminal lobe in EDR1-D792N  onsists mainly of β-strands that assembly 
to form the  entral β-sheet required for the binding of the nucleotide. However, in 
contrast to the typical five-stranded β-sheet seen in other protein kinase domain structures 
the  orresponding β-sheet in EDR1-D792N is formed by six β-strands. Due to disruption 
in the hydrogen-bonding pattern through the altered orientation of the Arg674, the first β-
strand is split into two separate β-strands, referred here as β1A and β1B. The β1A strand 
(residues 670 – 673) interacts with the C-terminal residues 685 - 688 of the β2-strand 
whereas the β1B forms an antiparallel intera tion with four N-terminal residues of β2 
(residues 681-684). In addition to the β-sheet, the N-terminal lobe of EDR1-D792N 
 ontains the αC-helix (residues 707 – 720), which is one of the characteristic structural 
elements in protein kinases and is involved in mediating the changes between the inactive 
and active state of the protein. The loop preceding the αC-helix is more disordered in the 
protomer B of EDR1-D792N than in the protomer A based on the lack of density for the 
residues Ala702 and Phe703. In both the residues from Asp200 to Ala706 show higher B-
factors compared to the average for the whole protein molecule. This phenomenon is not 
unusual in flexible linker regions that mediate movement, as is the case here. 
The C-terminal lobe of EDR1-D792N is mainly α-helical and consists of seven α-
helices (αD – αI) and four 3/10 helices. Additionally this subdomain includes an 
antiparallel two-stranded β-sheet made out of strands β7 (residues 798-800) and β8 
(residues 806-808). As expected for an inactive kinase, two short β-strands (β6 and β9 
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according to the nomeclature in PKA-Cα stru ture) are missing in EDR1-D792N 
structure. The residues of the β6-strand (residues 787 – 789) precede the conserved HRD 
motif (residues 790 – 792), which contains the highly conserved and catalytically 
important aspartate residue (Asp792). This motif is part of the catalytic loop, which is 
lo ated  etween the αE-helix and β-strand β7 and in EDR1 spans the residue range from 
784 to 797. The β-strand β9 is part of the structurally flexible activation loop, which is 
flanked by the conserved DFG and APE motifs and usually contains the primary 
phosphorylation site of the enzyme. In protomer B this activation loop is fully structured 
whereas in the protomer A a four-residue segment (residues 825-829) could not be build 
into the model. Both protomers also showed weak or complete lack of density for the 
residues Lys759 and Ser760, which are part of a surface loop  etween αD- and αE-helices 
in the C-terminal lobe. 
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Figure 42. The EDR1-D792N structure. As expected, EDR1-D792N exhibited the typical bilobal structure 
of protein kinases as shown here for the protomer B. The N-terminal lobe (in blue) typically consists of 
five-stranded β-sheet (β1-β5), however in the  ase of EDR1-D792N the β1 is split into two β-strands, β1A 
and β1B. Additionally the N-lobe includes the important αC-helix, which changes its orientation when the 
kinase shuffles between inactive and active state. The larger C-terminal lobe (in gold) has mainly α-helical 
stru ture and is formed  y the α-heli es αD – αI. The protein is shown as cartoon representation and the 
bound AMP-PNP molecule is depicted as grey sticks.  
 
4.3.4.2 Dimerization 
The involvement of dimerization in protein kinase domain activation is well-
established phenomenon both among prokaryotic and eukaryotic members of Ser/Thr 
protein kinases (STPKs) and protein tyrosine kinases (PTKs). An example is the 
activation of well-known oncogenic protein kinase BRAF, which is dependent on both 
homodimerization and also heterodimerization with pseudokinase KSR (kinase 
suppressor of Ras) (Rajakulendran et al., 2009) A recent example for the dimerization-
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dependent activation is the kinase domain of CTR1 (CTR1-kd), which is in its active state 
forms similar back-to-back dimers observed for its eukaryotic homolog B-RAF 
(Mayerhofer et al., 2012). In CTR1-kd three residues, Arg604, Phe611 and Met612 
mediate the central interactions in the back-to-back interface in a similar manner as 
observed for BRAF and KSR (Mayerhofer et al., 2012). Mutations that block the back-to-
back dimer formation significantly reduce the kinase activity of the protein thus 
indicating the biological importance of this interface (Rajakulendran et al., 2009; 
Mayerhofer et al., 2012). 
Despite its high similarity with CTR1- d, EDR1  inase domain didn’t appear to 
form dimers based on the static light scattering experiments on the Malvern system. 
However, in the crystal structure EDR1-D792N had surprisingly adopted a dimeric 
arrangement where the active sites of the protomers faced away from eachother as 
expected for an authentic back-to-back interface (Figure 43). To examinate the possibility 
to a similar back-to-back interface as observed for CTR1-kd, the dimer interface of 
EDR1-D792N was analyzed. It was noticed that the position of the conserved back-to-
back interface residues (Arg722, Phe729 and Leu730 in EDR1) differed significantly 
from the expected one. In the CTR1-kd structure the corresponding residues are correctly 
positioned at the center of the dimer interface, where they are able to interact with one 
another. Similar interactions are not observed in EDR1-D792N structure due to an altered 
orientation of the two protomers in comparison to CTR1. Instead, the three residues are 
approximately 14 Å apart from their counterparts and locate near the periphery of the 
dimer interface (Figure 44A). 
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Figure 43. The EDR1-D792N dimer as observed in the asymmetric unit. The active sites of the two 
protomers are located at the opposite faces in the observed dimer. This resembles the arrangement in the 
classical back-to-back interface.  
 
The lack of interaction between the central back-to-back interface residues in 
EDR1-D792N indicated that this enzyme had adopted a different type of dimeric 
arrangement in the asymmetric unit. The biological relevance of the observed dimer 
interface was analyzed using PISA (Krissinel&Hendrick, 2007). A set of 9 residues from 
each chain was attributed to the dimer interface and covered 740 Å
3
 and 755 Å
3
 for the 
protomers A and B, respectively (Figure 44B). Firstly, the small number of strong 
interactions (hydrogen bonds, salt bridges) at the interface indicated a weak protein-
protein contact. Secondly, the calculated surface area at the interface was significantly 
smaller than the one in the back-to-back dimer interface of CTR1, which covers 1249 Å
3
. 
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Based on these two observations, it was considered to be unlikely that the EDR1-D792N 
would have similar function as the canonical back-to-back interface. Additionally, the 
interface was classified as crystallographic contact by PISA.  
Figure 44. The EDR1-D792N dimer interface as observed in the asymmetric unit. A) The position of the 
back-to-back dimer interface residues in the EDR1-D792N dimer interface. B) The dimer formation in 
EDR1-D792N is mediated by a set of 9 residues, which cover a total of 740 Å
3
 and 755 Å
3
 for the 
protomers A (shown as green cartoon representation) and B (as surface representation with carbon atoms in 
grey, oxygens in red and nitrogens in blue), respectively. 
 
4.3.4.3 EDR1-D792N protomers in different activational state 
The accurate mass analysis with ESI-MS indicated that the EDR1-D792N would 
exist in a non-phosphorylated state and therefore inactive state. This was further 
supported by results from the kinase activity assays. Surprisingly, for one of the 
protomers (protomer B) a block of unassigned density was observed at the proximity of 
two threonine residues (Thr820 and Thr827). Furthermore, in both cases the observed 
density was continuous with the side chain of the threonine residue, which allowed the 
modeling of phosphorylated residue at the two positions. Although this didn’t  orrelate 
with the results from the activity assays and from the accurate mass determination 
experiments for EDR1-D792N, the location of the phosphorylations supported their 
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authenticity. Firstly, both of the putative phosphothreonine residues are located in the 
activation loop, which is known to be a primary site for phosphorylation in the active 
protein kinases. Furthermore, both Thr820 and Thr827 were listed as putative 
phosphorylation sites according to the peptide fingerprinting analysis of the WT EDR1 
kinase domain. Additionally, in the sequence alignment of EDR1 with CTR1 (Figure 45), 
Thr820 correspond to Thr704, which is a known phosphorylation site in CTR1 
(Mayerhofer et al., 2012). The same phenomenon was seen in the structural alignment of 
EDR1-D792N with active form of CTR1 kinase domain (PDB code: 3PPZ), where the 
phosphothreonine 820 (TPO820) adopted a nearly identical position with the 
phosphothreonine 704 (TPO704) (Figure 46A). Finally, the second phosphothreonine 
(TPO827) in EDR1-D792N was found to lie within a so-called basic pocket, where it 
interacts with two conserved arginine residues, Arg791 and Arg815 (Figure 46B). These 
interactions are characteristic to the primary phosphorylation site in the active form of 
RD-kinases (Nolen et al., 2004). 
 
 
Figure 45. The sequence alignment of EDR1 with CTR1. The activation segment is marked with square 
and the phoshoporylation sites of EDR1 as seen in the EDR1-D792N structure with red stars. 
 149 
 
 
Figure 46. The location of the two phosphothreonines in EDR1-D792N protomer B. A) The 
phosphothreonine 820 (TPO820) of EDR1 overlays with TPO704 of CTR1 (PDB code: 3PPZ) in the 
structural alignment of the two enzymes. The structures of EDR1-D792N and CTR1 kinase domain are 
shown as light grey and grey cartoon models with the activation loops in gold and blue, respectively. The 
phosphoresidues are shown as sticks. B) The second phosphoresidue, TPO827, interacts with two arginine 
residues within a so-called basic pocket as seen with other RD-kinases for the primary phosphorylation site. 
 
Interestingly, neither of the above mentioned threonine residues showed any sign 
of phosphorylation in the protomer A of EDR1-D792N. Furthermore, Thr827 is part of 
the activation loop segment, which is unstructured in this protomer. Since the 
stabilization of activation loop through phosphorylation is a known phenomenon in the 
transition from inactive to active state in protein kinases, the observed difference between 
the two protomers indicated that they might be in different activational states. In order to 
see if there would be additional factors to support this hypothesis, the structures of the 
two protomers were investigated in detail. The structural alignment of the EDR1-D792N 
protomers showed a high overall similarity in the protein backbone (r.m.s.d.-value of 
0.495 Å for 203 Cα-atoms) exept for the  atalyti ally important αC-helix and the 
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activation loop (Figure 47A). Both are known to be the key regulatory elements that 
mediate the transition between inactive and active state (Huse and Kuriyan, 2002). In the 
active-like protomer B, the N-terminal end of the αC-helix is approximately 5Å closer to 
the core of the protein than in the other protomer. The difference arises from the 
combined translational and rotational motion perpendicular to the pivotal axis of the 
helix. The observed rotation is approximately 10° around the helical axis. The αC-helix 
contains a conserved glutamate residue (Glu714), which in an active kinase forms a salt 
 ridge with a  onserved lysine residue (Lys696) from the β3-strand. The altered 
orientation of the αC-helix in the protomer B enables the formation of this salt bridge 
(Figure 47B). In the protomer A the glutamate is pulled away from its counterpart as 
would be expected for an inactive kinase (Figure 47C).   
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Figure 47. The overlay of the two EDR1-D792N protomers reveals distinct differences in their folding 
pattern. A) The most profound differences are seen in the orientation of the catalytical αC-helix (residues 
707 – 720) and of the activation loop (residues 810 – 837) highlighted here in dark green and gold for the 
protomers A and B respectively. B) Additionally in the protomer B a hydrogen bond between the conserved 
lysine (Lys696) at the N-terminal part of the protein and  onserved glutamate (Glu714) in the αC helix is 
observed. This hydrogen bond is one of the hallmark features for an active kinase and does not exist in the 
EDR1-D792N protomer A. C) In the protomer A the corresponding lysine and glutamate residue locate far 
apart due to the altered position of the αC-helix.  
 
The structural rearrangements that stabilize the activation loop are known to occur 
in the transition from inactive to active kinase. The phosphorylation of this flexible 
protein segment plays an important role in the stabilization process. In the protomer B of 
EDR1-D792N the interaction of TPO827 with Arg791 and Arg815 facilitate the correct 
folding of the activation loop. The former arginine residue is part of the conserved HRD 
motif in the catalytic loop and forms a hydrogen bond with the phosphate group oxygen 
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of TPO827 through its guanidinium group. The latter arginine is part of the activation 
loop and localizes two residues apart from the conserved DFG motif that marks the 
beginning of this loop. The hydrogen bonds between the TPO827 phosphate group 
oxygen and the hydrogen donors NH2 and NE of Arg815 help to orient the N-terminal 
end of the a tivation loop. As a result, the residues of the β6 and β9 are  rought into  lose 
contact and appear to form nearly a β-sheet like hydrogen bonding network (Figure 48A).  
This resembles very closely to the structural arrangement observed in active kinases. In 
the protomer A the lack of phosphorylation and subsequent lack of structural organization 
in the activation loop results in increased distance between the putative β6 and β9 strand 
residues as would be expected for an inactive kinase (Figure 48B). 
 
 
Figure 48. The organi ation of the putative β6- and β9-strand residues. One of the characteristic features of 
an active kinase is a small β-sheet formed by the β6- and β9-strand. A) In the active-like protomer, the 
rearrangement of the activation loop brings the residues of the putative β9-strand (815 – 817) in close 
proximity with the residues of its pairing β-strand (β6, residues 787 – 789). This observation further 
supports the active-like state of the protomer B. B) The corresponding residues in the protomer A are not 
interacting with eachother as would be expected for an inactive kinase. 
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4.3.4.4 Enzyme-substrate complex 
The structural analysis of the EDR1-D792N protomers indicated that one 
possessed the characteristics of an inactive kinase whereas the other resembles closely an 
active kinase. Recently a similar phenomenon was seen in the crystal structure of p21-
activated kinase PAK1, where an inactive protomer was paired with a protomer in an 
active-like conformation (Wang et al., 2011). The crystallized protein in this case was 
also a catalytically inactive variant of the enzyme. In the structure of this PAK1-
KD
K299R/D389N
 the protomers formed an enzyme-substrate complex, where the activation 
loop of the inactive protomer served as a substrate for the protomer in the active-like 
state. Since the orientation of the EDR1-D792N protomers within the asymmetric unit 
differed from the observed ES-complex of PAK1-KD
K299R/D389N
, the crystallographic 
contacts across the different asymmetric units were examined. Interestingly, an interface 
that mimicked the trans-autophosphorylation complex was indeed found between the 
symmetry-related molecules from the neighbouring asymmetric units (Figure 49A). As in 
the PAK1-KD
K299R/D389N
 structure, the activation loop of the inactive protomer 
(“su strate”) protrudes to the active site of the active-like protomer (“en yme”). 
Furthermore, a serine residue (Ser824) from the activation loop of the substrate molecule 
is optimally positioned to interact both with the mutated catalytically important aspartate 
residue (Asp792) and with the γ-phosphate group of the bound AMP-PNP in the active 
site of the neighbouring protomer (Figure 49B). This appears to mimic the state prior to 
the phosphoryl group transfer. The side chain hydroxyl group of Ser824 is within 3.8Å 
and 3.0Å range from the γ-phosphate of AMP-PNP (conformer B) and from the ND2 
atom of Asn792, respectively.  
 
 154 
 
Figure 49. The ES-complex of EDR1-D792N. A) The ES-complex interface is observed between the 
adjacent protein molecules across the different asymmetric units. The partially disordered activation 
segment (in orange) of the “ina tive” monomer A (in dar  green) protrudes to the a tive site of the 
monomer B (in gold). B) A serine residue (Ser824) of this activation segment interacts with the γ-phosphate 
of the AMP-PNP molecule and with the mutated catalytically important aspartate (Asp792) as indicated 
with the black dashed lines. 
 
In addition to its role as a substrate for the adjacent active-like protein molecule, 
the activation loop of the inactive protomer functions as an anchor to dock the substrate 
molecule into correct position. A set of 5 residues from this activation loop interacts via 
hydrogen bonds with the residues of the adjacent molecule (Figure 50A). These include 
two serine residues Ser823 and Ser824, which form hydrogen bonds through their OG1 
and main chain oxygens, respectively. Their interaction partners are Lys794 from the 
catalytic loop and Thr830 from the activation loop of the neighbouring molecule. Leu822 
and Phe821 participate in the coordination network via their main chain oxygen atoms, 
which find their hydrogen bond parthers from the side chain hydrogen donors of Ser679 
and Lys794. Additional hydrogen bonds are observed between the side chain of Asn819 
and the main chain oxygens of Trp867 and Met870. Asn819 forms also a hydrogen bond 
to the side chain of Glu832. 
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Figure 50. The anchor residues in the ES-complex interface. A) The residues from the activation loop of 
the inactive protomer (in dark green) form hydrogen bonds (black dashed lines) with the residues from the 
adjacent molecule (in gold). B) The specific αG-helix residues provide the important hydrophobic 
interactions between the protein molecules at the ES-complex interface.  
 
The residues of the αG-helix also play an important role in the ES-complex 
interface of EDR1-D792N as previously observed in the crystal structure of 
Mycobacterium tuberculosis PknB receptor serine/threonine kinase variant (Mieczkowski 
et al., 2008). The specific residues of the αG-helix stack together through hydrophobic 
interactions as shown in the figure 50B. The most important interactions appear to be 
mediated by the side chains of Val876 and Phe881. As the mutation of the important αG-
helix residues in M. tuberculosis PknB led to a significant loss of enzymatic activity, it 
was investigated whether the substitution of Val876 and Phe881 with glutamate would 
have the same effect on the kinase activity of EDR1. In addition to the single mutants, a 
double variant where both αG-helix residues were substituted with glutamate was made. 
The kinase activity of the enzyme variants was tested using the coupled kinase assay as 
described in materials and methods. The wild type EDR1 kinase domain was tested in 
parallel as comparison. The results of the coupled kinase assay results for the mutants and 
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for the wild type enzyme are shown in figure 51. As expected, the wild type enzyme was 
active with Vmax and Km values similar to the ones calculated before (see chapter 4.3.2.3). 
The three αG-helix mutants appeared to have lost their activity thus confirming the 
importance of the Val876 and Phe881 mediated interaction to the activity of the enzyme.  
 
 
Figure 51. The results from the coupled kinase assay for the αG-helix mutants of EDR1 kinase domain. 
The mutation of the two αG-helix residues (Val876 and Phe881) renders the enzyme inactive, which 
supports the importance of the αG-helix mediated interaction at the ES-interface and furthermore confirms 
the requirement of the ES-complex interface for the autophosphorylation activity if the enzyme. 
 
4.3.4.4 Nucleotide-binding in EDR1-D792N 
The combined co-crystallization and soaking with AMP-PNP resulted in 
successful incorporation of the nucleotide into the active site of the inactive EDR1 kinase 
domain. In both protomers a bulk of unassigned density was observed in the cleft between 
the two lobes that allowed the placing of the nucleotide analog to this site (Figure 52). 
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The observed density at the active site of the protomer B appeared to be large enough to 
fit two conformations for the AMP-PNP molecule. In the two conformers the β-phosphate 
groups point to opposite directions allowing however the γ-phosphates to be positioned in 
similar environment.   
 
 
Figure 52. The AMP-PNP bound to the active site of EDR1-D792N. A clear electron density for the AMP-
PNP was observed in the active site of both protomer A (A) and B (B). The difference electron density for 
the images was calculated by omitting the nucleotide from the EDR1-D792N model.  The map contour 
level was set up for 0.0502 electrons/Å
3
 (σ = 2.0). The program FFT (Read & Schierbeek, 1988) as part of 
CCP4 Suite were used to create the omit maps. 
 
The location of the nucleotide-binding pocket is conserved among the protein 
kinases. The lid of the binding pocket is formed by the highly conserved P-loop, which is 
found from all kinases and is important for the ATP-binding. The tip of the P-loop 
intera ts with the γ-phosphate group of the nucleotide. Other structural elements that 
define the binding pocket include the linker region defines the bottom of the pocket and 
contributes to the nucleotide binding both through hydrophobic interactions and hydrogen 
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bonds. The frame of the AMP-PNP lies on top of β-strand β7 and the pre eding 3/10 
helix, both if which are part of the C-terminal lobe.  
In both EDR1-D792N protomers the residues that form the binding pocket for the 
adenosine unit appeared to adopt a specific rotamer and show conserved interaction with 
the ligand (Figure 53). The adenosine ring is flanked by the side chains of Val683 and 
Leu799, which form hydrophibic interactions with the bound ligand. The bottom of the 
nucleotide-binding pocket is capped by the phenylalanine side chain (Phe745). The same 
phenylalanine also takes part in the hydrogen bond network through its main chain 
aminogroup, which interacts with the N1 nitrogen of the nucleotide. More variability is 
observed in the surroundings of the phosphate-tail. This is partly due to the 
conformational flexibility in the triphosphate unit of the AMP-PNP in protomer B but 
also changes in the rotameric form of certain residues, such as Arg753 and Lys696. In 
protomer A these two residues are involved in the hydrogen bond network with the 
ligand. However, in the active-like protomer the side chains of these two residues are 
facing away from the active site. Furthermore, the Lys696 is involved in the conserved 
hydrogen bond that is characteristic for an active kinase. 
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Figure 53. The AMP-PNP binding in the EDR1-D792N. A) The residues involved in the binding of the 
AMP-PNP in protomer A are shown as green stick representation. B) The AMP-PNP binding pocket in 
protomer B similar to its counterpart in protomer A. A few differences in the hydrogen bond network exist 
due to the altered orientation of Arg753 and Lys696 and also because of the additional AMP-PNP 
conformer in protomer B. 
 
4.4 Adenylation domain ApnA A1 of Non-Ribosomal 
Peptide Synthetase from Planktothrix agardhii strain 
PCC7821 
4.4.1 The ApnA A1 PCC7821 constructs 
The ApnA A1 is the first adenylation domain in the Anabaenopeptin synthetase, 
which is a Non-ribosomal peptide synthetase from cyanobacterium Planktothrix agardhii 
responsible for the synthesis of anabaenopeptin. The studied ApnA A1 enzyme from P. 
agardhii strain PCC7821 consisted of 546 amino acids and possessed the unusual ability 
to adenylate two very different amino acids, namely L-arginine and L-tyrosine 
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(Christiansen et al., 2011). The wild type enzyme was studied using X-ray 
crystallography to gain insights into its bi-specificity. From the structural studies, three 
active site residues, Glu204, Ser243 and Ala307 were found to play important role in the 
substrate binding and recognition. The importance of the residues in positions 243 and 
307 has already been indicated in the phylogenetic and biochemical studies on ApnA A1 
enzymes from different Planktothrix strains (Christiansen et al., 2011). Furthermore, 
according to sequence aligment of ApnA A1 PCC7821 with PheA, the three mentioned 
residues are part of the so-called specificity-conferring code (Table 29). The residues 
included in the specificity conferring code have been indicated to define the substrate 
specificity of the adenylating enzyme (Stachelhaus et al., 1999). Substitutions to the 
positions 204, 243 and 307 of ApnA A1 PCC7821 were made to investigate the effect on 
the binding specificity of the enzyme. The created variants are listed in the table 2 (in 
materials and methods section). 
 
Table 29. The ApnA A1 PCC7821 residues that correspond to the specificity-conferring code (Stachelhaus 
et al., 1999) from PheA. 
PheA ApnA A1 
Asp235 Asp200 
Ala236 Val201 
Trp239 Glu204 
Thr278 Ser243 
Ile299 Ile271 
Ala301 Gly273 
Ala322 Val298 
Ile330 Ile306 
Cys331 Ala307 
Lys517 Lys500 
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4.4.2 Protein production  
The wild type ApnA A1 PCC7821 and majority of the mutants were expressed and 
purified in the laboratory of Prof. Andrea Rentmeister (University of Münster). The 
mutants of ApnA A1 PCC7821 purified at EMBL Hamburg are listed in the table 30 
together with the final yield from total 800 ml of bacterial culture. The detailed 
expression and purification protocol has been described in materials and methods section. 
The NiNTA purification graphs and corresponding SDS-PAGE results for the Ala307 
variants (A307C, A307D, A307K and A307N) are shown as an example in the figure 54. 
The protein species in the elution fractions appear slightly above the 55 kDa molecular 
marker band in the SDS-PAGE gel, thus corresponding roughly to the calculated 63.4 
kDa molecular weigth of the ApnA A1 with the His6-tag attached. Similar results were 
obtained for the serine mutants, S243E, S243G, S243H and S243Q, and for the lysine 
mutants K415A, K500A and K415A/K500A. Based on the SDS-PAGE analysis, the 
elution fractions that contained the target protein were pooled together and dialyzed 
overnight at 4°C. The dialyzed sample for each mutant was analyzed on SDS-PAGE gel 
to confirm the final purity level of the sample. The results for this analysis are shown in 
the figure 55. High level of purity was observed already after dialysis step and therefore 
no additional purification steps were performed. 
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Figure 54. An example of the NiNTA purification results for the ApnA A1 PCC7821 variants. The NiNTA 
purification results for four of the A307 variants are shown. The abbreviations used: L = lysate, FT = Flow 
through, M = PageRuler Color Plus Prestained protein ladder (Fermentas/Thermo Fisher Scientific – 
Germany GmbH, Schwerte, Germany). The remaining lanes correspond to a specific purification fraction in 
the elution profile. 
 
Table 30. The yield of pure protein after final purification step for the ApnA A1 PCC7821 mutants purified 
at EMBL Hamburg. 
ApnA A1 PCC7821 mutant Final yield (mg) 
A307C 2.9 mg 
A307D 5.8 mg 
A307N 4.5 mg 
A307K 4.1 mg 
S243E 1.2 mg 
S243G 1.6 mg 
S243H 3.6 mg 
S243Q 6.1 mg 
E204G 1.8 mg 
K415A 6.1 mg 
K500A 4.1 mg 
K415A/K500A 5.2 mg 
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Figure 55. The dialyzed samples for the ApnA A1 PCC7821 mutants were analyzed on SDS-PAGE to 
evaluate their purity. M = PageRuler Color Plus Prestained protein ladder (Fermentas/Thermo Fisher 
Scientific – Germany GmbH, Schwerte, Germany). A) The SDS-PAGE analysis for A307C, S243E, S243G 
and E204G confirmed their purity. B) Same applied for the lysine (K415A, K500A and K415A/K500A), 
alanine (A307D, A307K, A307N) and serine mutants (S243Q and S243H). 
4.4.3 Crystallization 
The WT ApnA A1 PCC7821 for the crystallization experiments was purified by 
Julia Sandberg-Meinhardt (University of Hamburg). The initial crystallization trials were 
performed using commercial screens and sitting-drop vapor diffusion methods at the 
EMBL Hamburg high-throughput crystallization facility (Müller-Dieckmann, 2006). The 
selected commercial screens included PACT Suite, pHClear and pHClear II Suite, 
Classics I and II Suite, PEGs and PEGs II Suite from Qiagen. Prior to crystallization the 
protein was concentrated to 10 mg/ml.  
Two lead conditions were obtained from the Qiagen PACT suite, one with 25% 
Polyethylene glycol 1500 and 0.1 M Malonic acid-Imidazole-Boric acid (MIB) buffer at 
pH 5.0 (Solution no. 14) and the other with 25% Polyethylene glycol 1500 and 0.1 M 
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Malic acid-MES-TRIS (MMT) buffer at pH 6.0 (Solution no. 39) (Figure 56A and B). 
Based on these two conditions, manual optimization was performed using hanging-drop 
vapor diffusion method at 19°C and protein concentrations of 5, 10 and 13 mg/ml. In the 
manual screens the concentration of the main precipitant PEG1500 was varied between 
10 - 30 % in combination with BIS-TRIS, MES and HEPES buffers at pH 5.5, 6.5 and 
7.5, respectively. Similar trial was additionally conducted with another PEG compound of 
larger molecular weight, PEG 3350. For both PEGs a selection of salts, namely MgCl2, 
CaCl2, (NH4)2SO4 and LiSO4, were tested as additives at concentration 0.2 M. The 
crystals used for data collection and soaking experiments grew in one week in drops 
containing 24-30% Polyethylene glycol 3350 and 0.1 M MES or BIS-TRIS buffer in pH 
5.5 to 6.5 (Figure 56C). These crystals diffracted up to 1.90 Å and belonged to the space 
group P212121.  
 
 
Figure 56. The ApnA A1 PCC7821 crystals obtained from initial and manual optimization screens. A) 
Crystals from Qiagen PACT condition no. 14 (25% PEG 1500, 0.1 M MIB Buffer at pH 5.0). B) Crystals 
from Qiagen PACT condition no. 39 (25% PEG1500, 0.1 M MMT Buffer at pH 6.0). C) The optimized 
crystals from manual screens using PEG3350 at concentration 24 – 30 % and either 0.1 M MES or BIS-
TRIS buffer at pH range 5.5 to 6.5.  
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4.4.4 Structure determination and validation 
The raw data was indexed and integrated using program XDS (Kabsch, 2010) and 
scaled with SCALA (Collaborative Computational Project, Number 4, 1994). The data 
quality statistics are in the appendix. The phases were obtained from automated molecular 
replacement with program MOLREP 11.0 (Vagin&Teplyakov, 1997) using the crystal 
structure of phenylalanine activating subunit of Gramicidin synthetase 1 (PheA, PDB 
code: 1AMU) as a search model. In each case the asymmetric unit contained one 
molecule with Matthews coefficient of 2.0 Å
3
/Dalton and approximate solvent content of 
40 %.  
The final ApnA A1 PCC7821 models were obtained through repeated cycles of 
manual model building in COOT 0.7 (Emsley et al., 2010) and refinement in 
REFMAC5.7 (Murshudov et al., 1997). For the complex structures part of the protein was 
build into the electron density using ARP/wARP (Langer et al., 2008) and manually 
modified in COOT. The tyrosyl adenylate exists in the PDB with ligand ID YAP but is 
not readily available in COOT monomer library or in the REFMAC library. JLigand was 
used to create the adenylated L-tyrosine and the corresponding CIF component definition 
file using similar compound Phosphoric acid 2-amino-3-(4-hydroxy-phenyl)-propylester 
adenosin-5'yl ester (PDB Ligand code: TYA) as a template. The arginyl adenylate has not 
been observed in existing protein structures as ligand according to current knowledge. 
The program JLigand was employed to create a link between L-arginine and AMP 
monomers using existing restrains from the REFMAC library. The structure composition 
file from JLigand was then used in both COOT and REFMAC to fit and refine the created 
molecule to the electron density in the model. The data collection and refinement 
statistics are shown in the table 31. 
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Table 31. Data collection and refinement statistics for ApnAA1 PCC7821 structures. These were solved in 
absence of substrates (referred as Apo enzyme) and in complex with AMP-PNP (Complex 1), with both 
AMP-PNP and L-arginine (Complex 2), with arginyl adenylate (Complex 3) and finally with tyrosyl 
adenylate (Complex 4). Values in the parenthesis are for the high-resolution shell. 
 Apo Complex 1 Complex 2 Complex 3 Complex 4 
Data collection 
 
Space group 
Cell dimensions 
a, b, c (Å) 
 
α, β, γ (°) 
 
Resolution (Å) 
 
Rmerge 
I / σI 
Completeness (%) 
Redundancy 
 
Refinement 
 
Resolution (Å) 
No. reflections 
Rwork / Rfree 
No. atoms 
  Protein 
  Ligand/ion 
  Water 
B-factors 
  Protein 
  Ligand/ion 
  Water 
r.m.s. deviations 
  Bond lengths (Å) 
  Bond angles (°) 
 
 
P212121 
 
68.81, 81.19, 
89.59 
90.0, 90.0, 
90.0 
19.97–2.02 
(2.13–2.02) 
6.9 (65.1) 
14.1 (2.6) 
98.5 (91.4) 
6.5 (5.9) 
 
 
 
19.97-2.02 
33,052 
20.4/23.6 
 
3,240 
6 
109 
 
39.4 
59.7 
42.0 
 
0.01 
1.3 
 
 
 
P212121 
 
68.31, 81.81, 
89.73 
90.0, 90.0, 
90.0 
89.73–2.250 
(2.37–2.25) 
8.8 (42.6) 
15.5 (5.7) 
99.1 (98.4) 
5.5 (5.7) 
 
 
 
60.48-2.25 
24,495 
18.2/23.0 
 
3,825 
75 
105 
 
30.4 
38.7 
27.9 
 
0.01 
1.5 
 
 
P212121 
 
68.43, 82.69, 
90.15 
90.0, 90.0, 
90.0 
90.15–2.00 
(2.11–2.00) 
6.0 (51.5) 
21.7 (3.9) 
100.0 (100.0) 
6.6 (6.7) 
 
 
 
60.94-2.00 
35,245 
19.0/24.5 
 
3,838 
81 
145 
 
35.7 
42.9 
33.6 
 
0.01 
1.5 
 
 
P212121 
 
68.14, 81.85, 
89.65 
90.0, 90.0, 
90.0 
89.65–1.90 
(2.00–1.90) 
11.1 (114.0) 
16.6 (2.4) 
99.1 (99.0) 
13.2 (13.0) 
 
 
 
60.45-1.90 
34,891 
18.3/22.7 
 
3,904 
51 
164 
 
31.7 
44.1 
31.4 
 
0.02 
2.0 
 
 
P212121 
 
68.17, 82.24, 
90.06 
90.0, 90.0, 
90.0 
90.06–2.00 
(2.11–2.00) 
12.9 (85.3) 
12.2 (2.2) 
100.0 (100.0) 
6.5 (6.6) 
 
 
 
60.74-2.00 
40,188 
18.7/23.1 
 
3,845 
51 
122 
 
30.3 
41.1 
30.0 
 
0.02 
2.0 
 
4.4.5 Structural characterization 
4.4.3.1 The crystal structure of the apo ApnA A1 PCC7821 
The first crystal structure for the ApnA A1 PCC7821 was obtained in the absence 
of the amino acid and nucleotide substrates, and was therefore referred as the apo form of 
the enzyme. The apo-ApnA A1 PCC7821 structure consisted of residues 3 – 410 and 
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covered mainly the expected N-terminal domain (Figure 57). For the first two N-terminal 
residues and for the C-terminal residues 411 – 547 no interpretable electron density was 
observed, which indicated a lack of stabile three-dimensional organization or intristic 
flexibility in this region. The structure shared the closest resemblence with the N-terminal 
domain of PheA (residues 17-428) with root mean square deviation (r.m.s.d.) of 0.777 Å 
for Cα-atoms of 283 residues in the structural alignment of the two enzymes. The apo-
ApnA A1 PCC7821 structure exhibited the typical fold of the N-terminal domain of 
adenylating enzymes, and accordingly comprised three subdomains. Two of these 
domains consisted of a large β-sheet where most of the β-strands were parallel to each 
other and  onne ted via α-helix. These two subdomains, referred to as subdomain A and 
B analogous to PheA, formed together a five-layered αβαβα fold where the two β-sheets 
enclosed two of the α-helices between them with the remaining helices surrounding this 
core structure. In the apo-ApnA A1 PCC7821 stru ture the β-sheet of the subdomain A 
was shorter than in the PheA stru ture due to a missing β-strand  orresponding to β-
strand A7 in PheA. Therefore the subdomain A of ApnA A1 PCC7821 consisted only of 
six β-strands (A1-A6 in PheA). Additionally, the α-helix in the lin er region of β-strands 
A3 and A4 found in PheA does not exist in ApnA A1 PCC7821. The subdomain B of 
ApnA A1 PCC7821 was very similar with PheA, with the exception that N-terminus of 
this domain  ontained an additional α-helix in PheA. The third subdomain of ApnA A1 
PCC7821 (residues 328 – 409) was mainly formed  y β-strands and had a tertiary fold 
that resem led a distorted β-barrel. This subdomain was referred to as subdomain C, 
based on the nomenclature in PheA structure. 
The highly conserved phosphate-binding loop (P-loop), which is a common motif 
found from most ATP- and GTP-binding proteins, was located in the subdomain A.  The 
P-loop has in the adenylation domains of Non-ribosomal peptide synthetases consensus 
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sequence LAYxxYTSG(ST)TGxPKG (Marahiel et al., 1997), which corresponds to the 
residues 149 – 164 in ApnA A1 PCC7821. In crystal structures of ATP-binding proteins 
the whole P-loop or parts of it are occasionally missing, examples of which are the firefly 
luciferase and PheA structures. In both structures, the central residues of the P-loop have 
apparent conformational flexibility based on the absence of electron density (Conti et al., 
1997). In the apo-ApnA A1 PCC7821 the P-loop also appeared to have flexibility based 
on the weaker electron density for the two central residues Thr159 and Gly160. The entire 
P-loop could still be build into the model.  
 
Figure 57. The crystals structure of apo-ApnA A1 PCC7821. The structural composition of the enzyme has 
high similarity to the N-terminal domains of other adenylating enzymes. It can be divided into three 
su domains, where two su domains  om rise a mix of α-heli es and β-sheets and the third a distorded β-
barrel core structure. The α-heli es are depi ted in red, the β-strands in yellow and the loops in green. 
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4.4.3.2 The ApnA A1 PCC7821 complex structures 
The main aim of the structural studies with ApnA A1 PCC7821 was to elaborate 
the bi-specificity of the enzyme. To that end, the crystals of the apo-enzyme were soaked 
shortly in suitable cryo-solution with the substrates added as described in the materials 
and methods. The soaking experiments were successful and resulted in four different 
complex structures. Two of these were showed the incorporation of a non-hydrolyzable 
ATP analog, AMP-PNP both with and without L-arginine as co-substrate into the active 
site. These were expected to represent the enzymatic state of ApnA A1 PCC7821 prior to 
adenylation. The other two structures were obtained in the presence of the reaction 
products, adenylated L-tyrosine and adenylated L-arginine, which were derived from the 
enzymatic activity in the presence of the natural substrates, ATP and the amino acid.  
The four ApnA A1 PCC7821 complex structures showed the conserved domain 
organization of the adenylating enzymes. They consisted of a large N-terminal domain 
with three subdomains (residues 2-408) and a significantly smaller C-terminal domain 
(residues 409-490), which is connected to the N-terminal domain by flexible hinge of 
four residues (Figure 58). The active site located at the interface of these two domains 
with the C-terminal domain functioning as lid to close the substrate-binding pocket. 
When compared to the full-length ApnA A1 PCC7821, the obtained structure lacked the 
first N-terminal methionine residue and also about 60 residues (491 – 547) from the C-
terminal end. Additionally, no electron density was observed for the residues 445 – 451, 
whi h lo ate in a putative flexi le loop  etween two β-strands in the C-terminal domain.  
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Figure 58. The overall structural composition of the ApnA A1 PCC7821 in the presence of substrate, 
shown here with the adenylated L-tyrosine (in yellow) bound in the active site. This structure represents the 
common fold of adenylating enzymes from same superfamily, consisting of larger N-terminal domain 
(lilac) and smaller C-terminal one (light blue) linked together by a short flexible loop. The protein is 
represented as cartoon model with the bound adenylated L-tyrosine depicted as spheres.  
 
The N-terminal domain in the ApnA A1 PCC7821 complex structures showed the 
same structural characteristics as described for the apo form of the enzyme. Interestingly, 
in the substrate bound state a majority of C-terminal domain residues also became 
structured and could be built into the model. The C-terminal domain had adopted a 
similar conformation to the C-terminal domain of PheA with a r.ms.d.-value of 0.741 Å 
for Cα-atoms of 58 residues. It comprised a β-hairpin (residues 413 – 422) followed by a 
three-stranded β-sheet, where the first two adja ent β-strands are antiparallel and the third 
 172 
β-strand parallel to its neigh our. Additionally there are two α-helices in the C-terminal 
domain that pack against the three-stranded β-sheet. The last missing C-terminal residues 
of the ApnA A1 PCC7821 model form a long loop in PheA structure that folds against the 
three-stranded β-sheet. 
The comparison of the ApnA A1 PCC7821 models to the published crystal 
structure of PheA (Conti et al., 1997) revealed that the orientation of the C-terminal 
domain in respect to the N-terminal one differed in the two proteins (Figure 59). The 
conformation adopted by ApnA A1 PCC7821 has been first described for the Acetyl-CoA 
synthase of S. enterica (Gulick et al., 2003) and is referred as the thioester-forming 
conformation. In this conformation the C-terminal domain is rotated about 140° 
compared to PheA. The rotational movement of the C-terminal domain is mediated by the 
flexible hinge region between the two domains. The residues forming the hinge are part 
of a conserved motif, which in adenylation domains has the consensus sequence 
GRxDxQVKIRGxRIELGEIE (residues 408 – 427 in ApnA A1 PCC7821). This motif is 
shared among the superfamily of adenylating enzymes and contains conserved aspartate 
residue (Asp411 in ApnA A1 PCC7821) with putative function as the hinge residue 
(Marahiel et al., 1997; Gulick, 2009).  
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Figure 59. The structural alignment of ApnA A1 PCC7821 complex structure with the PheA structure. The 
overlay shows the different orientation of the C-terminal domain in the two enzymes. The C-terminal 
domain of ApnA A1 PCC7821 (in light blue) is rotated roughly 140° towards the N-terminal domain 
compared to the PheA (C-terminal domain depicted in yellow). The hinge region responsible for the 
rotational movement is highlighted in red.  
 
The active site of ApnA A1 PCC7821 is located at the cleft between the two 
domains and as mentioned above is mainly surrounded by the secondary structure 
elements from the subdomain B and C of the N-terminal domain. The C-terminal domain 
functions as a lid to the binding pocket and also contributes to the ligand-enzyme 
interaction network. In the AMP-PNP bound structures a clear electron density is 
observed for the adenosine unit and for major part of the phosphate moiety. However, the 
γ-phosphate group of AMP-PNP appeared to fluctuate between two possible 
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conformations. In one conformation the γ-phosphate group is pointing inside the N-
terminal domain, where it interacts with the P-loop. In the other it is facing a cavity, 
which is connected to the surface of the enzyme. The examination of the binding site in 
the presence of the amino acid substrate (both in free and adenylated form) revealed that 
the side chain of this substrate is sandwiched between the α-helical linker of β-strands B3 
and B4 from one side, and the β-strands B5 and B6 from the other as seen for 
phenylalanine in PheA. For the adenylated L-tyrosine and L-arginine, the calculation of 
omit map results in a uniform density is observed for the amino acid and AMP units thus 
confirming the presence of the adenylation reaction product (Figure 60A and B, 
respectively). In the presence of AMP-PNP no link between the amino acid ligand and the 
nucleotide is observed, as expected. 
 
 
Figure 60. The bound adenylated amino acid at the active site of ApnA A1 PCC7821. The difference 
electron density for the adenylate reaction intermediates of ApnA A1 PCC7821 was calculated by omitting 
the ligands from the model. A) The map for tyrosyl adenylate intermediate contoured at 0.12464 e*Å
-3
 (σ = 
2.0) and B) for the arginyl adenylate at 0.14328 e*Å
-3
 (σ = 3.0).  
 
In order to get an overview of the accessibility of molecules to the active site, the 
surface models of the four ApnA A1 PCC7821 complex structures were evaluated. Due to 
the position of the C-terminal domain in relation to the N-terminal one, the active site 
appeared to be virtually inaccessible for other than solvent molecules. However, a smaller 
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putative exit cavity for the pyrophosphate was identified. The presumable role of this 
cavity as exit route for the phosphates was supported by the observation that two 
phosphates were modeled in the tyrosyl adenylate structure at the proximity of this cavity. 
Additionally in one of the two conformations of AMP-PNP, the γ-phophate group points 
towards this cavity (Figure 61A and B). In this particular conformation the γ-phosphate 
group is also in the proximity of the carboxyl acid group of the protein when both AMP-
PNP and L-Arginine are present in the active site. It was also noted that the size cavity of 
the putative phosphate exit cavity appeared to be larger in the structure with AMP-PNP 
bound than in the adenylate containing structure. A closer examination of the residues 
lining this cavity revelaed that two phenylalanine residues, Phe199 and Phe419 appeared 
to play an important role in modifying its size. These phenylalanines had a different 
conformation in the pre-reaction state of the enzyme (AMP-PNP bound) in comparison to 
the post-reaction state with adenylated amino acid bound inside (Figure 61C).  
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Figure 61. The putative exit cavity of ApnA A1 PCC7821. A) – B) The surface models of the ApnA A1 
PCC7821 in complex with adenylated amino acid (in lilac) and in complex with AMP-PNP (in yellow) 
revealed a putative phosphate exit cavity. The size of this cavity is larger prior to the completion of the 
adenylation reaction based on the comparison of the two models. C) Two phenylalanine residues, Phe199 
and Phe419 appeared to play a role in modifying the size of the cavity.  
 
4.4.3.3 Nucleotide binding site 
The active site of ApnA A1 PCC7821 located at the interface of the N-terminal 
and C-terminal domains as observed for other adenylating enzymes with known three-
dimensional structure. The nucleotide-binding site lies in the cleft between the N-terminal 
subdomains B and C with the ri ose ring fa ing the β-hairpin of the C-terminal domain. 
Subsequently majority of the residues involved in the binding of the nucleotide arise from 
 177 
the N-terminal domain. The four complex structures of ApnA A1 PCC7821 were 
compared to identify residues that retain their conformation and interaction with the 
nucleotide substrate, independent of its existence as free molecule or as part of the 
adenylation product. These residues were considered to be important for the correct 
docking of the nucleotide substrate and included both amino acids with charged side 
chains and with hydrophobic or polar side chains (Figure 62).  
The adenine ring is lined from one side by the main chain atoms of residues 274 – 
276 whereas on the opposite site it is packed agaist the side chain of Tyr299. The bottom 
of the nucleotide-binding pocket is capped by the side chains of Ile328 and Tyr406. The 
Tyr299 is also forms a hydrogen  ond 2’O -group of the ribose unit through a highly 
conserved aspartate residue (Asp394). This aspartate is part of a conserved motif 
(S/T)GD that is shared among the members of the adenylating enzyme superfamily. It has 
a spe ifi  role in sta ili ing the C3’ endo  onformation of the ri ose unit  y forming 
hydrogen bonds to its hydroxyl groups. These interactions occur between the OD1 and 
OD2 of Asp394 and 2’ and 3’ hydroxyl groups of the ribose ring as observed for the 
corresponding residue Asp413 in PheA. Other residues that are involved in the main 
hydrogen bond network in the nucleotide-binding pocket of ApnA A1 PCC7821 include 
Asn297, Val298 and Thr302. Out of these Asn297 and Thr302 also seemed to have 
conserved role in the nucleotide binding since their position and coordination patterns 
overlap with their PheA counterparts, Asn321 and Thr326. Asn297 forms a hydrogen 
bond to the exocyclic aminogroup of the adenine ring through its OD1 atom and possible 
through this interaction enables the differentiation between adenine and guanine. Val298 
also has a part in this hydrogen bond network through its main chain carbonyl oxygen.  
Although most of the interactions with the nucleotide arise from the N-terminal 
domain, a few important residues from the C-terminal domain also contribute to the 
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nucleotide binding. A lysine residue (Lys415) from the C-terminal β-hairpin was found to 
take a central position as it formed hydrogen bonds both with the amino acid and the 
nucleotide. The position of Lys415 is invariant in the four ApnA A1 PCC7821 complex 
structures. However, its interaction network varied slightly depending on whether the 
adenylation had occurred or not. In the obtained ApnA A1 PCC7821 complex structures, 
Lys415 formed hydrogen  onds to O4’ and O5’ of the nu leotide. In adenylate  ound 
structures there were additional hydrogen bonds to the O1P atom of the phosphate group 
and to the carbonyl oxygen of the amino acid. While the latter one also exist in the 
complex model with AMP-PNP and L-arginine, the former one is replace with hydrogen 
bond between Lys415 and the -phosphate group when AMP-PNP is bound to the active 
site.  
In addition to Lys415, two other residues, Arg409 and Arg420, from the C-
terminal domain appeared to have a role in the nucleotide binding. The former 
participated in the hydrogen bond network via interaction with O2 of the α-phosphate 
group. Arg420 on the other hand interacted with the one of the α-phosphate oxygens and 
also forms a salt bridge with the Glu303. 
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Figure 62. The residues involved in the nucleotide binding in ApnA A1 PCC7821. Most of these residues 
are highly conserved and form specific interactions with the bound substrate. Their location in the active 
site is shown here in the presence of tyrosyl adenylate (in yellow). Both the tyrosyl adenylate and the active 
site residues are shown as sticks. The active site residues are coloured in lilac while the rest of the protein is 
shown in light gray (cartoon representation). 
 
4.4.3.4 Amino acid binding pocket 
The ApnA A1 structures with amino acid substrate bound, both in adenylated form 
(L-arginine and L-tyrosine) and as free amino acid (only L-arginine) were used to identify 
the residues that have specific interaction with the substrate and thus contribute the most 
to the binding specificity of the enzyme. The majority of the residues that surround the 
amino acid in the active site of ApnA A1 PCC7821 appeared to be hydrophobic or polar 
in nature. These were postulated to have a role in modifying the size of the binding 
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pocket since they interacted with the substrate mainly through hydrophobic interactions. 
Two valine residues, Val201 and Val298 lie in opposite sides of the active site with the 
side chain of the amino acid substrate sandwiched between them. Similarly, the side chain 
of Ala307 and the main chain atoms of Ile272 and Gly273 were positioned on the 
opposite faces of the amino acid binding pocket. The binding pocket is capped by the side 
chains of Ile271 and Tyr183. Tyr183 is also involved in the hydrogen bond network with 
the substrate through Glu204 to which it is coordinated via its OH-group. Two conserved 
residues Asp200 and Gly300 are coordinated to the α-aminogroup of the substrate in a 
similar manner than Asp235 and Gly324 in PheA. Asp200 forms hydrogen bond to the α-
aminogroup through its side chain carboxyl oxygen OD1 whereas Gly300 interacts with 
the substrate via its main chain carbonyl oxygen. Also Ile306 participates to this network 
 y forming a hydrogen  ond to the α-aminogroup via its main chain carbonyl oxygen. In 
order to form this interaction, Ile306 has adopted an unfavorable conformation based on 
the dihedral angles that are outside the allowed region in Ramachandran plot 
(Ramakrishnan&Ramachandran, 1965). In tyrosyl adenylate, arginyl adenylate and in the 
AMP-PNP containing structures with and without the L-arginine, the corresponding ϕ 
angles for the Ile306 are 85°, 87°, 84° and 84°, and Ψ angles -63°, -59°, -69° and -65°, 
respectively. Same phenomenon was also observed for the corresponding isoleusine 
(Ile330) in PheA structure, which indicates that this residue has an important role in the 
amino acid binding. Finally, two residues lying at the bottom of the binding pocket were 
observed to have specific interaction with the side chain of the amino acid substrate. 
These glutamate (Glu204) and serine (Ser243) residues were both coordinated to the 
substrate through their side chain but had variations in the coordination chemistry 
depending on the bound substrate and also whether the adenylation reaction had occurred 
or not. Details of this will be described further. Figure 63 shows the composition of the 
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amino acid binding pocket in ApnA A1 PCC7821 with the tyrosyl adenylate complex 
structure as an example.  
 
 
Figure 63. The amino acid binding pocket of ApnA A1 PCC7821. The residues that in ApnA A1 PCC7821 
are involved in forming the amino acid binding pocket are shown here in the presence of tyrosyl adenylate 
(in yellow). A group of hydrophobic residues, namely Val201, Ile271, Val298 and Ala307 spread around 
the side chain of the amino acid substrate and putatively affect on the shape of the pocket. Asp200 and 
Gly300 are two  onserved residues that intera t with the α-aminogroup of the bound ligand. Two residues, 
Ser243 and Glu204 appear to have more unique role in the amino acid binding and in case of the tyrosyl 
adenylate, form hydrogen bonds to the OH-group of the tyrosyl side chain. 
 
The recognition of the correct substrate lies in the residues surrounding it. The 
comparison of the three ApnA A1 PCC7821 structures representing the binding of the 
amino acid prior to the adenylation reaction (for L-arginine) and after it (for both L-
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arginine and L-tyrosine) two residues with putative role in recognition of the substrate 
were identified. These residues, Glu204 and Ser243 are located at the bottom of the 
amino acid binding pocket and appear to function as docking residues for the substrate 
side chain, Glu204 through its side chain carboxylic acid group and Ser243 through its 
hydroxyl group (Figure 64). Their interaction with the substrate appears to be dependent 
on both the nature of the substrate but also on the reaction state. In the case of Glu204 this 
difference arises form the rotation of its side chain carboxylic acid group whereas with 
Ser243 the changes in the side chain conformation of the arginine substrate in two 
separate states mediates the change in the coordination chemistry. 
The most apparent difference in the coordination of Glu204 with the substrate is 
seen with the binding of the adenylated amino acid.  In the presence of tyrosyl adenylate, 
the carboxylate group of Glu204 is rotated so that it forms hydrogen bond to the OH-
group of tyrosine through its OE1 oxygen (Figure 64A). In this conformation Glu204 also 
forms a hydrogen bond to nearby tyrosine residue (Tyr183). However when arginyl 
adenylate is bound to the active site, the carboxyl group of Glu204 is rotated to enable the 
formation of a salt bridge with the guanidium group of the arginyl adenylate (Figure 
64B). This interaction compensates the positive charge of the arginine substrate in 
otherwise relatively hydrophobic/polar environment, which is more adopted for tyrosine 
binding. It also abolishes the hydrogen bond between Tyr183 and Glu204. Surprisingly, 
the salt brigde does not seem to exist prior to the adenylation reaction as was observed for 
the L-arginine in the presence of AMP-PNP (Figure 64C). Instead the arginine substrate 
forms a hydrogen bond to the OE1 oxygen of Glu204 through its NH2 atom hydrogen. 
The observed change in the binding pattern between adenylated and free L-arginine 
results from the difference in the adopted rotamer in the two. Prior to the adenylation 
reaction an elongated conformation is observed for the arginine substrate allowing it to 
 183 
protrude deeper into the binding pocket. Interestingly upon the formation of the arginyl 
adenylate the side chain of the amino acid substrate adopts a conformation that mimics 
the shape of the tyrosine side chain. In this conformation similar binding pattern with 
Ser243 is observed for both the arginyl adenylate and for the tyrosyl adenylate. The 
interaction with Ser243 occurs via water molecule through which it forms hydrogen 
bonds to the hydroxyl group of tyrosine and NH1 of arginine in the tyrosyl adenylate and 
arginyl adenylate structures, respectively. In the arginine and AMP-PNP containing 
complex the Ser243 forms a direct, though rather long (3.2 Å) hydrogen bond to NH2 of 
arginine.  
 
 
Figure 64. The key residues involved in the amino acid recognition and binding in ApnA A1 PCC7821. A) 
– C) The binding network of Glu204 and Ser243 in the presence of the tyrosyl adenylate, arginyl adenylate 
and free arginine are shown. A nearby tyrosine residue (Tyr183) is also participating in the hydrogen bond 
network through interaction with Glu204.  
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In order to find residues that could play a role in the amino acid binding activity, 
the structure of ApnA A1 PCC7821 was aligned with selected A-domain or A-domain 
like structures with both amino acid substrate and nucleotide bound to the active site. The 
selected structures were for D-Alanyl Carrier Protein DltA from B. cereus (PDB code: 
3DHV, Du et al. 2008), for NRPS adenylation protein CytC1 from Streptomyces (PDB 
code: 3VNS, Ueki et al. publication not available) and for PheA. The DltA and CytC1 
structures Special focus was paid on residues that interacted with the side chain of the 
bound target of adenylation. As a result two non-conserved residues, which correspond to 
Val201 and Ala307 in ApnA A1 PCC7821 and flank the binding pocket, were noticed to 
have some correlation with the size of the substrate. In PheA that like ApnA A1 PCC7821 
has a substrate with a large side chain (phenylalanine) these residues were Ala236 and 
Cys331, i.e. residues with relatively compact side chain. On the other hand in the DltA, 
the amino acid binding pocket size was reduced by the replacement of leucine (Leu198) 
in the same position with Val201. However, the residue corresponding to Ala307 was 
also alanine (Ala302) in DltA. The most significant difference was in the structure of the 
D-Valine binding NRPS adenylation protein CytC1 where the active site size was 
noticeably reduced by the two flanking side chains of Phe209 and Phe315 corresponding 
to Val201 and Ala307, respectively. The overlay of the Val201 and Ala307 with the 
corresponding residues in DltA, CytC1 and PheA are shown in figure 65.  
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Figure 65. The structural alignment of selected four active site residues from ApnA A1 PCC7821 (in 
yellow), D-Alanyl Carrier protein DltA (in brown, PDB code: 3DHV), NRPS adenylation protein CytC1 (in 
grey, PDB code: 3VNS) and PheA (in dark green, PDB code: 1AMU). The size of the residues at the 
positions 201 and 307 (ApnA A1 PCC7821 numbering) appear to correlate with the size of the substrate. 
The residues and the bound substrates are shown as stick representation. 
 
4.4.6 Activity assays for the ApnA A1 PCC7821 mutants 
4.4.6.1 Enzymatic activity with the proteinogenic amino acid substrates 
The wild type ApnA A1 from P. agardhii strain PCC7821 is bi-specific enzyme 
that uses both L-tyrosine and L-arginine as substrate. The analysis of the ApnA A1 
PCC7821 complex structures indicated that a serine (Ser243) and a glutamate residue 
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(Glu204) have an important role in defining the substrate specificity of the enzyme. 
Additionally an alanine residue (Ala307) was suggested to have a suitable position in the 
active site to create mutants with specificity towards smaller substrates as illustrated in 
the figure. The role of the residues at positions 243 and 307 in determination of substrate 
specificity had previously indicated when ApnA A1 enzymes from different Planktothrix 
strains were characterized phylogenetically and biochemically (Christiansen et al., 2011). 
The authors of the study noted that enzymes with acidic residues at the positions 243 and 
307 were explicitly using basic amino acid as substrate.  
As an attempt to change the substrate specificity of ApnA A1 PCC7821, several 
variants were made by substituting the active site residue at position 204, 243 or 307 with 
another amino acid. It was hypothesized that replacement of the residue either in position 
243 or 307 with an acidic one would make the enzyme more suitable for basic amino 
acids and vice versa. As Glu204 was expected to be particularly important for the 
arginine binding, it was replaced with the small glycine to see if this would abolish the 
enzymatic activity for the arginine substrate. The ApnA A1 PCC7821 mutants were then 
tested against the 20 canonical amino acids using the hydroxamine-trapping assay as 
described in the methods section. This assay has been originally developed to study the 
adenylation activity of NIS synthetases (Kadi & Challis, 2009) and was adopted to test 
the activity of the ApnA A1 PCC7821 variants. The results of the assay are summarized 
in figure 66. The significance threshold for the measurements was calculated based on the 
absorbance value and corresponding standard deviation from the measurements with the 
wild type enzyme in absence of substrates. This resulted in the significance threshold 
value of 0.08 in the activity assays with the proteinogenic amino acids. The absorbance 
values in the final graphs are the average from five replicates for wild type enzyme while 
the values for the variants were derived from duplicate measurements. 
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Figure 66. The summary of the hydroxylamine-trapping assay results for the wild type and the variants of 
ApnA A1 PCC7821.  The left bar indicates the tested amino acids, the upper bar the tested enzyme. The 
potential substrates are marked with + sign. Additionally the substrate with highest activity is marked with 
red colour whereas the substrate with detectable but lower activity is marked with yellow colour. Blue 
colour and – sign indicate very low or non-detectable activity. 
 
The results for the wild type ApnA A1 PCC7821 are shown in figure 67A. 
Similarly, the A307G, S243V and S243R variants showed activity only towards the two 
natural substrates, L-arginine and L-tyrosine (Figure 67B – D). The wild type behavior of 
the A307G variant is not suprising since the introduced mutation mainly provides more 
space in the active site rather than additional interaction partner for possible new 
substrates. However, the replacement of Ser243 with a large and the most bacic amino 
acid, arginine, was expected to have an effect on the catalytic activity. As it created an 
additional positive charge in the active site, it was postulated to drive the catalytic activity 
of the enzyme towards negatively charged residues or possibly inhibit the binding of the 
arginine substrate. One possible explanation for the observed wild type like behavior is 
the elimination of the added charge by a nearby glutamate residue (Glu205), which 
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locates near the putative catalytically important glutamate (Glu204). However, without 
structural information for the S243R variant, the reason for the observation remains 
speculative. 
 
 
Figure 67. The results of the hydroxylamine-trapping assay for the wild type ApnA A1 PCC7821 and the 
wild type like variants. A) As expected the wild type enzyme activated only L-arginine and L-tyrosine. B) - 
D) Similarly, three ApnA A1 PCC7821 variants, A307G, S243V and S243R were observed to have WT-
like behaviour and use L-tyrosine and L-arginine as substrates. 
 
Several ApnA A1 PCC7821 variants were found to be inactive or were considered 
as inactive due to a significantly reduced enzymatic activity. Especially the substitutions 
to position 307 often resulted in loss of enzymatic activity. These included the A307E 
variant, which was expected to prefer more basic amino acids, such as arginine and lysine 
as substrate based on the observations on the ApnA A1 enzymes in other Planktothrix 
strains (Figure 68A). Also the substitution of Ala307 with a larger polar residue did not 
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make the enzyme more prone to use smaller polar substrates as was observed with the 
A307F variant (Figure 68B). A possible explanation could be the loss of the correct 
protein folding or creation of environment that abolishes the substrate binding. The 
results for the rest of the A307 variants are shown in appendix 5. In addition to the 
number of Ala307 mutants, six of the tested Ser243 variants appeared as inactive. The 
results for S243E and S243K are shown as example in the figure 68C and D, respectively. 
A possible explanation for the inactivity of the former variant might be in the repulsion 
between the mutated residue and the two nearby glutamate residues (Glu204 and 
Glu205), which disables the folding of the protein. The abolished activity of the S243K 
variant was surprising as the similar S243R variant behaved like the wild type enzyme. 
The results for the four other inactive variants (S243C, S243I, S243Q and S243W) are 
presented in the appendix 5.  
 
 
Figure 68. Inactive variants of ApnA A1 PCC7821. The substitutions to position 307 and in some case to 
position 243 in ApnA A1 resulted in the loss of the enzymatic activity according to the hydroxylamine-
trapping assay. The results for the A307E, A307F, S243E and S243K variants are shown as example. 
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Interestingly, several ApnA A1 mutants showed altered substrate specificity 
according to the hydroxylamine-trapping assay. For a majority of these variants, the 
mutation had resulted to a shift from bi-specific to monospecific towards one of the 
original substrates, i.e. either towards L-tyrosine or L-arginine. From the tested variants, 
S243D and S243N appeared to prefer L-arginine as substrate (Figure 69A and B). This 
observation was in line with the initial hypothesis that more acidic substrate-binding 
pocket would be better adapted for basic amino acid substrates. The S243D variant also 
showed residual activity towards lysine, which further supported the theory. Why S243D 
variant was active and similar S243E variant was not, could be due to the longer side 
chain of glutamate when compared to aspartate. The one carbon difference is possibly 
enough to avoid the repulsion between the closely spaced negatively charged side chains. 
 
 
Figure 69. The hydroxylamine-trapping assay results for the S243D and S243N variants with specificity 
towards L-arginine. The S243D mutant appears to have residual activity for L-lysine as well, which is in 
line with the original hypothesis that added negative charge would create an enzyme more suitable for 
positively charged amino acids. 
 
The monospecificity to L-arginine is not unusual since it has been observed with 
ApnA A1 enzymes from other Planktothrix strains as indicated in the study by 
Christiansen et al. (2011). However, an ApnA A1 enzyme that would explicitly use L-
tyrosine as substrate has not been isolated so far according to the current knowledge. 
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Interestingly, a majority of the active ApnA A1 PCC7821 variants activated solely L-
tyrosine. These included A307V and A307L from the Ala307 variants and S243L, 
S243M, S243P and S243Y from the Ser243 variants (Figure 70A – F). The common 
factor for these monospecific variants was that the introduced mutation increased the 
hydrophobic surface in the amino acid binding pocket. This presumably provides a more 
optimal enviroment for the aromatic side chain of L-tyrosine and thus enhanced the 
enzymatic activity for this substrate.  
 
 
Figure 70. The ApnA A1 PCC7821 variants that preferred L-tyrosine as a substrate according to the 
hydroxylamine-trapping assay. A) – B) The substitution of Ala307 with slightly larger aliphatic amino acid 
provided additional hydrophobic surface in the active site and thus more favorable enviroment for L-
tyrosine substrate. C) – F) Similarly the introduced hydrophobic or polar residue with larger side chain at 
position 243 appeared to favor L-tyrosine activation.  
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The most interesting group of ApnA A1 PCC7821 variants appeared to have 
acquired capability to activate an amino acid other than L-tyrosine or L-Arginine. Some 
still possessed WT-like activity as well but a few clearly preferred the new amino acid 
substrate. The mutants of the former type included S243G, S243T and E204G. The two 
serine mutants appeared to be able to adenylate in addition to the wild type substrates also 
L-tryptophan (Figure 71A and B). The E204G variant differed from S243G and S243T in 
that it appeared to be unable to activate L-arginine (Figure 71C). The most plausible 
explanation for this observation was the loss of the important salt bridge between the L-
arginine substrate and the glutamate residue. Interestingly, in one of the ApnA A1 
PCC7821 variants the introduced mutation resulted in loss of wild type activity and 
instead L-tryptophan was preferred as a substrate. In this variant the active site serine 
(Ser243) had been substituted with histidine (Figure 71D). The change in the specificity 
could be exlained through favorable interaction between the histidine and the substrate 
via ring stacking and specific hydrogen bonds. However, without structural information 
the reason for the observed activity can only be speculated.  
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Figure 71. The ApnA A1 PCC7821 variants that were observed to activate L-tryptophan in addition or 
instead of the native substrates, L-arginine and L-tyrosine.  
 
As described earlier, the S243E variant was found to be inactive althought based 
on initial predictions it was assumed to activate basic amino acids, i.e. L-arginine and L-
lysine. The inactivity was proposed to result from the repulsion between the introduced 
negatively charged glutamate and the nearby active site glutmates (Glu204 and Glu205). 
Threfore a double mutant, where Glu204 was substituted with a glycine and Ser243 with 
a glutamate, was made. Surprisingly, the double mutant was found to activate mainly L-
tryptophan (Figure 72). A partial explanation for the observed behaviour could be an 
increase in the size of the binding pocket due to the replacement of the glutamate residue 
with the small glycine. 
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Figure 72. The hydroxylamine-trapping assay results for the E204G/S243E double mutant of ApnA A1 
PCC7821. The double variant appeared to activate explicitly L-tryptophan as shown here. 
 
4.4.6.2 Unnatural amino acids as substrate candidates 
The conducted hydroxylamine-trapping assays for the ApnA A1 PCC7821 
variants showed that the substrate specificity of the enzyme could be altered. In few cases 
the ApnA A1 PCC7821 variant was able to adenylate a new substrate, namely L-
tryptophan either in addition to the native substrates or as the only substrate. However, 
the activity of the mutants was tested only for the canonical proteinogenic amino acids. 
As the A-domains of NRPSs are known to use also non-proteinogenic residues as 
substrates, it was interesting to investigate whether the specific ApnA A1 PCC7821 
variants with altered specificity would be able to use unnatural amino acids as substrate. 
Two unnatural amino acids, 4-Azido-phenylalanine (Az) and 4-Fluoro-phenylalanine (Fl) 
(Figure 73A and B) were chosen since they possess an aromatic ring and thus shared 
 195 
resemblance with the natural substrates of the studied enzyme. The ApnA A1 PCC7821 
mutants chosen for testing were E204G, E204G/S243E, S243H, S243T and S243N. The 
first four were capable of adenylating L-tryptophan, whereas S243N was monospecific 
for L-arginine. The WT enzyme was also tested for comparison and to define the 
significance threshold for these measurements. The calculated significance threshold 
value was 0.06. The WT ApnA A1 PCC7821 and the chosen variants were also tested 
against L-tyrosine, L-arginine, L-tryptophan and L-glycine as a control.  
 
 
Figure 73. Two unnatural amino acids were chosen as substrate candidates for a selected set of ApnA A1 
PCC7821 variants. A) The 4-Azido-phenylalanine (Az) resembles the native substrates as it has aromatic 
ring and positively charged group at the end of the side chain. B) 4-Fluoro-phenylalanine is similar to Az 
with the exception of the missing positive charge at the side chain.  
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As expected, the WT ApnA A1 PCC7821 activated mainly its native substrates 
(Figure 74A). Interestingly, the tested variants appeared to accept the unnatural amino 
acids as substrates with the 4-azido-phenylalanine as a better substrate candidate. For the 
E204G variant 4-azido-phenylalanine appeared as equally good and preferred substrate 
with L-tyrosine (Figure 74B). The enzyme variant was also capable of activating 4-
Fluoro-phenylalanine at the comparable level with L-tryptophan. The E204G/S243E 
double variant showed nearly equal activity towards the tested unnatural amino acids as 
towards the preferred L-tryptophan substrate (Figure 74C). In the case of S243N, the 
enzyme had an apparent preference for L-arginine but from the tested aromatic substrates, 
4-azido-phenylalanine came out as the strongest candidate (Figure 74D). The S243T 
mutant appeared to have most relaxed specificity as it activated the tested unnatural 
amino acids, L-tryptophan and the two native substrates at comparable levels based on 
the measured absorbance values (Figure 74E). Finally, S243H showed very interesting 
behaviour. As described in the previous chapter, this enzyme variant was virtually 
monospecific for L-tryptophan when tested against the 20 proteinogenic amino acids. 
However, it appeared that the unnatural amino acid 4-Azido-phenylalanine was even 
slightly better substrate for this S243H variant than L-tryptophan (Figure 74F). 
Additionally, the enzyme appeared to be able to adenylate 4-Fluoro-phenylalanine but not 
as efficiently as the two substrates mentioned above. 
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Figure 74. A selection of ApnA A1 PCC7821 variants was tested against unnatural amino acids 4-Azido-
phenylalanine (Az) and 4-Fluoro-phenylalanine (Fl) alongside with the wild type enzyme. A) The wild type 
enzyme preferred as expected its natural substrates based on the measured A540-values. B) - F) All of the 
five tested ApnA A1 PCC7821 variants showed activity towards the unnatural amino acids. 4-Azido-
phenylalanine was the preferred substrate out of the two. 
 
4.4.6.3 Active site lysine 
Previously it has been shown that the catalytically important lysine residue arises 
from the conserved sequence motif PxxxxGKxx(R/K), located at the end of the C-
terminal domain in adenylation subunits (Marahiel et al., 1997; Gulick, 2009). The 
corresponding lysine (Lys500) of ApnA A1 PCC7821 was part of a putative C-terminal 
loop with no observable electron density even in the presence of substrate. Furthermore, 
due to the orientation of the C-terminal domain in ApnA A1 PCC7821, another conserved 
lysine (Lys415) had taken the position of the presumably catalytic lysine (Figure 75). The 
Lys415 (Lys434 in PheA) is part of the conserved motif that also includes the hinge 
region and forms similar hydrogen bond network in the active site as the Lys517 in PheA. 
In PheA structure a lysine (Lys517) corresponding to Lys500 of ApnA A1 PCC7821 is 
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the central coordinating residue in the active site and interacts both with the AMP and the 
phenylalanine molecule. To study the possibility that Lys415 would take the role of 
Lys500, single substitutions to these two positions were made by replacing the lysine 
with an alanine. Additionally, a double variant where both lysines were replaced with 
alanine was created. The hypothesis was that if these lysines would have ability to replace 
each other then only the double mutant should be completely inactive. The activity of 
these mutants was studied using the hydroxylamine-trapping assay as described in 
materials and methods. 
 
Figure 75. The two conserved lysines. The conserved lysine of the C-terminal domain, corresponding to 
Lys517 in PheA and Lys500 in ApnA A1 has shown to be important for the catalytic activity of the 
adenylating enzymes. The different C-terminal domain orientation in ApnA A1 PCC7821 results the 
replacement of this vital lysine with another conserved lysine residue, Lys415. The corresponding lysine in 
PheA, Lys434, is located further away from the active site. The Lys500 of ApnA A1 is on the other hand 
part of the putative C-terminal loop that appered to be disordered and could not be modeled.  
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The activity of the three lysine mutants, K415A, K500A and K415A/K500A was 
tested against the 20 canonical proteinogenic amino acids and compared to the activity of 
the wild type enzyme. As expected, the double mutant was shown to be inactive (Figure 
76A). However, when the single variants were tested it was found that Lys500 was 
indeed critical for the catalytic activity of the enzyme and the loss of this lysine could not 
be recovered by the lysine at position 415 (Figure 76B and C). The K500A variant had no 
enzymatic activity whereas the K415A variant was fully active and behaved as the wild 
type enzyme. 
 
 
Figure 76. The results for the lysine variants of ApnA A1 PCC7821 from the hydroxylamine-trapping 
assay. A) The K415A/K500A double mutant showed the expected lack of enzymatic activity. B) The 
K500A variant was also inactive, which supports its critical role as a catalytic residue. Lys415 is not able to 
recover the loss of catalytic activity. C) K415A mutant of ApnA A1 PCC7821 shows similar activity to 
wild type, which indicates that this lysine is not required for the adenylation reaction to occur. 
 
 
 
 
 
 
 200 
5. DISCUSSION 
5.1 Ethylene receptor 1 
5.1.1 The expression and isolation of the full-length ETR1 
The plant hormone ethylene and its signaling pathway have been the topic of 
intense research for years. This can be attributed to the central role of ethylene as a 
regulator of several important developmental processes and responses to both biological 
and environmental stress factors in plants. The well-known effect of ethylene in fruit 
ripening has also made it an amenable target for industrial applications. Ethylene is 
known to bind to ER-located receptors, which resemble the prokaryotic sensor histidine 
kinases. Like ethylene receptors, these sensor histidine kinases are involved in mediating 
responses to environmental changes. In the model plant Arabidopsis thaliana, a group of 
five ethylene receptors initiate a signaling cascade that is known to include a putative 
MAPKKK called CTR1 and a member of NRAMP metal ion transporter family, EIN2. 
Ethylene signaling represents an interesting signaling pathway where prokaryotic-like 
sensor histidine kinase at the ER-membrane regulates its pathway together with a 
MAPKKK, a canonical eukaryotic signaling component. 
Despite the accumulated knowledge on the molecular determinants in ethylene 
signaling pathway, very little is known how the signal is mediated from the 
transmembrane domain of the receptor to its cytosolic domains and further to the 
downstream components such as CTR1. The structural characterization of a full-length 
ethylene receptor would provide the means for better understanding of these initial steps 
in the signaling pathway. Since the ethylene receptor ETR1 from A. thaliana is the best-
characterized member of its family and shorter constructs of it had been studied in the 
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group before, it was chosen as a main target for the structural studies in this thesis work. 
A published protocol for the expression and purification of ETR1 (Voet-van-Vormizeele 
& Groth, 2008) was used as a starting point.  
The expression of the full-length ETR1 in E. coli was attempted using the 
published protocol. To this end, both the gene for the receptor from A. thaliana cDNA 
library and the synthetic ETR1 gene codon-optimized for E. coli were cloned into the E. 
coli expression vector pET15b, which added an N-terminal His6-tag to the target protein 
for affinity purification. Additionally, both the native gene and the synthetic one were 
cloned into two other E. coli expression vectors (pETM-11/LIC and 
pETM11SUMO3GFP) to examine if this would have influence on the expression. The 
expression tests were mainly conducted in the E. coli C41(DE3) and C43(DE3) strains, 
which are more suited for membrane protein expression (Miroux & Walker, 1996) and 
according to Voet-van-Vormizeele and Groth (2008) were successfully used to produce 
ETR1. However, the attempts to express the receptor protein in E. coli were not 
successful. As a stable expression using baculovirus expression vector system was 
achieved, the production of the protein in E. coli was not pursued further. 
When the expression of ETR1 in E.coli was proven to be challenging, alternative 
expression systems more adapted to eukaryotic protein expression were investigated. As 
Dr. Imre Berger was a member of the Thesis Advisory Committee (TAC), this provided 
the opportunity to test ETR1 expression in the Multibac expression system developed in 
the Berger lab at EMBL Grenoble. The multibac expression system is a baculovirus 
expression vector system (BEVS) that is especially suited for production of large 
eukaryotic complexes (Berger et al., 2004; Fitzgerald et al., 2006; Bieniossek et al., 
2008). For the expression of ETR1 in Multibac system, the synthetic E. coli codon-
optimized gene of the receptor protein in a pFastBac HTa vector was ordered form 
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GenScript (GenScript USA Inc., Piscataway, USA). The integration of the target gene 
into the baculoviral genome was carried out in E. coli stain DH10EMBacY, which carries 
the baculaviral DNA as an artificial chromosome. The production of the initial virus (V0), 
virus amplification as well as the expression of the target protein was performed in 
Spodoptea frugiperda Sf21 cells using HyClone culture medium. For the protein 
expression, the insect cells were infected with the amplified (V1) virus and kept in 
constant density until the day of proliferation arrest after which they started to express the 
target protein. The protein levels of the simultaneously expressed YFP were monitored to 
determine when the maximal expression level for ETR1 was reached. During the initial 
virus amplification, it was noticed that 48 hours after dpa the cells started to disrupt 
resulting in significant loss of viable cells. The most probable cause for this was 
suggested to be the insertion of the overexpressed target protein into the cell membrane. 
Therefore, in the large-scale expression trials the cells were harvested at the 48
th
 hour 
after dpa. The successful expression of the target protein was confirmed by SDS-PAGE 
analysis and Western blot.  
After the expression of ETR1 was established, the next step was to isolate and 
purify the receptor from the insect cells. A modified protocol for membrane protein 
isolation from E. coli cells was used. The buffers in the initial experiments included TRIS 
pH 7.6 and 100 mM NaCl as the main components and 0.5% n-dodecyl-β-D-maltoside 
(DDM) as the detergent in the solubilization step. The non-ionic DDM was chosen as the 
detergent since it commonly used in isolation of membrane proteins and thus provided a 
good starting point. In the first isolation trials, the majority of the protein appeared to 
remain in the insoluble protein fraction. This indicated that the composition of the buffers 
was not optimal as the pH of the buffer and the salt concentration can have an effect on 
the solubilization capacity of the detergent. Therefore as an attempt to improve the 
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isolation process the pH and NaCl concentration were varied. Both increased and 
decreased pH was tested in combination with lower and higher salt concentration. 
Additionally, the DDM concentration in the solubilization step was increased from 0.5 % 
to 1.0 %. More protein was recovered in the initial lysis step when TRIS at pH 8 and 
NaCl concentration 20 mM was used but the solubilization was still not successful.  
The full-length ETR1 was successfully expressed in insect cells during this thesis 
work. Additionally encouraging results were obtained from the initial isolation and 
solubilization attempts. The main bottleneck in this step appeared to be in the final 
overnight solubilization step, which indicates that the chosen detergent might not be 
suitable. Therefore for future prospects several detergents should be screened. Possible 
candidates for testing would be other non-ionic detergents such as octyl-β-D-
glu opyranoside (β-OG), polyoxyethylene-(9,5)-p-t-octylphenol (Triton X-100) or Tween 
20/40/80, or ionic ones such as N,N-Dimethyldodecylamine-N-oxide (LDAO) or 3-[(3-
Cholamidopropyl)dimethylammonium]-1-propanesulfonate (CHAPS). The main 
challenge is to find a detergent that would solubilize the protein without affecting its 
stability. Ionic detergents are usually relatively harsh and might denaturate the protein 
when used at higher concentrations. Therefore the detergent screening would require not 
only investigation of suitable detergents but also their concentration.  
5.1.2 The SAXS model of ETR1-ΔTM 
The cytosolic portion of ETR1 (ETR1-ΔTM) was considered an intruiging target 
for structural studies since it provides the necessary elements for the interaction with the 
downstream signaling components, such as CTR1. Furthermore, an available expression 
and purification protocol existed for the ETR1-ΔTM  onstru t (Mayerhofer, 2011). The 
purified ETR1-ΔTM was prone to aggregate, whi h was pro lemati   on erning 
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structural studies. Previously, the addition of NDSB was shown to stabilize the protein. 
However, in the structural characterization of ETR1-ΔTM using SAXS, the presence of 
stabilizing NDSB component caused additional scattering effect and subsequently a 
buffer mismatch at higher angles of the scattering curve. The SAXS models in the 
presence of the NDSB compound indicated dimeric arrangement of the protein with an 
overall dumbbell shape (Mayerhofer, 2011). In the current study, a more SAXS 
compatible stabilizing agent was found from glycerol. The final SAXS data obtained in 
the presence of glycerol was of good quality and no additional scattering from the buffer 
was observed. The calculated Dmax-value of 190 Å as well as MM estimation from Porod 
volume (161 kDa) agreed with the MM of the dimeric molecule (130 kDa) while the 
obtained MMSAXS-value (53 kDa) from comparison with BSA standard was in line with 
the MM of the monomer (65 kDa). Therefore, based on the SAXS parameters determined 
from the scattering data, ETR1-ΔTM appered to exist in monomer-dimer equilibrium in 
the solution as was seen in the presence of NDSB. Both ab initio bead modeling and the 
rigid body refinement using crystallographic high-resolution structures resulted in the 
expected dumbbell shaped dimer with the GAF domains at the top and the CA and 
receiver domains at the bottom of the central helical bundle. The overall dimensions of 
the dimer in presence of glycerol were slightly larger than in the presence of NDSB, 
which appeared to result from the flexible movement of the receiver domain. To this end, 
a flexibility analysis was performed using EOM approach. The results from this analysis 
indicated a possible switching between a more extended and more compact 
conformations with Rg-values of 54 Å and 51 Å, respectively. The more abundant species 
has the Rg of 54 Å, which correlates well with the Rg-value of 56 Å from the rigid body 
modeling.  
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In the current study, the main aim for the ETR1-ΔTM  onstru t was to find 
stabilizing purification conditions that would allow the collection of SAXS data without 
scattering effect from the buffer components. This was achieved by replacing the NDSB 
compound with glycerol and resulted in better fit at the higher angles in the structural 
modeling. The obtained ab initio and rigid body models confirmed the dimeric 
arrangement of ETR1-ΔTM with an overall dum  ell shape as was seen in the presen e 
of NDSB. The observed flexibility at the C-terminal end of the construct could possibly 
be result from the lack of the cytosolic interaction partner, CTR1. Therefore for future 
prospects, structural studies in the presence of CTR1 should be done.  
5.2 EDR1 
The mitogen-activated protein kinases (MAPKs) play a crucial role in wide 
variety of cellular responses in eukaryotic organisms. They are involved in signaling 
cascades that regulate developmental processes, stress responses and apoptosis, among 
others. The protein kinase Enhanced Disease Resistance 1 (EDR1) from Arabidopsis 
thaliana is a Raf-like MAPKKK that acts as negative regulator of plant defence and 
programmed cell death. The Arabidopsis plants that carry a mutation in the edr1 gene 
display enhanced disease resistance to powdery mildew, which is caused by the fungus 
Erysiphe cichoracearum (Frye & Innes, 1998, Frye et al., 2001). EDR1 has been linked 
to several plant signaling cascades, such as abscisic acid, jasmonic acid and ethylene 
signaling pathways (Frye et al., 2001). It shares high sequence identity with another A. 
thaliana MAPKKK, CTR1, which negative regulates ethylene-signaling pathway. EDR1 
has been shown to be involved in regulation of ethylene-induced senescence but not via 
the main ethylene signaling pathway based on the triple response assays (Frye et al., 
2001).  
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5.2.1 Autophosphorylation activity of EDR1 kinase domain 
The A. thaliana EDR1 has previously been shown to possess Ser/Thr kinase 
activity and furthermore to be able autophosphorylate in trans. The autophosphorylation 
is not an uncommon phenomenon among protein kinases and is linked to the activation of 
the enzyme through phosphorylation of flexible activation segment. Furthermore, the 
activation of protein kinases through phosphorylation has been shown to be in some cases 
dimerization dependent. Recent example of dimerization-dependent activation is the 
kinase domain A. thaliana CTR1, whi h was shown to form spe ifi  “ a  -to- a  ” 
dimers in the active, phosphorylated state (Mayerhofer et al., 2013). Mutations on the 
important dimer-interface residues led to inactivation of the enzyme. Due to its similarity 
with CTR1, EDR1 was also postulated to show similar dimerization-dependent 
behaviour. To this end, the kinase domain of EDR1 was cloned, expressed and purified 
for crystallization and subsequent structural characterization. 
The wild type EDR1 kinase domain was resistant to crystallization despite of the 
vigourous attempts. The SDS-PAGE analysis of the purified sample indicated the 
presence of a protein impurity, which had molecular mass near the target protein and 
could therefore not be removed by SEC. Based on the accurate mass analysis with ESI-
MS and peptide-fingerprinting experiments the purified enzyme sample contained 
multiple protein species in different phosphorylation states. The main protein species 
appeared to possess 3, 4 or 5 phosphorylated residues. The peptide-fingerprinting MS 
analysis with trypsin and chymotrypsin digested samples led to the identification of nine 
putative phosphorylation sites, which corresponded to the amount of predicted sites. As 
was observed with CTR1-kd, also the phosphorylations sites of EDR1 kinase domain 
concentrated on the activation segment.  
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The structural studies on the wild type EDR1 kinase domain were hampered due 
to the heterogeneity of the protein sample. As differently phosphorylated protein species 
appeared to be one source of the heterogeneity, a kinase inactive version of the enzyme 
was made. To this end, the catalytically important aspartate (Asp792) was substituted 
with asparagine. This aspartate is part of a conserved HRD (sometimes referred as HxD 
motif) and indicated to function as catalytic base that accepts the proton from the 
hydroxyl group of the target residue in phosphotransfer reaction (Hanks & Hunter, 1995). 
The EDR1-D792N construct was expressed and purified under similar conditions as the 
wild type enzyme. Based on the SDS-PAGE analysis the purified protein sample 
contained only the target protein and no additional protein species were detected. 
Additionally, an accurate mass analysis with ESI-MS was performed for EDR1-D792N to 
confirm the homogeneity of the purified sample. As expected, the most abundant protein 
species detected had a molecular mass of 32,008 Da, which corresponds very accurately 
the non-phosphorylated EDR1-D72N construct. To confirm the inactive state of EDR1-
D792N, a coupled-kinase assay was performed. In this assay the consumption of ATP is 
directly proportional to the oxidation rate of NADH, which could be measured. The 
EDR1-D792N showed no activity in this assay while for the wild type kinase domain 
appeared to be fully active and allowed the calculation of kinetics parameters according 
to Michaelis-Menten equation.  
 
5.2.1.1 EDR1 not activated by dimerization? 
The kinase inactive EDR1-D792N was successfully crystallized in the presence of 
nucleotide analog AMP-PNP. The crystals belonged to the space group P3221 and 
diffracted x-rays to 2.55 Å resolution. The asymmetric unit was found to contain two 
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molecules, which led to investigate the possibility whether similar back-back dimer 
would be observed as seen for CTR1. In the back-to-back dimer of CTR1, the central 
interactions at the interface are formed by three residues, Arg604, Phe611 and Met612. 
The corresponding residues of EDR1 (Arg722, Phe729 and Leu730) were found also to 
locate at the interface of the putative EDR1-D792N dimer. However, they were 
positioned at the periphery of the interface and were not interacting with their partner 
residues in the neighbouring molecule. Further examination of the interface by PISA 
revealed that the covered surface area was significantly smaller than expected for a back-
to-back interface. Therefore it became clear that the dimeric arrangement observed in the 
crystal structure of EDR1-D792N differed from the expected back-to-back interface. This 
difference was also easy to detect by visual inspection of the surface models for the 
EDR1-D792N crystal structure and the CTR1-kd dimer (Figure 77A and B). It is 
questionable whether the inactive state of the enzyme is the reason for the observed 
packing as the kinase inactive CTR1-D676 also formed back-to-back dimer in the crystal 
structure. Furthermore, when the oligomerization state of EDR1-kd and EDR1-D792N 
was examined using SEC-LS/UV/RI, it was found that both the wild type kinase domain 
and its inactive version were primarily in monomeric form. Therefore it was concluded 
that the autophosphorylation activity of EDR1-kd is unlikely to be dependent on 
homodimerization.  
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Figure 77. The dimeric arrangement observed in the asymmetric unit of EDR1-D792N differed from the 
back-to-back dimer of CTR1. A) The surface representation of EDR1-D792N dimer as observed in the 
crystal structure. B) The back-to-back dimer of CTR1-kd (PDB code 3PPZ) shown as surface. 
 
5.2.1.2 AMP-PNP binding site 
The crystal structure of EDR1-D792N exhibited the expected bi-lobal 
organization of protein kinase. The active site of the enzyme located at the conserved 
position between the N-terminal and C-terminal lobe of the enzyme. Both copies of 
EDR1-D792N were found to have AMP-PNP bound to the active site. The position and 
the binding mode for the adenosine ring of the nucleotide analog were virtually identical 
in the two chains (Figure 78). Some minor differences could were found in the 
coordination network of the triphosphate unit due to the altered rotamer of Lys696 and 
Arg753 in the chain B. Lys696 was found to participate in salt bridge formation with 
Glu714 in chain B while in chain A it provided hydrogen bond to the oxygen of the β-
phosphate group. Similarly, Arg753 was only participating in the nucleotide binding in 
the chain A while in the chain B it was facing away from the active site and towards a 
EDR1-D792N molecule from adjacent asymmetric unit. 
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Figure 78. The overlay of AMP-PNP binding pocket for the EDR1-D792N chains A (in grey) and B (in 
gold).  A highly similar binding mode for the nucleotide between the two chains was observed. 
5.2.1.3 Enzyme-substrate complex of EDR1-D792N 
The overall fold of EDR1-D792N shared closest resemblance with the crystal 
structure of CTR1-D676N, which was in line with the high sequence homology between 
the two enzymes and also with the inactive state. The hallmark features that separate 
active kinase from an inactive one include a salt bridge between conserved lysine and 
glutamate residue (Lys696 and Glu714 in EDR1) and structural rearrangement of the 
activation segment and αC-helix (Kornev et al., 2006). The phosphorylation induced 
folding of the activation segment allows the formation of a short two-stranded β-sheet 
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(strands β6 and β9), whi h doesn’t exit in an ina tive  inase, often due to the lack of 
stable conformation for the activation segment. The chain A in EDR1-D792N crystal 
structure was found to have the characteristics of an inactive kinase. Due to the 
orientation of the αC-helix, the glutamate residue (Glu714) was pulled away form Lys696 
thus disabling the formation of the conserved salt bridge. Additionally, part of the 
activation segment was disordered and lacked stabile 3D organization. This comprised 
four residues preceding the P+1 loop at the C-terminal end of the activation segment. 
Surprisingly, the second molecule (chain B) in the asymmetric unit of EDR1-D792N was 
found to have fully folded activation segment. Furthermore, two threonine residues 
appeared to be phosphorylated despite the expected non-phosphorylated and inactive state 
of the protein. These phosphorylations located at positions 820 and 827 correlating with 
putative phosphorylation sites from the peptide fingerprinting analysis with the wild type 
enzyme. TPO820 aligned with known phosphorylation site of CTR1-kd (TPO704) while 
TPO827 adopted similar position with an assumed primary phosphorylation site of CTR1 
(SEP710) (Figure 79). The phosphate group of TPO827 was accommodated within the 
so-called basic pocket as seen for primary phosphorylation sites in other kinases.  
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Figure 79. The phosphorylation of the activation loop in the active-like EDR1-D792N molecule. EDR1-
D792N was observed to contain two phosphorylations at one of the molecules in the asymmetric unit. 
These phosphorylations located in the activation loop and had nearly identical position with two confirmed 
phosphorylation sites of CTR1-kd (numering in blue colour). The activation segment of CTR1-kd is shown 
in blue and of EDR1-D792N in gold with the phosphorylated residues as sticks for both. 
 
The observed difference in the phosphorylation state between the two molecules 
in the crystal structure of EDR1-D792N led to more detailed comparison. The structural 
alignment of the two chains revealed that the phosphorylated EDR1-D792N molecule 
possessed the described characteristics of an active kinase. Recently, similar phenomenon 
was observed in the crystal structure of the catalytically inactive PAK1 kinase domain 
(PAK1-KD
K299R/D389N
) where the asymmetric unit also contained two copies of the 
enzyme with one in inactive and the other in active conformation (Wang et al., 2011). 
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However, the observed dimeric arrangement for PAK1-KD
K299R/D389N
 represented the 
expected trans-autophosphorylation complex of protein kinases. The importance of 
similar transautophosphorylation complex had been previously shown for the receptor 
Ser/Thr kinase PknB from M. tuberculosis (Mieczkowski et al., 2008). However, the 
enzymes in the PknB complex were both in an inactive state. Interestingly, when the 
interfaces between EDR1-D792N molecules across different asymmetric units were 
examined, a putative enzyme-substrate complex was found. In this complex the partially 
disordered activation segment of the inactive EDR1-D792N molecule functioned as the 
substrate and protruded the active site of the neighbouring molecule in the active site. A 
serine residue (Ser824) was optimally positioned near the γ-phosphate group of the bound 
AMP-PNP and the side chain carboxyl oxygen of the mutated aspartate (Asp792). This 
appeared to mimic the situation prior to the phosphotransfer reaction, which involves 
deprotonation of the target hydroxyl group by the aspartate and subsequent nucleophilic 
atta   of the deprotonated hydroxyl group to the γ-phosphate. Similar phenomenon was 
observed in the crystal structure of PAK1-KD
K299R/D389N
, but for a residue from a different 
part of the activation loop. The reason for this appeared to be in the different folding 
pattern of the activation loop in EDR1-D792N when compared to PAK1-KD
K299R/D389N
. 
Additionally, the orientation of the protein molecules in the ES-complex differed in the 
two, based on the structural alignment of the EDR1-D792N enzyme-substrate dimer with 
the PAK1-KD
K299R/D389N
 structure (Figure 80). It has been previously proposed that the 
rotation of the molecules in relation to one another helps to orient the phosphorylation 
target to correct position in the active site. This could also explain the observed difference 
between the ES-complex of EDR1-D792N and PAK1-KD
K299R/D389N
. 
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Figure 80. The structural alignment of EDR1-D792N ES-complex with the corresponding one for PAK1-
KD
K299R/D389N
. Based on the overlay, the orientation of the molecules in the complex differed between the 
two. The inactive and active-like EDR1-D792N molecules are shown as dark green and gold cartoon 
representatios. The PAK1-KD
K299R/D389N
 ES-complex is shown in gray cartoon model. The figure also 
shows the different orientation of the partially unfolded activation loops for the two enzymes. These loops 
are coloured in purple and blue for EDR1-D792N and PAK1-KD
K299R/D389N
, respectively.  
 
To confirm the authentity of the ES-complex seen between the EDR1-D792N 
molecules from adjacent asymmetric units, the features of the interface were investigated. 
The residues from the αG-helix appeared to form a zipper-like organization that promoted 
the interaction between the two molecules. The importance of αG-helices in the ES-
complex formation was shown for the PknB protein kinase where mutations that 
disrupted the interaction between the αG-helices resulted in an inactive enzyme. Using 
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the mutational studies with PknB as an example, a phenylalanine (Phe881) and a valine 
(Val876) from the αG-helix of EDR1-kd were substituted with alanine. Addtionally a 
double alanine substitution was made. Indeed, the three αG-helix mutants of EDR1-kd 
were shown to be inactive in the coupled kinase assay. This supported the observations 
from the structural studies and gave a clear indication that the transautophosphorylation 
requires also in EDR1 the formation of αG-helix mediated ES-complex. 
 
5.3 ApnA A1 PCC7821 
5.3.1 Structural basis for the substrate recognition 
The A-domains of Non-ribosomal peptide synthetases have been extensively 
studied the past decades in order to understand the underlying features that define their 
substrate specificity. A combination of genetical and structural studies has been employed 
to gain information about the key residues at the active site of these enzymes. The main 
aim for these studies has been to obtain enzyme variants with altered substrate specificity 
that could then be used to create new biologically active peptides for a variety of 
industrial applications. The first breakthrough was the first crystal structure of PheA and 
the subsequent discovery of the so-called spe ifi ity  onferring  ode (“Sta helhaus 
 ode”), whi h defined a set of ten important a tive site residues (Sta helhaus et al., 
1999).  This code allowed the prediction of the catalytic activity for newly found A-
domains but also to some level to modify the activity of A-domains with known subtsrate 
specificity (Eppelmann et al., 2002; Stevens et al., 2006; Chen et al., 2009; Villiers & 
Hollfelder, 2011; Thirlway et al., 2012). However, the engineering of the known A-
domains has mainly led to variants with activity towards substrates that are similar to the 
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natural one. Structural information from A-domains with different substrate specificities 
would therefore provide the knowledge on the binding of the specific amino acids.  
Recently, a bi-specific A-domain was discovered from a cyanobacterium 
Planktotrix agardhii (Christiansen et al., 2011). The enzyme ApnA A1 is part of the 
initiation module in an Anabaenopeptin synthetase and is an interesting enzyme of its 
class since it is able to use both tyrosine and arginine as natural substrates. The side 
chains of these two substrates have very different chemical properties, which made it 
difficult to understand how the active site of the enzyme accommodates both of them. To 
understand the bi-specificity of this enzyme, X-ray crystallography was used to 
investigate ApnA A1 from a P. agardhii strain PCC7821. The plasmid with the gene for 
the wild type enzyme with an N-terminal His6-tag was obtained from G. Christiansen and 
the expression and subsequent purification was conducted in Hamburg University in the 
lab of Prof. A. Rentmeister. The crystallization experiments and data collection were 
done at EMBL Hamburg. 
The first structure for ApnA A1 PCC7821 was obtained in the unliganded form. It 
was noticed that structure consisted of residues 2 – 410, which covered mainly the N-
terminal domain of the enzyme. Based on a structural alignment, the fold of the 
unliganded ApnA A1 PCC7821 resembled the N-terminal domain of PheA (Figure 81). 
The lack of interpretable elecron density for the C-terminal residues 411-547 indicated 
that they were disordered, presumably due to a lack of stabilizing interaction between the 
N-terminal and C-terminal domain in the absence of the bound substrate. Indeed, when 
the native crystals of ApnA A1 PCC7821 were soaked in the presence of AMP-PNP, a 
non-hydrolyzable ATP analog, the C-terminal domain residues 411-444 and 452-492 
could be built into the model. The topology of the C-terminal domain was similar to the 
C-terminal domain of PheA. However, the overall conformation of ApnA A1 PCC7821 
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differed from PheA. Instead, ApnA A1 PCC7821 had adopted the so-called closed 
conformation similar to the one seen for the Acetyl-coenzyme A Synthetase from S. 
enterica (PDB code: 1PG4) and for DltA from B. subtilis (PDB code: 3E7W). Two 
arginine residues (Arg409 and Arg420) and a lysine (Lys415) from the C-terminal 
domain of ApnA A1 PCC7821 were found to interact with the bound nucleotide and thus 
promoted the observed overall conformation. The arginine residues and the lysine formed 
hydrogen  onds to the α- and β-phosphate groups of the AMP-PNP, respectively. The 
expected catalytic lysine (Lys500) from a conserved motif at the C-terminal domain was 
found not to locate at the active site but in fact was part of the unstructured C-terminus. 
Since Lys415 had taken the position of Lys500, it was initially hypothesized to be an 
alternative catalytic lysine. However, the substitution of Lys500 with alanine rendered the 
enzyme completely inactive while the variant with similar mutation at position 415 
behaved like the wild type enzyme. Therefore it was confirmed that Lys500 is also 
required for the catalytic activity in ApnA A1 PCC7821 while Lys415 is not. 
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Figure 81. The structural alignment of the unliganded ApnA A1 PCC7821 with PheA. The structure of 
ApnA A1 PCC7821 included only the N-terminal domain of the enzyme and had similar overall fold with 
the N-terminal domain of PheA. The two protein structures are shown as cartoon representation, ApnA A1 
PCC7821 in dark lilac, the PheA N-terminal domain in dark green and the C-terminal domain in yellow.  
 
The structure of the ApnA A1 PCC7821 in complex with AMP-PNP revealed that 
the nucleotide binding site located in a cleft between the two domains and shared the 
conserved elements with other adenylating enzymes. To gain insights into the amino acid 
binding and subsequently into the bi-specificity of ApnA A1 PCC7821, the crystal 
structure of the enzyme was solved in complex with AMP-PNP and L-arginine, and also 
in complex with the adenylated amino acid substrates, L-tyrosine and L-arginine. Despite 
the apparent difference between the side chains of these amino acids, it was found that 
both were surprisingly bound within the same binding pocket. The amino acid binding 
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pocket of ApnA A1 PCC7821 located at conserved position within the N-terminal domain 
as seen with other adenyalting enzymes and comprised a set of residues, which included 
most of the specificity-conferring code residues (Figure 82). The exception was the 
catalytic lysine (Lys500), the position of which was taken by Lys415 due to the 
alternative orientation of the C-terminal domain as decribed for the AMP-PNP complex. 
Three active site residues at positions 204, 243 and 307 were implied to have specific role 
in accommodating the side chains of the amino acid substrates. The importance of the 
residue at position 307 in discriminating between naturally occurring monospecific and 
bi-specific ApnA A1 variants had already previously been indicated when the enzymes 
from different Planktothrix species were studied (Christiansen et al., 2011). The 
corresponding alanine residue of ApnA A1 PCC7821 located at the edge of the binding 
pocket to allow van der Waals interactions with the side chain of the substrate. 
Additionally, based on the structural alignment of ApnA A1 PCC7821 with three known 
A-domain (PDB codes: 3DHV, 3VNS and 1AMU), there appeared to be some correlation 
between the side chain size of the residue at identical position with Ala307 and the amino 
acid substrate. The glutamate and serine residues at positions 204 and 243 at the base of 
the substrate-binding pocket were found to provide the key hydrogen bond partners for 
the bound substrate. The side chain carboxy group of Glu204 was observed to tilt slightly 
to allow formation of a bidentate salt bridge with the guanidium group of the arginine 
substrate. With the hydroxyl group of L-tyrosine substrate Glu204 formed a single 
hydrogen bond. The interactions with Ser243 occurred via a water molecule that 
functioned as a bridge between the substrate and the hydroxyl group of Ser243. 
Interestingly, in order to achieve the described coordination network and fit the shape of 
the pocket better, the side chain of the adenylated arginine adopted a conformation that 
mimicked the shape of the tyrosine side chain (Figure 83).  
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Figure 82. The specificity-conferring code residues at the active site of ApnA A1 PCC7821. The catalytic 
and invariant lysine residue (Lys500) is not shown since it was part of unstructured loop, which could not 
be built into the model. The residues as well as the bound arginyl adenylate are shown as sticks in cyan 
while the rest of the protein is shown as cartoon representation in light grey. 
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Figure 83. The side chain rotamer of the adenylated arginine mimicked the shape of the aromatic ring of 
tyrosine. The three active site residues, Glu204, Ser243 and Ala307 were considered to be important for the 
substrate binding of ApnA A1 PCC7821 based on structural and phylogenetic analysis. The alanine residue 
is packed against the side chain of the amino acid substrate, as shown here for the adenylated arginine. The 
Glu204 is either hydrogen bonded to the substrate, as seen with tyrosine or in the case of arginine forms a 
salt bridge to the guanidium group of arginine through its side chain carboxylate. 
 
The active site residues Glu204, Ser243 and Ala307 were reasoned to be optimal 
targets for mutational studies as their location and interaction with substrate indicated a 
high importance for the substrate binding and activity of the enzyme.  
5.3.2 Alteration of the ApnA A1 PCC7821 substrate specificity  
Previous studies on the ApnA A1 enzymes from seven different Planktothrix 
strains indicated that naturally occurring amino acid substitutions at specific positions 
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have an effect on the substrate specificity of the enzyme (Christiansen et al., 2011). More 
specifically, it was noted that the enzymes with acidic residue at the positions 243 and 
307 activated only basic amino acid substrates (arginine, homoarginine and lysine) while 
the enzymes with more neutral residues, namely serine and alanine at corresponding 
positions were able to use both basic and aromatic amino acids as substrates. The 
structural studies on a bi-specific ApnA A1 from P. agardhii strain PCC7821 supported 
the important role of both Ala307 and Ser243 in the substrate binding.  Additionally, 
Glu204 was found to be involved in the central hydrogen bond network with the side 
chain of the amino acid substrate. Based on the combined information from the studies by 
Christiansen et al. (2011) and the obtained results from the structural analysis for ApnA 
A1 PCC7821, a number of substitutions to the positions 204, 243 and 307 were made with 
the aim to change the substrate specificity of the enzyme. It was hypothesized that 
variants with more basic binding pocket would provide more optimal enviroment for the 
activation of acidic amino acids and vice versa. Additionally, the removal of hydrogen 
bond donor at the position 204 or 243 and its replacement with aliphatic amino acid were 
expected to favor binding of more hydrophobic/aliphatic amino acids. The substitution of 
the residue at position 307 with a larger hydrophobic residue was expected to create an 
enzyme variant with activity towards smaller hydrophobic/polar substrates. 
The standard method to study the activation of amino acids in adenylating 
enzymes is the ATP-pyrophosphate assay, which requires the use of radiolabeled ATP 
analog. However, the ApnA A1 PCC7821 variants were tested using a new assay known 
as hydroxylamine-trapping assay (see materials and methods for a detailed description), 
which has been successfully employed to determine the adenylation activity of NIS 
synthetases (Kadi & Challis, 2009). The assay was proven to be suitable for the activity 
studies of the target protein as the wild type enzyme showed the expected activation of L-
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tyrosine and L-arginine. In few instances also the enzyme variant behaved as the wild 
type enzyme presumably either due to negligible change in the active site by the 
introduced mutation (A307G) or due to compensation by the nearby residues (S243R). 
Interestingly, the majority of the active variants were found to be monospecific for L-
tyrosine. Substitution of the alanine at position 307 with a slightly larger non-polar 
residue (Val, Leu) eliminated the activation of L-arginine but retained the activity for L-
tyrosine. Similarly, the replacement of Ser243 with a non-polar (Leu, Met, Pro) or a 
larger polar residue (Tyr) resulted in an enzyme, which appeared explicitly activate L-
tyrosine. It was reasoned that a non-polar residue with a side chain of moderate size at 
position 307 provided additional surface for van der Waals interactions with the aromatic 
ring of tyrosine thus promoting its binding while the bulkier side chain of arginine can no 
longer be accommodated. The tyrosine substrate appeared to be better adjusted to the loss 
of a hydrogen bonding parther at position 243 when additional hydrophobic interactions 
were provided by the modified amino acid. 
The substitution to position 243 or 307 with acidic amino acids (Asp, Glu) was 
expected to create a variant that would activate mainly basic amino acids (Lys, Arg). 
Indeed, the S243D variant was shown to mainly activate arginine but also lysine but to a 
far less extent. Surprisingly, substitution of asparagine to position 243 also had a similar 
effect and the corresponding enzyme variant appeared monospecific for arginine. 
However, it was noticed that replacing Ala307 with charged amino acids resulted in an 
inactive enzyme, probably because it inpaired proper folding of the enzyme. Similarly, 
the S243E variant was found to be inactive.  
Most of the active ApnA A1 PCC7821 variants did not acquire new substrate 
specificity but rather lost the ability to activate one of the native substrates. However, in 
few instances the substitution led to activity for L-tryptophan. This often correlated with 
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the increased space in the active site, as was the case with the substitution of glycine 
either to position 204 or 243. Similarly, the introduced threonine into position 243 
appeared to create more space and also putatively additional hydrophobic contact for the 
large side chain of the tryptophan substrate. The S234G and S243T variants were also 
retained their wild type activity while the E204G variant no longer activated arginine. 
The latter observation indicated that this active site glutamate was critical for the binding 
of the arginine substrate. An interesting change in the activity was seen when histidine 
was substituted to position 243. The corresponding enzyme variant accepted only L-
tryptophan as substrate, possible through optimal ring stacking between the active site 
residue and the tryptophan substrate.  
5.3.3 From natural to un-natural amino acids 
The P. agardhii PCC7821 ApnA A1 provided a good starting point for alteration 
of the substrate specificity, as it is capable of adenylating two amino acids with very 
different chemical properties. Indeed, the mutants showed that the substrate specificity of 
the enzyme could be altered. However, the active variants appeared to prefer one of the 
native substrates or tryptophan, which similarly to tyrosine has a large, aromatic side 
chain. The attempts to change the active site suitable for smaller and/or acidic residues 
were not successful. As the A-domains of other NRPSs are known to use also non-
proteinogenic amino acids as substrates, the possibility that one of the ApnA A1 
PCC7821 variants would have also acquired specificity towards a non-proteinogenic 
amino acid was examined. Two unnatural amino acids, 4-azidophenylalanine and 4-
fluorophenylalanine with applications in bio-orthogonal click chemistry (Baskin & 
Bertozzi, 2007) were chosen as both had similar chemical properties with the native 
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substrate. Both 4-azidophenylalanine and 4-fluorophenylalanine contain a side chain with 
aromatic ring similar to tyrosine.  
Four single substitution variants (S243H, S243N, S243T, E204G) and the 
E204G/S243E double variant of ApnA A1 PCC7821 were tested as these were expected 
to have large enough binding pocket or the suitable environment for the activation of the 
unnatural amino acids based on the initial activation assays with the proteinogenic amino 
acids. All five were found to be able to activate the tested unnatural amino acids but to 
variable levels. 4-azidophenylalanine was better accepted as substrate candidate than 4-
fluorophenylalanine. Its activation was in general at equal or comparable level with the 
preferred proteinogenic substrate for the tested variants. However, the S243N and S243H 
variants appeared to be exceptions to this rule. The former showed lower levels of 
activation for the unnatural amino acid than for its preferred proteinogenic substrates L-
arginine. Surprisingly, the latter variant had a minor but still noticeable preference for 4-
azidophenylalanine over the tryptophan substrate.  
The NRPS system provides an efficient way to produce biologically active 
peptides for a number of purposes, including in pharmaceutical industry. The central role 
of A domains in defining which amino acid is incorporated to the peptide product, has 
made them a target of intense research the past decades. The discovery of specificity-
conferring code (Stachelhaus et al., 1999) was a breakthrough as it allowed the prediction 
and alteration of the substrate specificity of A domains. Also in the current study of the 
bi-specific cyanobacterial enzyme ApnA A1 PCC7821, it was found that the important 
substrate-binding residues were part of the specificity-conferring code. As in the previous 
studies with other A domains, a radical alteration of the substrate specificity of ApnA A1 
PCC7821 was proven to be challenging. However, specific mutants of ApnA A1 
PCC7821 were found to accept un-natural amino acids (4-fluorophenylalanine and 4-
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azidophenylalanine) as substrates, which has not been shown for other A domain 
according to current knowledge. Whether the unnatural amino acid can be incorporated 
into the final peptide product should be tested. As the use of recombinant DNA 
technology is possible in Planktothrix, this would provide possibility to test the 
functionality of the mutant A domain as part of the NRPS enzyme complex within the 
host organism. A possible problem might lie in the assumption that A domain is the only 
one carrying amino acid selection capacity, as recent studies have indicated that also the 
C domain has substrate specificity to some extent. However, if the incorporation of 4-
azidophenylalanine by the ApnA A1 PCC7821 variant would succeed, this could provide 
a mean to study the binding targets and localization of the produced anabaenopeptin 
within the living cell through click chemistry mediated labeling. 
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LIST OF ABBREVIATIONS 
A domain Adenylation domain 
ACC  1-aminocyclopropane-1-carboxylic acid 
ACO  ACC oxidase 
ACS  ACC synthase 
Acs  Acetyl-CoA synthase 
ACV  δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine 
ATP  Adenosine triphosphate 
BIIC  baculovirus infected insect cell 
BSA  Bovine serum albumin 
CA  catalytic ATP-binding 
CoA  Coenzyme A 
CTR1  Constitutive triple response 1 
DAMP  Damage-associated molecular patterns 
DHB  2,3-dihydroxybenzoate 
DhbE  2,3-dihydroxybenzoate (DHB) activating adenylation domain 
DHp  dimerization histidine phosphotransfer 
DltA  D-Alanine carrier protein 
dpa  day of proliferation arrest 
EBF1 & 2 EIN3-targeting F-box proteins 1 & 2 
EDR1  Enhanced disease resistance 1 
EIL  EIN3-like 
EIN2  Ethylene Insensitive 2 
EIN3  Ethylene Insensitive 3 
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EIN4  Ethylene Insensitive 4 
EOL1  ETO1-like1 
EOM  Ensemble optimization method 
EREBP Ethylene-Response-Element-Binding-Protein 
erf1  ethylene response factor 1 
ERS1 & 2 Ethylene Response Sensor 1 & 2 
ESI  electrospray ionization 
ETP1 & 2 EIN2 targeting protein 1 & 2 
ETO1  Ethylene overproducer 1 
ETR1 & 2 Ethylene receptor 1 & 2 
ETR1-ΔTM The cytosolic portion of ETR1 
GAF  cGMP-specific phosphodiesterase, adenylyl cyclases and FhlA 
GFP  Green Fluorescence Protein 
HR  Hypersensitive response 
IPTG  isopropyl-β-D-thiogalactopyranoside 
ISR  Induced systemic resistance 
LB  Luria-Bertani 
MALDI matrix-assisted laser desorption/ionization 
MAMP Microbe-associated molecular patterns 
MAPK  Mitogen-activated protein kinase 
MAPKKK Mitogen-activated protein kinase kinase kinase 
MS  mass spectrometry 
MTA  5'-methylthioadenosine 
NADPH Nicotinamide adenine dinucleotide phosphate 
NDSB  non-detergent sulfobetaine 
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NIS  NRPS-independent siderophores 
NMR  Nuclear Magnetic Resonance 
NRAMP Natural resistance-associated macrophage protein 
NRPS  Non-ribosomal peptide synthetase 
PAMP  Pathogen associated molecular patterns 
PCP  Peptide carrier protein 
PCR  Polymerase Chain Reaction 
PEG  Polyethylene glycol 
PheA  Phenylalanine adenylation subunit of Gramicidin S synthetase 1 
PPTase Phosphopanthetheinyl transferase 
PR  Pathogenesis-related 
PRR  Pattern recognition receptors 
PTI  PAMP-triggered immunity 
RAN1  Responsive-to-Antagonist 1 
SA  Salicylic acid 
SAR  Systemic acquired resistance 
SAXS  Small Angle X-ray Scattering 
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEC  size-exclusion chromatography 
SOC  Super optimal broth with catabolite repression 
S-Adomet S-Adenosyl-L-methionine 
TB  Terrififc Broth 
YFP  Yellow Fluorescence Protein 
 
 
 232 
Amino acids 
Alanine  Ala  A 
Cysteine  Cys  C 
Aspartate  Asp  D 
Glutamate  Glu  E 
Phenylalanine  Phe  F 
Glycine  Gly  G 
Histidine  His  H  
Isoleucine  Ile  I 
Lysine   Lys  K 
Leucine  Leu  L 
Methionine  Met  M 
Asparagine  Asn  N 
Proline   Pro  P 
Glutamine  Gln  Q 
Arginine  Arg  R 
Serine   Ser  S 
Threonine  Thr  T 
Valine   Val  V 
Tryptophan  Trp  W 
Tyrosine  Tyr  Y 
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Appendix 1 – The table of primers 
Table A1. The list of primers used to clone the main constructs. The abbreviation ETR1s stands for the 
synthetic gene of the receptor. The overlap with the inserted gene is underlined.  
Primer 
Type 
Target* Cloning 
site 
Primer sequence (5’  3’) 
Forward ETR1 LIC CAGGGCGCCATGATGGAAGTCTGCAATTGTATTGAACCG 
Reverse ETR1 LIC GACCCGACGCGGTTACATGCCCTCGTACAGTACCCG 
Forward ETR1 NdeI CATATGGAAGTCTGCAATTGTATTGAACCGC 
Reverse ETR1 BamHI GGATCCTTATTACATGCCCTCGTACAGTACCCG 
Forward ETR1 NcoI CCATGGAAGTCTGCAATTGTATTGAACCGC 
Reverse ETR1s LIC GACCCGACGCGGTTATTACATGCCTTCATACAGCACACGCGG 
Forward ETR1s LIC CAGGGCGCCATGGAAGTGTGTAATTGCATTGAACCGC 
Forward ETR1s NdeI GATCATATGGAAGTGTGTAATTGCATTGAACCGC 
Reverse ETR1s BamHI GACAGGATCCTCATTACATGCCTTCATACAGCACAC 
Forward ETR1s NcoI GATCCATGGAAGTGTGTAATTGCATTGAACC 
Forward EDR1 LIC TACTTCCAATCCAATGCCGATGATGCAGATGTTGGTGAATGTGAAATTCC 
Reverse EDR1 LIC TTATCCACTTCCAATGTTATTGTGGTGTAGGAAGTACAAGCCGGTTC 
* ETR1 gene with NCBI accession no. NM_105305 and EDR1 gene with NCBI accession no. NM_100745 
used for primer design. 
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Appendix 2 – Nucleotide sequence for the ApnA A1 
PCC7821 construct 
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Appendix 3 – The Thermofluor screens of EMBL 
Hamburg 
Table A2. Thermofluor Buffer screen developed at EMBL Hamburg (Boivin et al. 2013). 
 
Table A3. Additive screen for thermofluor experiments (Boivin et al. 2013). 
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Appendix 4 – MS protocol of Proteomics Core Facility 
at EMBL Heidelberg 
LC-MS for the determination of molecular weight 
The samples were treated with 1% trifluoroacetic acid (TFA) prior to injection 
into the Acquity UPLC System equipped with ACQUITY UPLC Protein BEH C4 
Column (300 Å, 1.7 µm, 2.1 mm X 150 mm, Waters Corporation, Milford, USA) for 
protein separation. The amount of injected sample was approximately 10 µg. The samples 
eluting out from the column were directly subjected to mass spectrometry analysis using a 
Q-TOF II mass spectrometer (Waters Corporation, Milford, USA). The sample ionization 
was conducted using a standard ESI source in positive ion mode.  The solvents used in 
the protein separation contained 0.1 % formic acid (aqueous solution, referred as solvent 
A) and 0.1% formic acid in acetonitrile (solvent B). The samples were loaded at a 
constant flow of 0.2 mL/min in a solvent mixture containing 96% solvent A and 4% B. 
The column was held at 4% B for 5 min before ramping to 25% B by 6 min.  This was 
followed by a linear gradient to 80% B until 17 min. 
For the Q-Tof, a spray voltage of 3.5 kV was applied with a cone voltage of 35 V 
and extraction cone at 5 V. The desolvation of the samples was conducted at 350°C while 
the source temperature was set to 120°C. Nitrogen was used as the desolvation gas at a 
flow rate of 500 l/min. Collision energy was set at 5 eV with argon in the collision cell at 
a pressure of 4.5 e-5 mbar.  Data was acquired in continuum mode over the mass range 
500-3500 m/z with a scan time of 0.5 s and an interscan delay of 0.1 s. Prior to sample 
data acquisition, an external calibration against a reference standard of intact myoglobin 
was performed. Spectra from the chromatogram protein peak were summed and the intact 
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mass was calculated using the MaxEnt1 maximum entropy algorithm 
(Waters/Micromass, Waters Corporation, Milford, USA). The molecular weight was 
obtained by deconvoluting to zero charge. 
 
Sample preparation for in-solution digestion 
 
For trypsin digestion the used reagents were dissolved in 50 mM ammonium 
bicarbonate while for chymotrypsin digestion buffer containing 100mM TRIS-HCl at pH 
8.0, 10mM CaCl2 were used. The digestion was performed using approximately 100 µg 
of protein, which was diluted to 1 µg/µL in the suitable buffer (50 mM ammonium 
bicarbonate for trypsin, 100mM Tris-HCl pH 8.0 and 10mM CaCl2 for chymotrypsin).  
Prior to the digestion, the protein was reduced by treatment with DTT (2.5 µL of 50 mM 
DTT/100 µl solution) at 56 °C for 30 minutes and alkylated by treatment with 
iodoacetamide (2.5 µL of 110 mM stock) at room temperature protected from light for 20 
minutes. The trypsin digestion (1 µL of a 1 µg/µL solution) was carried out overnight at 
37 °C and the chymotrypsin digestion at 25°C. 
 
LC-MS/MS of the digested protein 
 
The separation of the peptides was conducted using the nanoAcquity UPLC 
system (Waters Corporation, Milford, USA) equipped with a nanoAcquity Symmetry 
C18 trapping column (5µm, 180 µm x 20 mm, Waters Corporation, Milford, USA) and a 
nanoAcquity BEH C18 analytical column (1.7µm, 75µm x 200mm, Waters Corporation, 
Milford, USA).  The outlet of the analytical column was connected directly to an LTQ 
Orbitrap Velos Pro hybrid mass spectrometer (Thermo Fisher Scientific) using the 
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Proxeon nanospray source (ESI-source). Solvent A was 0.1 % formic acid in water and 
solvent B 0.1 % formic acid in acetonitrile. The samples were loaded with a constant flow 
of solvent A at 5 µL/min onto the trapping column using a trapping time of 6 minutes.  
The elution of peptides via the analytical column was conducted at a constant flow of 0.3 
µL/min. During the elution step, the percentage of solvent B was increased in a linear 
fashion from 3 % to 7 % in 10 minutes, then to 25 % in 20 minutes and finally to 40% in 
10 minutes.  The peptides were injected into the mass spectrometer via a Pico-Tip Emitter 
(360 µm OD x 20 µm ID; 10 µm tip; New Objective, Inc., Woburn, MA, USA) by 
applying a spray voltage of 2.2 kV. The capillary temperature was set to 300 °C. Full 
scan MS spectra with mass range 300-1700 m/z were acquired in profile mode in the FT 
with resolution of 30000. The maximal filling time was set at 500 ms with limitation of 
10
6
 ions. Up to 15 of the most intense ions from the full scan MS were selected for 
sequencing in the LTQ.  Normalized collision energy of 40 % was used. The 
fragmentation was carried out after accumulation of 3 x 10
4
 ions or after filling time of 
100 ms for each precursor ion depending on which occurred first. MS/MS data was 
acquired in centroid mode. Only multiply charged (2+, 3+, 4+) precursor ions were 
selected for MS/MS. The dynamic exclusion list was restricted to 500 entries with 
maximum retention period of 30s and relative mass window of 10 ppm. A lock mass 
correction was applied using a background ion (m/z 445.12003) in order to improve the 
mass accuracy. 
 
Data analysis 
 
The filtering of the data was performed using MaxQuant software (version 
1.1.1.36, Cox & Mann, 2008). The same software was used to create the .mgf files, which 
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were needed for searching in MASCOT version 2.2.03 (Matrix Science). The data were 
searched against a species-specific (Arabidopsis thaliana) Uniprot database with a list of 
common contaminants included. The data were searched with the following 
modifications: Carbamidomethyl (C) (Fixed) and Oxidation (M) (Variable), Phospho 
(ST).  The mass error tolerance for the full scan MS spectra was set at 20 ppm and for the 
MS/MS spectra at 0.5 Da. A maximum of 1 missed cleavage was allowed. Only peptides 
with a mascot score greater than 20 were reported. 
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Appendix 5 – Hydroxylamine assay results for inactive 
ApnA A1 PCC7821 variants 
 
Figure A1. The rest of the hydroxylamine-trapping assay results for the inactive ApnA A1 PCC7821 
variants with the substitution at position 243. A) – D) The substitution of Ser243 with larger polar or 
hydrophobic residue (cysteine, isoleusine, glutamine or tryptophan) resulted in inactive enzyme. 
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Figure A2. A) – L) The rest of the hydroxylamine-trapping assay results for the inactive ApnA A1 
PCC7821 variants with the substitution at position 307.  
